Books by Subject

Oncology

  • 2013 Springer
    M. Alma Rodriguez, Ronald S. Walters, and Thomas W. Burke, editors.
    Introduction / M. Alma Rodriguez -- History of MD Anderson's tumor registry / Sarah H. Taylor -- Statistical methods / Geoffrey G. Giacco, Sarah H. Taylor and Kenneth R. Hess -- Breast cancer / Aman U. Buzdar ... [et al.] -- Prostate cancer / Deborah A. Kuban ... [et al.] -- Non-small cell lung cancer / Ritsuko Komaki, Anne S. Tsao, and Reza J. Mehran -- Small cell lung cancer / Frank V. Fossella -- Colon cancer / Cathy Eng, Patrick Lynch, and John Skibber -- Ovarian cancer / Robert L. Coleman and David M. Gershenson -- Cervical cancer / Patricia J. Eifel and Charles Levenback -- Endometrial cancer / Thomas Burke ... [et al.] -- Pancreatic cancer (exocrine) / Jason Fleming ... [et al.] -- Kidney cancer / Scott E. Delacroix Jr. ... [et al.] -- Bladder cancer / Robert S. Svatek ... [et al.] -- Cutaneous melanoma / Jeffrey E. Gershenwald, Geoffrey G. Giacco, and Jeffrey E. Lee -- Liver cancer / Evan S. Glazer and Steven A. Curley -- Esophageal cancer / Linus Ho ... [et al.] -- Gastric cancer / Alexandria T. Phan and Paul F. Mansfield -- Acute myeloid leukemia / Emil J. Freireich -- Chronic lymphocytic leukemia/small lymphocytic lymphoma / Apostolia-Maria Tsimberidou and Michael J. Keating -- Hodgkin lymphoma / Michelle Fanale ... [et al.] -- Non-hodgkin indolent B-cell lymphoma / Sattva S. Neelapu -- Non-hodgkin aggressive B-cell lymphoma / M. Alma Rodriguez -- Multiple myeloma / Donna Weber and Raymond Alexanian -- Head and neck cancer / Ehab Hanna ... [et al.] -- Thyroid cancer / Steven I. Sherman, Nancy Perrier, and Gary L. Clayman -- Soft tissue sarcomas / Vinod Ravi, Raphael Pollock, and Shreyaskumar R. Patel -- Sarcomas of bone / Valerae Lewis.
  • 2005- HighWire
  • 2015 ScienceDirect
    edited by John D. Schuetz, Toshihisa Ishikawa.
    ABC Transporters and Cancer provides invaluable information on the exciting and fast-moving field of cancer research. Here, outstanding and original reviews are presented on a variety of topics. This volume covers ABC transporters and cancer, and is suitable for researchers and students alike.
  • 2014 ClinicalKey
    [edited by] John E. Niederhuber, James O. Armitage, James H. Doroshow, Michael B. Kastan, Joel E. Tepper.
    Part I. Science of Clinical Oncology -- Section A. Biology and Cancer -- 1. Molecular Tools in Cancer Research -- 2. Intracellular Signaling -- 3. The Cellular Microenvironment and Metastases -- 4. Control of the Cell Cycle -- 5. Pathophysiology of Cancer Cell Death -- 6. Cancer Immunology -- 7. Stem Cells, Cell Differentiation, and Cancer -- 8. Vascular and Interstitial Biology of Tumors -- Section B. Genesis of Cancer -- 9. Environmental Factors -- 10. DNA Damage Response Pathways and Cancer -- 11. Viruses and Human Cancer -- 12. Genetic Factors: Hereditary Cancer Predisposition Syndromes -- 13. Genetic and Epigenetic Alterations in Cancer -- 14. Immunodeficiency and Cancer -- Section C. Diagnosing Cancer -- 15. Flow Cytometry in Oncologic Diagnosis -- 16. WHO Classification of Hematologic Malignancies -- 17. Pathology, Biomarkers, and Molecular Diagnostics -- 18. Imaging -- Section D. Preventing and Treating Cancer -- 19. Biostatistics and Bioinformatics in Clinical Trials -- 20. Structures Supporting Cancer Clinical Trials -- 21. Oncology and Health Care Policy -- 22. Discovery and Characterization of Cancer Genetic Susceptibility Alleles -- 23. Cancer Prevention, Screening, and Early Detection -- 24. Nicotine Dependence: Current Treatments and Future Directions -- 25. Surgical Interventions in Cancer -- 26. Establishing and Maintaining Vascular Access -- 27. Basics of Radiation Therapy -- 28. Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents -- 29. Cancer Pharmacology -- 30. Hematopoietic Stem Cell Transplantation -- 31. Gene Therapy in Oncology -- 32. Therapeutic Antibodies and Immunologic Conjugates -- 33. Complementary and Alternative Medicine -- Part II. Problems Common to Cancer and its Therapy -- Section A. Hematologic Problems and Infections -- 34. Disorders of Blood Cell Production in Clinical Oncology -- 35. Diagnosis, Treatment, and Prevention of Cancer-Associated Venous Thromboembolism -- 36. Infection in the Patient with Cancer -- Section B. Metabolic and Paraneoplastic Syndromes -- 37. Hypercalcemia -- 38. Tumor Lysis Syndrome -- 39. Paraneoplastic Neurologic Syndromes -- 40. Cancer-Related Pain -- 41. Cancer Cachexia -- 42. Nausea and Vomiting -- 43. Oral Complications -- 44. Dermatologic Toxicities of Anticancer Therapy -- 45. Fatigue -- 46. Caring for Patients at the End of Life -- Section C. Local Effects of Cancer and Its Metastasis -- 47. Acute Abdomen, Bowel/Biliary Obstruction, and Fistula -- 48. Superior Vena Cava Syndrome -- 49. Spinal Cord Compression -- 50. Brain Metastases and Neoplastic Meningitis -- 51. Bone Metastases -- 52. Lung Metastases -- 53. Liver Metastases -- 54. Malignant Effusions -- Section D. Complications of Therapy -- 55. Rehabilitation of Individuals with Cancer -- 56. Survivorship -- 57. Neurologic Complications -- 58. Pulmonary Complications of Anticancer Treatment -- 59. Cardiac Effects of Cancer Therapy -- 60. Reproductive Complications -- 61. Endocrine Complications -- 62. Second Malignant Neoplasms -- Section E. Special Populations -- 63. Cancer in the Elderly: Biology, Prevention, and Treatment -- 64. Special Issues in Pregnancy -- 65. Acquired Immunodeficiency Syndrome and Cancer -- Part III. Specific Malignancies -- 66. Cancer of the Central Nervous System -- 67. Eye, Orbit, and Adnexal Structures -- 68. Cancer of the Head and Neck -- 69. Melanoma -- 70. Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas -- 71. Cancer of the Endocrine System -- 72. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer -- 73. Diseases of the Pleura and Mediastinum -- 74. Cancer of the Esophagus -- 75. Cancer of the Stomach and Gastroesophageal Junction -- 76. Cancer of the Small Bowel -- 77. Colorectal Cancer -- 78. Cancer of the Rectum -- 79. Cancer of the Anal Canal -- 80. Liver and Bile Duct Cancer -- 81. Carcinoma of the Pancreas -- 82. Cancer of the Kidney -- 83. Bladder Cancer -- 84. Prostate Cancer -- 85. Cancer of the Penis -- 86. Testicular Cancer -- 87. Cancers of the Cervix, Vulva, and Vagina -- 88. Uterine Cancer -- 89. Cancers Arising in the Ovary -- 90. Gestational Trophoblastic Disease -- 91. Cancer of the Breast -- 92. Sarcomas of Bone -- 93. Sarcomas of Soft Tissue -- 94. Carcinoma of Unknown Primary -- 95. Pediatric Solid Tumors -- 96. Childhood Leukemia -- 97. Childhood Lymphoma -- 98. Acute Leukemias in Adults -- 99. Myelodysplastic Syndromes -- 100. Myeloproliferative Neoplasms -- 101. Chronic Myeloid Leukemia -- 102. Chronic Lymphocytic Leukemia -- 103. Hairy Cell Leukemia -- 104. Multiple Myeloma and Related Disorders -- 105. Hodgkin Lymphoma -- 106. Non-Hodgkin Lymphoma -- 107. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma -- 108. Adult T-Cell Leukemia-Lymphoma.
  • 2008
    [edited by] Martin D. Abeloff, James O. Armitage, John E. Niederhuber, Michael B. Kasten, W. Gillies McKenna.
    Status: Not Checked OutLane Catalog Record
  • 2006. Springer
    David E. Wazer, Douglas W. Arthur, Frank A. Vicini, (eds.).
    Also available: Print – 2006
  • 2009 Springer
    David E. Wazer, Douglas W. Arthur, Frank A. Vicini, editors.
  • 2007 Springer
    Isao Ishikawa.
  • 2015
    [by Laura Skopec].
    In 2014, the American Cancer Society Cancer Action Network (ACS CAN) analyzed coverage of cancer drugs in the health insurance marketplaces created by the Affordable Care Act (ACA) and found that transparency of coverage and cost-sharing requirements were insufficient to allow cancer patients to choose the best plan for their needs. In this updated analysis, we found that coverage transparency has improved somewhat since 2014, but significant barriers remain for cancer patients. To address these barriers, we provide nine recommendations to states and the U.S. Department of Health and Human Services to increase transparency of coverage and cost-sharing, ensure adequate access to medically necessary drugs via an exceptions process, make cost-sharing more predictable and affordable for patients, and monitor the marketplace for evidence of discrimination against persons with high-cost conditions such as cancer.
  • 2012 Springer
    Laurence Klotz, editor.
  • 2012 Springer
    William C.S. Cho, editor.
  • 2009
    [edited by] Cynthia C. Chernecky, Kathleen Murphy-Ende.
    Status: Not Checked OutLane Catalog Record
    Acute pancreatitis / Jean Ellsworth-Wolk -- Acute respiratory distress syndrome / Mercedes K. Young -- Malignant ascites / Deborah Murphy -- Bronchitis obliterans / Laura Milligan and Yvonne D. Martin -- Cardiac tamponade and pericardial effusions / Brenda K. Shelton -- Carotid artery rupture / Catherine Sargent -- Cognitive dysfunction / Nancy Jo Bush -- Depression and anxiety / Nancy Jo Bush -- Diabetes insipidus / Jennifer U. Varma -- Diabetes mellitus / Timothy L. Wren and Kathleen R. Wren -- Disseminated intravascular coagulation (DIC) / Brenda K. Shelton -- Dyspnea and airway obstruction / Cynthia C. Chernecky and Libby Montoya -- End-of-life care / Cynthia Brown and Kathleen Murphy-Ende -- Esophageal varices / Lori Ann Brown -- Ethics in adult oncology and critical care nursing / Marlene M. Rosenkoetter -- Fever / Angela L. Daniel -- Gastrointestinal obstruction : biliary, gastric, and bowel obstructions / Kathleen Murphy-Ende -- Graft versus host disease / Jill K. Burleson -- Heart failure / Jacqueline R. Gannuscio -- Hemorrhage secondary to cervical cancer / Brenda K. Cobb and Cynthia C. Chernecky -- Hemorrhagic cystitis / Cathy Fortenbaugh -- Hepatic encephalopathy / Kathleen Murphy-Ende -- Tumor-induced hypercalcemia / Kathryn E. Pearson -- Hyperkalemia / Mary Pat Lynch -- Hyperleukocytosis in childhood leukemia / Kristin Casey -- Hypernatremia / Mady Stovall -- Hypersensitivity reactions to chemotherapy / Teresa Kuntzsch and Cassie A. Voge -- Hyperurecemia / Libby Montoya -- Hypokalemia / Mary Pat Lynch -- Hypomagnesemia / Lyle Stuart Baker, Jr., Brenda K. Shelton, and Michael I. Agugo -- Hyponatremia / Cynthia C. Chernecky, Demica N. Jackson, and Angela L. Daniel -- Increased intracranial pressure / Kara L. Penne -- Lactic acidosis, type B / Catherine Sargent -- Lambert-Eaton myasthenic syndrome / Dionne T. Savage -- Malnutrition and cachexia / Kathy G. Kravits and Marcia Grant -- Pain management : nociceptive and neuropathic / Christine Miaskowski -- Pathological fractures / Cynthia C. Chernecky -- Pleural effusions : malignant / Diane G. Cope -- Pulmonary fibrosis / Cynthia C. Chernecky -- Seizures / Mary P. Lovely -- Sepsis and septic shock / Kathy A. Shane -- Sinusoid occlusive syndrome / Patricia C. Buchsel -- Spinal cord compression / Christine Miaskowski -- Spiritual distress in people with cancer / Martha Meraviglia, Carol D. Gaskamp, and Rebecca R. Sutter -- Suicidal ideation / Kathleen Murphy-Ende -- Superior vena cava syndrome / Molly Loney and Nancy Kelly -- Syndrome of inappropriate antidiuretic hormone (SIADH) / Jeanne Held-Warmkessel -- Tumor lysis syndrome / Brenda K. Shelton -- Typhlitis in pediatrics / Kaci L. Osenga.
  • 2007 Springer
    edited by Judith E. Karp.
    Approaching the treatment of AML from a biological perspective : an overview / Farhad Ravandi and Francis Giles -- Aberrant transcription factors in AML / Alan D. Friedman -- Myelodysplasia-related AML / Jane E. Parker -- Therapy-related AML / Lucy A. Godley and Michelle Le Beau -- The DNA damage response, DNA repair, and AML / David P. Steensma -- Altered apoptosis in AML : potential implications for pathogenesis and therapeutic response / Ruben A. Mesa and Scott H. Kaufmann -- Drug resistance transporters in AML / Douglas D. Ross -- Impact of cytogenetics on clinical outcome in AML / David Grimwade -- APL : a classic tale of bench to bedside / Olga Frankfurt ... [et al.] -- Emerging therapeutics for AML / Edward A. Sausville -- FLT3 : a prototype receptor tyrosine kinase target in AML / Mark Levis -- Farnesyl transferase inhibitors in the therapy of AML / Jeffrey E. Lancet -- Modulating gene expression as a therapeutic approach in the treatment of AML / Tamer Fandy, Hetty Carraway, and Steven D. Gore -- Differentiation therapy in AML / Tara L. Lin and William Matsui -- Stem cell transplantation for AML / Javier Bolaños-Meade and Richard J. Jones -- Tumor vaccines in leukemia / Ivan Borrello -- Treatment, outcomes, and challenges of newly diagnosed AML in children and adolescents / Robert J. Arceci -- AML in older adults / Richard M. Stone -- Dameshek smiles : molecular clues to the chronic myeloproliferative disorders unmasked / Jason Gotlib -- New designs for clinical trials / Elihu Estey.
    Also available: Print – 2007
  • 2010 Springer
    Lalitha Nagarajan, editor.
    Also available: Print – 2010
  • 2007 Springer
    P.P. Pandolfi and P.K. Vogt (eds.).
    APL as a paradigm in biomedical research : a journey toward the cure / P.P. Pandolfi -- Mouse models of acute promyelocytic leukemia / S.C. Kogan -- The PLZF gene of t(11;17)-associated APL / M.J. McConnell and J.D. Licht -- SUMO, the three Rs and cancer / J.-S. Seeler ... [et al.] -- Emerging role for microRNAs in acute promyelocytic leukemia / C. Nervi ... [et al.] -- The theory of APL revisited / P.P. Scaglioni and P.P. Pandolfi -- Treatment of acute promyelocytic leukemia by retinoids / P. Fenaux, Z.Z. Wang, and L. Degos -- Arsenic trioxide and acute promyelocytic leukemia : clinical and biological / Z. Chen ... [et al.] -- Front line clinical trials and minimal residual disease monitoring in acute promyelocytic leukemia / F. Lo-Coco and E. Ammatuna -- Histone deacetylase inhibitors in APL and beyond / K. Petrie, N. Prodomou, and A. Zelent -- Monoclonal antibody therapy of APL / P.G. Maslak, J.G. Jurcic, and D.A. Scheinberg -- Targeting APL fusion proteins by peptide interference / A. Melnick -- The design of selective and non-selective combination therapy for acute promyelocytic leukemia / Y. Jing and S. Waxman.
    Also available: Print – yyyy
  • 2011 CRCnetBASE
    edited by X. Allen Li.
  • 2010 Springer
    Paul M. Schneider (ed.).
  • 2011 Springer
    Yury A. Rovensky.
    Extracellular matrix -- Cytoskeleton -- Pseudopodia and adhesion structures -- Adhesive interactions of tissue cells with the extracellular matrix -- Cell migration -- Cell responses to chemical heterogeneity of substrata: adhesive islets or paths -- Topographic cell responses -- Intercellular adhesive interactions.
  • 2017 Springer
    edited by Ofer Reizes, Nathan A. Berger.
    Adipocytokines provide the circuitry by which adipose tissue communicates among its component cells which include adipocytes, stromal cells, immune cells and vascular elements, with adipose tissue depots in other locations throughout the body and with other tissues in order to regulate physiologic processes of energy intake, utilization, and distribution. Since disturbances, both qualitative and quantitative, in adipocytokine function contribute significantly to many of the comorbidities associated with obesity, including diabetes, cardiovascular disease and cancer, this volume, which discusses most of the major adipocytokines independently and collectively and their roles in normal and pathologic processes, should be useful to all individuals seeking a deeper understanding of these processes. Moreover, it provides a valuable complement to the series on Energy Balance and Cancer, in which each volume is focused on a specific aspect of this process, which now constitutes an expanding problem as the obesity pandemic continues and more of the population reaches the age where cancer is most prevalent. This volume should provide a valuable resource to all clinicians and scientists engaged in caring for susceptible patients and in exploring the relation between energy balance and cancer as well as an important platform to providing the background for research development.
  • 2013 Springer
    Mikhail G. Kolonin, editor.
    Preface: Obesity, Adipose Tissue and Cancer Progression -- Metabolic Perturbations Associated with Adipose Tissue Dysfunction and the Obesity-Cancer Link -- Increased Adiposity and Colorectal Cancer -- Adiposity and Diabetes in Breast and Prostate Cancer -- Increased Adipocity and Endometrial Cancer Risk -- Adipokines: Soluble Factors from Adipose Tissue Implicated in Cancer -- Animal Models to Study the Interplay between Cancer and Obesity -- Unraveling the local influence of tumor-surrounding adipose tissue on tumor progression: cellular and molecular actors involved -- Trafficking of Cells from Adipose Tissue to Tumor Microenvironment -- The Impact of Obesity Intervention on Cancer: Clinical Perspectives -- Index.
  • 2009 Springer
    edited by Monica Castiglione and Martine J. Piccart.
    Also available: Print – 2009
  • 2011 Springer
    Gary D. Hammer, Tobias Else, editors.
    "This first edition of the textbook “Adrenocortical Carcinoma: Basic Sciences and Clinical Concepts” provides a concise compilation of relevant data advancing our current understanding of this rare cancer. Chapters are dedicated to various aspects of both the basic biology and the clinical science relating to adrenocortical carcinoma (ACC). Expert clinicians introduce the reader to current state-of-the-art clinical care of patients with ACC. As a considerable body of knowledge on ACC has accumulated over the last decades, expert scientists have authored additional sections that serve as a reference source for the experienced researcher as well as an introduction for the trainee in the laboratory or clinic. Clinical topics span the epidemiology, diagnosis and therapy of ACC. Scientific topics areas span the pathology and pathophysiology of ACC with a special focus on experimental models of adrenocortical tumors and recent advances in the genetic aspects and signaling pathways in ACC. The content of this book was compiled and edited with the intent of facilitating the translation of knowledge into future diagnostic and therapeutic tools that will ultimately improve patient care."--Publisher's website.
  • 2011 Springer
    edited by Anjali Advani and Hillard Lazarus.
    A perspective on the treatment of acute lymphoblastic leukemia in adults -- Acute lymphocytic leukemia: clinical features and making the diagnosis -- The biology of adult acute lymphoblastic leukemia -- Minimal residual disease in acute lymphoblastic leukemia -- Cytogenetics -- Acute lymphoblastic leukemia: epidemiology -- Prognostic factors in adult acute lymphoblastic leukemia (ALL) -- The generalized care of the patient with acute lymphoblastic leukemia -- Treatment of acute lymphoblastic leukemia in middle-age and older adults -- Pharmacology of acute lymphoblastic leukemia therapy -- Assessment of response to treatment -- T-cell acute lymphoblastic leukemia -- Burkitt lymphoma and leukemia -- Treatment of acute lymphoblastic leukemia in young adults -- Philadelphia chromosome positive acute lymphoblastic leukemia -- Molecular therapies -- Treatment of relapsed acute lymphoblastic leukemia -- Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adults -- Hematopoietic stem cell transplantation in Philadelphia-positive acute lymphoblastic leukemia -- Special challenges: genetic polymorphisms and therapy -- Late consequences of therapy of acute lymphoblastic leukemia -- Immunotherapy for acute lymphoblastic leukemia -- Unique subtypes in acute lymphoblastic leukemia.
  • 2015 Karger
    volume editor, Karl Lenhard Rudolph.
    Speakers at the symposium -- Stem cells in adult intestine / Feng, J., Sperka, T. -- Molecular mechanisms of muscle stem cell aging / Schwërer, S., Tümpel, S. -- Mechanism of functional alterations in hematopoietic stem cell aging / Morita, Y. -- The microenvironment, aging, and disease / Geiger, H. -- Sestrins in aging and metabolism / Tang, D., Tao S. -- Telomeres and stem cell aging / Felix, D.A. -- DNA damage and checkpoint responses in adult stem cells / Romanov, V., Shukla, A., Ju, Z.
  • 2013 Springer
    edited by Nikhil C. Munshi, Kenneth C. Anderson.
    Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact.
  • 2013 Springer
    edited by Nikhil C. Munshi, Kenneth C. Anderson.
    Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact.
  • 2012 Future Med
    editors, Piero Picci, Pietro Ruggieri.
    Advances in bone metastasis management / Piero Picci & Pietro Ruggieri -- Pathways to metastases : how do metastases develop in bone / Jeff Toreson & Robert E. Turcotte -- Metastatic spread to bone : the role of chemotherapy / Stefano Ferrari, Emanuela Palmerini, Andreas F. Mavrogenis & Pietro Ruggieri -- Bone stroma inhibition in prostate cancer / Michael A. Carducci & Daniel Keizman -- Management of bone metastases in breast cancer / Toni Ibrahim & Dino Amadori -- Radiotherapy for bone metastases / Julia Di Giovanni, Janet Nguyen, Marko Popovic & Edward Chow -- Bisphosphonates for bone metastases / Esther Chan & Urban Emmenegger -- Surgical treatment for spinal metastases / Roberto Casadei, Andreas F. Mavrogenis, Marco Manfrini & Pietro Ruggieri -- Surgical treatment for pelvic bone metastases / Andreas F Mavrogenis, Eugenio Brunocilla, Giuseppe Bianchi, Nicola Fabbri & Pietro Ruggieri -- Surgical treatment for metastatic pathological fractures / Andreas F. Mavrogenis, Roberto Casadei & Pietro Ruggieri -- Palliative treatments : selective arterial embolization for bone metastases / Giuseppe Rossi, Andreas F. Mavrogenis, Piero Picci & Pietro Ruggieri -- Palliative treatments : electrochemotherapy and thermoablation / Giuseppe Bianchi, Laura Campanacci, Eugenio Rimondi & Pietro Ruggieri -- Novel targeted therapies of bone tumors and future directions / Dominique Heymann -- Index.
  • 2008 Springer
    edited by William J. Gradishar and William C. Wood.
    Also available: Print – 2008
  • 2010
    Rebecca Rakow-Penner.
    Breast magnetic resonance imaging (MRI) is becoming an increasingly valuable technology for breast cancer detection, especially for women at high risk for the disease. Stanford Hospital alone performed approximately 1,000 breast MRIs last year. This demand and need to increase specificity of breast MRI motivates improving current breast MR protocols, as well as exploring new applications of MR technology to breast imaging. Most clinical breast MR exams are performed at a 1.5T field strength. 3T scanners, however, are becoming more prevalent in the clinical setting and thus the breast MR protocol needs to be tuned accordingly. The first project includes measurements of T1 and T2 of breast fat and glandular tissue at 1.5T and 3T and the corresponding recommendation for altering the TR and TE for 3T breast imaging. The beating heart posterior to the breast often produces artifacts in breast MR images. The second project is a cylindrical saturation method that reduces unwanted signal from the heart while avoiding signal loss from the breast tissue of interest. Detecting tumor oxygenation non-invasively may give insight on tumor differentiation, predict susceptibility to antiangiogenic therapeutics, and monitor chemotherapeutics. The third project introduces the application of BOLD contrast imaging, a technique usually applied in functional brain MR imaging for characterizing tumor oxygenation in the breast.
  • 2012 Springer
    Roberto Scatena, Alvaro Mordente, Bruno Giardina, editors.
    1. Cancer Stem Cells: A Revisitation of the "Anaplasia" Concept / Roberto Scatena -- 2. Stem Cells and Cancer Stem Cells: New Insights / Toru Kondo -- 3. Molecular Biology of Cancer Stem Cells / Oswaldo Keith Okamoto -- 4. Biomarkers of Cancer Stem Cells / Jun Dou and Ning Gu -- 5. Cancer Stem Cells and the Microenvironment / Alfonso Colombatti, Carla Danussi, Eliana Pivetta, and Paola Spessotto -- 6. Leukemia Stem Cells / Steven W. Lane and David A. Williams -- 7. Cancer Stem Cells and the Central Nervous System / Serdar Korur, Maria Maddalena Lino, and Adrian Merlo -- 8. Cancer Stem Cells and Glioblastoma Multiforme: Pathophysiological and Clinical Aspects / Akio Soeda, Mark E. Shaffrey, and Deric M. Park -- 9. Breast Cancer Stem Cells / Nuria Rodríguez Salas, Enrique González González, and Carlos Gamallo Amat -- 10. Colon Cancer Stem Cells / Ugo Testa -- 11. Liver Tumor-Initiating Cells/Cancer Stem Cells: Past Studies, Current Status, and Future Perspectives / Kwan Ho Tang, Stephanie Ma, and Xin-Yuan Guan -- 12. Pancreatic Cancer Stem Cells / Erica N. Proctor and Diane M. Simeone -- 13. Cancer Stem Cells and Renal Carcinoma / Benedetta Bussolati and Giovanni Camussi -- 14. Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers / Patrizia Bottoni, Bruno Giardina, and Roberto Scatena -- 15. Cancer Stem Cells: An Innovative Therapeutic Approach / Roberto Scatena, Patrizia Bottoni, Alessandro Pontoglio, Salvatore Scarà, and Bruno Giardina -- 16. Cancer Stem Cell and ATP-Binding Cassette: Which Role in Chemoresistance? / Andrea Silvestrini, Elisabetta Meucci, Giuseppe Ettore Martorana, Bruno Giardina, and Alvaro Mordente -- 17. Stem Cells and Cancer Stem Cells: Biological and Clinical Interrelationships / Cinzia Bagalà and Carlo Barone -- 18. Immunomodulatory Functions of Cancer Stem Cells / Tobias Schatton, Jennifer Y. Lin, and Markus H. Frank.
  • 2015 Springer
    Lewis E. Foxhall, Maria Alma Rodriguez, editors.
    This volume presents the MD Anderson experience in providing care and services to the rapidly growing population of cancer survivors, which is currently estimated to be 12 million in the United States and more than 25 million worldwide. As cancer survival rates have increased, it has slowly become clear that the challenges faced by people with cancer do not end with treatment but simply change. This book aims to assist community oncologists, physicians, and their staff, who care for the vast majority of cancer survivors, by disseminating models of surveillance for disease recurrence, screening for second primary cancers, education regarding potential late effects of treatment, and psychosocial counseling. These models have proven valuable to cancer survivors who receive care at MD Anderson.
  • 2013 Springer
    Sami Malek, editor.
    Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course. While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL. In this book, CLL experts have contributed state-of-the-art summaries of various important aspects of CLL biology and have discussed the translational implication of such findings. This book, which is directed at physicians and researchers alike, aims to educate broadly and deeply. Intentionally, the many aspects and nuances of CLL clinical care that can only really be appreciated through direct patient care are not covered here, but instead, the book presents basic aspects of CLL that underlie many of the contemporary decisions that are made in CLL research and clinical settings. We hope that this book will critically inform the community and stimulate interest in CLL, which will ultimately translate into better CLL research, prognostication and therapy, with the end goal of providing a better outlook for patients afflicted with this common leukemia.
    Also available: Print – 2013
  • 2014 Springer
    Samir A. Farghaly, editor.
    This volume is an up-to-date resource on the international state-of-the-art in the diagnosis and management of ovarian cancer. While this devastating disease has been considered mainly a disease of the Western hemisphere, the book moves beyond our conventional understanding and embraces knowledge from around the world. It focuses on recent advances in diagnosis, including genetic screening; improvements and expanded choices in management, such as gene therapy and the optimization of chemotherapeutic agents; and the latest laparoscopic and robotic surgical techniques. Further chapters address histopathologic features of this disease, and related psychosocial and quality of-life-issues. The book is aimed at the wide range of practitioners who care for patients with ovarian cancer and researchers who study the disease: general surgeons, surgical oncologists, gynecological oncologists, medical oncologists, pediatric oncologists, gynecological pathologists, gynecologists, gynecological cancer epidemiologists, gynecological onco-psychologist, genetic counselors, geneticists, and cancer research scientists.
  • 2013 Springer
    Lawrence Panasci, Raquel Aloyz, Moulay Alaoui-Jamali, editors.
    Repair of DNA Interstrand Cross-links Produced by Cancer Chemotherapeutic Drugs / Anderson T. Wang, Peter J. McHugh -- DNA-PK, a Pharmacological Target in Cancer Chemotherapy and Radiotherapy? / Bernard Salles D.V.M., Ph.D. -- Growth Factor Receptor Signaling, DNA Damage Response, and Cancer Cell Susceptibility to Chemotherapy and Relapses / Moulay Alaoui-Jamali, Amine Saad, Gerald Batist -- The Relationship Between DNA-Repair Genes, Cellular Radiosensitivity, and the Response of Tumors and Normal Tissues to Radiotherapy / David Murray, Matthew Parliament -- Important Roles of ERCC1 in DNA Repair and Targeted Therapy / Jennifer J. Hu, Joseph de la Garza -- The Role of BRCA1 and BRCA2 in Anticancer Drug Therapy / Andrew Y. Shuen, Jorge S. Reis-Filho -- DNA-PK in CLL Chemotherapy / L. Amrein, D. Davidson, R. Aloyz, L. Panasci -- Poly(ADP) Ribose Polymerase at the Interface of DNA Damage Signaling and DNA Repair / Jana Krietsch, Michele Rouleau, Michel Lebel -- Cellular Protection Against the Antitumor Drug Bleomycin / Dindial Ramotar Ph.D., Mustapha Aouida Ph.D. -- ATR as a Therapeutic Target / Fiona K. Middleton, Nicola J. Curtin -- Telomeres, Telomerase, and DNA Damage Response in Cancer Therapy / Raina A. Tamakawa, Helen B. Fleisig -- RAD51 Is a Key Protein of DNA Repair and Homologous Recombination in Humans / Alexander V. Mazin Ph.D., Olga M. Mazina.
  • 2007 Springer
    Febrizio d'Adda di Fagagna ... [et al.], editors ; edited under the auspices of the the European Institute of Oncology ... and the FIRC Institute of Molecular Oncolgy Foundation.
    Genome instability, checkpoints, and the cell cycle. Comparison of DNA replication in Xenopus laevis and simian virus 40 / Maren Oehlmann, Cathal Mahon, and Heinz-Peter Nasheuer. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors / P. Mathijs Voorhoeve ... [et al.] An investigation into 53BP1 complex formation / Kevin C. Roche and Noel F. Lowndes. Short abstracts--session I -- Tumor and microenvironment interactions. Tumor promotion by tumor-associated macrophages / Chiara Porta ... [et al.] The AP-2[alpha] transcription factor regulates tumor cell migration and apoptosis / Francesca Orso ... [et al.] Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation / Massimiliano Ruscica ... [et al.] Short abstracts--session II -- Animal models. The Arf tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia / Richard T. Williams and Charles J. Sherr. Short abstracts--session III -- Transcription and epigenetics. Short abstracts--session IV -- High-throughput approaches and imaging. Identification and validation of the anaplastic large cell lymphoma signature / Roberto Piva, Elisa Pellegrino, and Giorgio Inghirami. Cell-cycle inhibitor profiling by high-content analysis / Fabio Gasparri, Antonella Ciavolella, and Arturo Galvani. Short abstracts-session V -- Novel pathways and therapeutic targets. Regulation for nuclear targeting of the Abl tyrosine kinase in response to DNA damage / Kiyotsugu Yoshida. Short abstracts--session VI -- Poster abstracts.
    Also available: Print – 2007
  • 2011 Future Med
    editor, Kjell Öberg.
    Advances in neuroendocrine tumor management / Kjell Öberg -- Classification of digestive neuroendocrine neoplasm / Guido Rindi & Frediano Inzani -- Molecular profile and diagnosis / Christos Toumpanakis -- Surgical approach / Rossella Bettini & Massimo Falconi -- Somatostatin analogs / Wouter W. de Herder -- Combinational chemotherapy and radiotherapy / Emilio Bajetta, Emilio Bombardieri, Laura Catena, Monica Valente & Nadia Bianco -- Which therapy for which patient? / Kjell Öberg.
  • 2014 Springer
    Vincenzo Zappia, Salvatore Panico, Gian Luigi Russo, Alfredo Budillon, Fulvio Della Ragione, editors.
    This book comprises proceedings from the Third International Conference on Advances in Nutrition and Cancer, held in Naples in May 2012. This highly multidisciplinary meeting analyzed nutrition and cancer from different perspectives and on the basis of distinct and up-to-date experimental approaches. Knowledge on the relation between lifestyle, diet, and cancer is explored in a number of contributions, and the role of dietary intervention in cancer patients is discussed. Issues of vital interest to the research community, such as epidemiological and experimental oncology (genetics, epigenetics, and the mechanisms of action of natural compounds in the diet), receive detailed consideration. A further key topic is the emerging molecular technologies (the -omics) that can cast light on the interplay between nutrition and human malignancies. Chapters take the form of reviews that include sections presenting expert opinions. Advances in Nutrition and Cancer will be an invaluable source of topical information for all researchers and clinicians with an interest in this field.
    Also available: Print – 2014
  • 2012 Future Med
    editor, Peter E. Schwartz.
    Advances in ovarian cancer management / Peter E. Schwartz -- Etiology and overview / Gang Ye, Stefanie Bernaudo & Chun Peng -- Diagnostic imaging in the management of ovarian masses / Amit Mahajan, Indukala Doddamane & Shirley McCarthy -- Initial surgical management of ovarian cancer / Jason Knight & Peter G. Rose -- Initial chemotherapy for the treatment of ovarian cancer / Katherine M. Moxley & Robert S. Mannel -- Neoadjuvant chemotherapy in the management of advanced ovarian cancer / Peter E. Schwartz -- Intraperitoneal chemotherapy : its use in epithelial ovarian cancer / Neesha Dhani & Helen Mackay -- Chemotherapeutic management of recurrent ovarian cancer / Marcia Hall -- Emerging chemotherapy agents in ovarian cancer / Daliah Tsoref & Amit M. Oza -- Surgical management of recurrent ovarian cancer / Eelco de Bree -- Angiogenesis in ovarian cancer / Vincent Castonguay & Amit M. Oza -- Antigen-specific immunotherapy for ovarian cancer / Dana M. Roque & Alessandro D. Santin -- Poly(ADP-ribose) polymerase inhibitors and epithelial ovarian cancer -- Thomas P. McNally, Gillianne G.Y. Lai & Richard T. Penson -- Emerging targeted therapies / Mirko Marabese & Massimo Broggini -- Palliative care in ovarian cancer / Cynthia O'Sullivan, Elizabeth Ercolano & Ruth McCorkle -- Guidelines in ovarian cancer / Domenica Lorusso, Antonella Pietragalla & Giovanni Scambia -- Index.
  • 2011 Future Med
    editors, Helmut Friess, Norbert Hüser.
    Advances in pancreatic cancer treatment / Helmut Friess & Norbert Hüser -- Pathophysiology of pancreatic cancer / J. Matthias Löhr, Stephan L. Haas & Rainer Heuchel -- Molecular diagnostics in pancreatic cancer / David K. Chang, Sean M. Grimmond & Andrew V. Biankin -- Surgical therapy for pancreatic cancer / Norbert Hüser, Volker Assfalg & Helmut Friess -- Multimodal treatment concepts in pancreatic cancer / Daniel Reim, Alexander Novotny & Helmut Friess -- Consensus guidelines in pancreatic cancer treatment / Wasif Saif -- Drugs in clinical trials & future directions / Zhiqiang Huang & Donald J. Buchsbaum.
  • 2007 Springer
    Santiago González-Moreno, editor.
    Management of Peritoneal Surface Malignancy: A Short History / Paul H. Sugarbaker -- The Natural History of Free Cancer Cells in the Peritoneal Cavity / Yutaka Yonemura, Taiichi Kawamura, Etsurou Bandou, Gorou Tsukiyama and Yoshio Endou, et al. -- Pathological Evaluation and Implications of Serosal Involvement in Gastrointestinal Cancer / Linmarie Ludeman and Neil A. Shepherd -- Principles of Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis / Eelco de Bree and Dimitris D. Tsiftsis -- Experimental and Pharmacokinetic Studies in Intraperitoneal Chemotherapy: From Laboratory Bench to Bedside / Eelco de Bree and Dimitris D. Tsiftsis -- Technology for the Delivery of Hyperthermic Intraoperative Intraperitoneal Chemotherapy: A Survey of Techniques / Amod A. Sarnaik, Jeffrey J. Sussman, Syed A. Ahmad, Benjamin C. McIntyre and Andrew M. Lowy -- Adjuvant Intraperitoneal Chemotherapy: A Review / Paul H. Sugarbaker -- Clinical Research Methodology in Peritoneal Surface Oncology: A Difficult Challenge / François-Noël Gilly, Olivier Glehen, Annie C. Beaujard and Eddy Cotte -- Lessons Learnt from Clinical Trials in Peritoneal Surface Oncology: Colorectal Carcinomatosis / Frans A. N. Zoetmulder and Vic J. Verwaa -- Experimental Models and Questions in Basic Science Research for Pseudomyxoma Peritonei / Laura A. Lambert, Donald H. Lambert and Paul Mansfield -- Peritoneal Carcinomatosis of Colorectal Origin: Recent Advances and Future Evolution Toward a Curative Treatment / Dominique Elias and Diane Goere -- Pathologic Characterization and Differential Diagnosis of Malignant Peritoneal Mesothelioma / Nelson G. Ordóñez -- Advances in Clinical Research and Management of Diffuse Peritoneal Mesothelioma / Marcello Deraco, Dario Baratti, Nadia Zaffaroni, Antonello Domenico Cabras and Shigeki Kusamura -- Advances in the Management of Gastric Cancer with Peritoneal Dissemination / Yutaka Yonemura, Taiichi Kawamura, Etsurou Bandou, Gorou Tsukiyama and Masayuki Nemoto, et al. -- Intraperitoneal Chemotherapy in the Management of Ovarian Cancer / Maurie Markman.
    Also available: Print – 2007
  • 2011 Future Med
    editor, Dimitrios H. Roukos.
    Personalized genomic medicine: is a cancer care revolution achievable? / Dimitrios H. Roukos -- Targeting the individual cancer patient / Georgios Baltogiannis, Christos S. Katsios & Dimitrios H. Roukos -- Biomarkers-guided targeted drugs: new clinical trials design and practice necessity / Ming-Wen An, Sumithra J. Mandrekar & Daniel J. Sargent -- Personalized management for breast cancer / George C. Zografos, Dimosthenis T. Chrysikos, Paraskevi Liakou & Flora Zagouri -- Personalized management for non-small-cell lung cancer / Martin Früh, Florent Baty, Lukas Kern, Martin P. Putora & Martin Brutsche -- Personalized management for colorectal cancer / Ana Custodio & Jaime Feliu -- Successes, challenges and future directions / Stephen J. Clarke.
  • 2011 Future Med
    editor, Nagahiro Saijo.
    Advances in personalized therapy for lung cancer / Nagahiro Saijo -- Biomarkers in lung cancer / Tobenna Nwizu & Ravi Salgia -- EGF receptor-targeted drugs / Tetsuya Mitsudomi -- Antiangiogenic therapies for non-small-cell lung cancer / Suresh S. Ramalingam & Chandra P. Belani -- DNA-targeted drugs / Judith Meza-Junco & Michael B. Sawyer.
  • 2013 Future Med
    editor, Kjell Öberg.
    Advances in pulmonary neuroendocrine tumor management / Kjell Öberg -- Classification / Mauro Papotti -- Molecular imaging & peptide receptor radionuclide therapy / Richard P. Baum, Harshad R. Kulkarni & Dieter Hörsch -- Biotherapy : somatostatin analogs and IFN-[alpha] / Dan Granberg -- Typical and atypical bronchial carcinoid tumors / Michael Beckles, Dalvinder Mandair, Christos Toumpanakis & Martyn Caplin -- Small-cell lung cancer and large-cell neuroendocrine tumors of the lung / David Planchard & Eric Baudin -- Thymic neuroendocrine tumors / Piero Ferolla -- Algorithm for management of bronchopulmonary neuroendocrine tumors / Kjell Öberg -- Index.
  • 2011 Springer
    Branislav Jeremić (editor) ; foreword by Luther W. Brady ... [et al.].
  • 2012 Springer
    Gabriella Castoria, Antimo Migliaccio, editors.
    [1.] Non-genomic Action of Steroid Hormones: More Questions than Answers / Antimo Migliaccio, Gabriella Castoria, Antonio Bilancio, Pia Giovannelli, Marzia Di Donato and Ferdinando Auricchio -- Part I. Breast Cancer -- [2.] Progesterone Signaling to Chromatin in Breast Cancer Cells. Two Initial Cycles of Remodeling / Guillermo P. Vicent, Roser Zaurin, Cecilia Ballaré, A. Silvina Nacht, Roni H. G. Wright, Francois Le Dily, Giancarlo Castellano, Jofre Font-Mateu and Miguel Beato -- [3.] Cooperative Interactions Between c-Src, Estrogen Receptors and Receptor Tyrosine Kinases in Breast Cancer / Sarah J. Parsons, Jessica E. Pritchard, Emily M. Fox and Margaret A. Shupnik -- [4.] Cross Talk Between ER[alpha] and Src Signaling and Its Relevance to ER Status and Hormone Responsiveness / Jun Sun, Wen Zhou, Zafar Nawaz and Joyce M. Slingerland -- [5.] Post-translational Modifications of ER Alpha in Rapid Estrogen's Action / Muriel Le Romancer, Coralie Poulard, Stéphanie Sentis, and Laura Corbo -- [6.] Sex-Steroid Rapid Action and Its Role in Invasiveness and Metastasis of Breast Cancer / Marina Ines Flamini, Angel Matias Sanchez, Xiao-Dong Fu and Tommaso Simoncini -- [7.] Unraveling the Role of GPER in Breast Cancer / Rosamaria Lappano and Marcello Maggiolini -- [8.] Nongenomic Actions of Estrogens and Xenoestrogens Affecting Endocrine Cancer Cells / Cheryl S. Watson, Dragoslava Zivadinovic, Yow-Jiun Jeng, Rebecca A. Alyea, Terumi Midoro-Horiuti, Randall Goldblum and Anannya Banga -- Part II. Prostate Cancer -- [9.] Differential Functions of Stromal and Epithelial Androgen Receptor in Prostate Cancer Before and After Castration Resistant Stage / S. Lee, K.-P. Lai, S. Yeh and C. Chang -- [10.] Role of Androgens and Androgen Receptor in Prostate Cancer: Genomic and Non-Genomic Actions / Sara Marchiani, Lara Tamburrino, Monica Muratori, Lorella Bonaccorsi, Gianni Forti and Elisabetta Baldi -- [11.] Mechanisms of Signal Transduction in Prostate Cancer: The Role of PI3-Kinase Pathway in Androgen Action / Laurent Morel and Silvère Baron -- [12.] The IGF-I Axis in Prostate Cancer: The Role of Rapid Steroid Actions / Antonino Belfiore -- Androgen Receptor Pathway in Prostate Cancer: Old Target and New Drugs / Christophe Massard and Karim Fizazi -- Part III. New Tools for Steroid Receptor Analysis and Regulatory Networks -- [13.] Quantitative Visualization of Sex Steroid Receptor Functions: AR and ER[alpha] / Michael J. Bolt, Sean M. Hartig, Adam T. Szafran, Sanjay N. Mediwala, Marco Marcelli and Michael A. Mancini -- [14.] Micropatterned Surfaces as Tools for the Study of the Rapid Non-genomic Actions of Steroid Receptors / Andrew C. B. Cato, Emmanuel Oppong and Sylwia Sekula-Neuner.
  • 2016 Springer
    Mieczyslaw Pokorski, editor.
    The role of dysregulated microRNA expression in lung cancer / M. Krutakova [and seven others] -- Laryngeal cancer: 12-year experience of a single center / V. Calkovsky, P. Wallenfels, A. Calkovska, A. Hajtman -- Polymorphisms of selected DNA repair genes and lung cancer in chromium exposure / E. Halasova, [and nine others] -- Associations of CYP1A2 polymorphisms with the risk haplotypes in lung cancer in the Slovak population -- T. Matakova, E. Halasova, A. Dzian, R. Hruby, M. Halasa, K. Javorka, M. Skerenova -- Impact of endobronchial ultrasound guided transbronchial needle aspiration on diagnostic yield of bronchoscopy in patients with mediastinal lymph node enlargement -- K. Osinka, M. Zielińska-Krawczyk, P. Korczyński, B. Górnicka, R. Krenke -- The effect on cognition of mitochondrial respiratory system proteins in peripheral blood mononuclear cells in the course of lung cancer -- S. Michalak, J. Rybacka-Mossakowska, J. Gazdulska, I. Gołda-Gocka, R. Ramlau -- Lung cancer and multiple neoplasms: a retrospective analysis -- A. Romaszko, E. Świetlik, A. Doboszyńska, P. Szpruch, J. Luks -- Humoral immune response against neural antigens and its effects on cognition in lung cancer patients -- J. Rybacka-Mossakowska, R. Ramlau, J. Gazdulska, I. Gołda-Gocka, W. Kozubski and S. Michalak. -- Active case finding among homeless people as a means of reducing the incidence of pulmonary tuberculosis in general population -- J. Romaszko, A. Siemaszko, M. Bodzioch, A. Buciński, A. Doboszyńska -- Cryptogenic organizing pneumonia: IL-1[beta], IL-6, IL-8, and TGF- [beta]1 serum concentrations and response to clarithromycin treatment -- E. Radzikowska and [six others].
    Also available: Print – 2016
  • 2011 Future Med
    editors, Clifford A. Hudis, Tiffany A. Traina.
    Advances in the management of triple-negative breast cancer / Tiffany A. Traina & Clifford A. Hudis -- Etiology and risk factors / Laura Fejerman & Elad Ziv -- Diagnosis and pathology / Govardhanan Nagaiah & Jame Abraham -- Molecular subtypes and emerging therapeutic opportunities / Anastasia Constantinidou, Robin L. Jones & Jorge S. Reis-Filho -- Molecular profile of triple-negative breast cancer / Leonel F. Hernandez-Aya & Ana Maria Gonzalez-Angulo -- Role of metabolic rehabilitation-based approach in TNBC : biguanide metformin and more / Lev M. Berstein, Garik A. Dashyan & Vladimir F. Semiglazov -- Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer / Mark Robson -- Targeted therapies: EGFR inhibitors / Farrah M. Datko & Maura N. Dickler -- Targeted therapies : other agents in clinical trials / Brian R. Haney, Nathan M. Shumway & George E. Peoples -- Combined therapies and future directions / Anastasia Pazaiti & Ian S. Fentiman.
  • 2012 Future Med
    editor, Michael D. Prados.
    Advances in the pathogenesis and treatment of glioblastoma multiforme / Michael Prados -- Pathogenesis, molecular characteristics and prognostic factors for survival / Keith L. Ligon -- Standard treatment approaches for newly diagnosed glioblastoma / Soon-Tae Lee & Patrick Y. Wen -- Targeted therapeutic strategies for relapsed disease / John F. de Groot & Howard Colman -- Genes, viruses, toxins and vaccines as therapeutic modalities / Tal Shahar, Manish K. Aghi & Zvi Ram -- Drug delivery strategies for glioblastoma / Pin-Yuan Chen, Dali Yin, John Forsayeth & Krystof S. Bankiewicz -- Index.
  • 2012 Future Med
    editors, Michael J. Keating, Constantine Tam.
    Advances in the treatment of B-cell chronic lymphocytic leukemia / Michael J. Keating & Constantine Tam -- Chronic lymphocytic leukemia : diagnosis and clinical staging / Stephen P. Mulligan & Constantine S. Tam -- Genetics in chronic lymphocytic leukemia / Stephan Stilgenbauer & Thorsten Zenz -- To treat or not to treat / Marco Montillo, Alessandra Tedeschi & Enrica Morra -- Chronic lymphocytic leukemia chemotherapy : two decades of progress / Carol Moreno & Emili Montserrat -- Stem cell transplantation / David G. Maloney -- Treatment options for refractory chronic lymphocytic leukemia / Marina Motta & Alessandra Ferrajoli -- Prognostic markers in chronic lymphocytic leukemia / Renata Walewska & David Oscier -- Therapeutic agents in development and future direction / Sarah Mougalian & Susan O'Brien -- Index.
  • 2013 Future Med
    editors, Giuseppe Saglio, Carmen Fava.
    Advances in the treatment of chronic myeloid leukemia / Giuseppe Saglio & Carmen Fava -- Diagnosis and classification of the risk / Gabriele Gugliotta, Fausto Castagnetti, Francesca Palandri, Michele Baccarani & Gianantonio Rosti -- Genetics of chronic myeloid leukemia / Giovanna Rege-Cambrin, Emilia Giugliano & Patrizia Scaravaglio -- Molecular monitoring / Martin C. Müller, Christian Dietz & Benjamin Hanfstein -- Current targeted therapy with tyrosine kinase inhibitors / Massimo Breccia & Giuliana Alimena -- Stem cell transplantation and high-dose chemotherapy / Deena Iskander, Jane F. Apperley & Jirí Pavlu -- Treatment options for tyrosine kinase inhibitor-resistant chronic myeloid leukemia / Stephan Joseph Dorkhom, Hady Ghanem & Elias Jabbour -- Prognostic factors and future direction for chronic myeloid leukemia / David Marin & Antonia Rotolo -- Chronic myeloid leukemia : the possibility of a cure / Manuel Sobrinho-Simões, David M. Ross & Junia V. Melo -- Index.
  • 2011 Springer
    David Wallach, Andrew Kovalenko, Marc Feldmann, editors.
    Roles of the TNF family in tissue homeostasis and normal development -- Novel aspects of signaling activation by the TNF family: novel aspects of the functions of the TRAFs and cIAPs -- Novel aspects of signaling activation by the TNF: ubiquitin modification of signaling proteins -- Novel aspects of signaling activation by the TNF family: TNF signaling and gene regulatory networks -- Roles of the TNF family in infectious diseases and interrelationship of the TNF family and pattern recognition receptor signaling: roles of the TNF family in infectious diseases -- Roles of the TNF family in infectious diseases and interrelationship of the TNF family and pattern recognition receptor signaling: interrelationship of the TNF family and pattern recognition receptor signaling -- Novel aspects of immune regulation by the TNF family -- Control of lymphocyte function and repertoire by the TNF family -- Advances in applying our knowledge to therapy: mechanisms of pathological and therapeutic effects of the TNF family -- Advances in applying our knowledge to therapy: rational design of new means for therapeutic modulation of function of the TNF family -- Roles of the TNF family in neuronal development, function, and pathology -- Cell death mechanisms controlled by the TNF family -- Contributors to abstracts of talks and posters at the 12th TNF Conference -- Abstracts of talks and posters presented at the 12th TNF Conference.
    Also available: Print – 2011
  • 2014 Springer
    Joseph D. Rosenblatt, Eckhard R. Podack, Glen N. Barber, Augusto Ochoa, editors
    Recent advances in understanding of fundamental immunology have created new insights into the dynamic interactions between tumors and the immune system. This includes new understanding of T- and B-cell interaction, immune inhibitory mechanisms including the biology of T regulatory cells, myeloid suppressor cells, and dendritic cell subsets. Enhanced understanding of mechanisms underlying T-cell anergy such as arginine deprivation, immunosuppressive cytokines, defective innate and interferon response pathways, and NKG2D downregulation have all provided new insight into suppression of anti-tumors.
  • 2013 ScienceDirect
    edited by Devanand Sarkar and Paul B. Fisher.
    Ch. 1. AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression -- Ch. 2. AEG-1/MTDH/LYRIC: clinical significance -- Ch. 3. AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis -- Ch. 4. Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer -- Ch. 5. Drug resistance mediated by AEG-1/MTDH/LYRIC -- Ch. 6. The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease -- Ch. 7. AEG-1/MTDH/LYRIC in liver cancer -- Index.
  • 2007 Springer
    edited by C. Meyers.
    Also available: Print – 2007
  • 2006 Springer
    American Joint Committee on Cancer ; editors, Frederick L. Greene ... [et al.].
  • 2012 Springer
    edited by Carolyn C. Compton ... [et al.].
  • 2010 STAT!Ref, Limited to 7 simultaneous users
    American Joint Committee on Cancer ; [editors, Stephen B. Edge ... et al.].
    General information on cancer staging and end-results reporting -- Head and neck -- Digestive system -- Thorax -- Musculoskeletal sites -- Skin -- Breast -- Gynecologic sites -- Genitourinary sites -- Ophthalmic sites -- Central nervous system -- Lymphoid neoplasms -- Personnel and contributors.
  • 2011 Springer
    Samir Zakhari, Vasilis Vasiliou, Q. Max Guo, editors.
    The World Health Organization has identified chronic alcohol consumption as one of the top ten risk factors for worldwide burden of disease. The International Agency for Research on Cancer has identified alcohol as carcinogenic to humans, including cancers of the upper aerodigestive tract, colon, liver and breast. Alcohol{u2019}s actions may be direct e.g. effects on retinoic acid and one-carbon metabolism, or indirect, through metabolites such as acetaldehyde and reactive oxygen species or through various signaling pathways that influence cell cycle and apoptosis that may contribute to carcinogenesis. This volume reviews the state of the art in alcohol-related cancer research in ten chapters.
  • 2014 Springer
    Philip Rubin, Louis S. Constine, Lawrence B. Marks, editors.
    The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of ALERT Adverse Late Effects of Cancer Treatment is to offer a coherent multidisciplinary approach to the care of cancer survivors. The central paradigm is that cytotoxic multimodal therapy results in a perpetual cascade of events that affects each major organ system differently and is expressed continually over time. Essentially, radiation and chemotherapy are intense biologic modifiers that allow for cancer cure and cancer survivorship but accelerate senescence of normal tissues and increase the incidence of age-related diseases and second malignant tumors. Volume 1 of this two-volume work focuses on the general concepts and principles relevant to late effects and on the dynamic interplay of molecular, cytologic and histopathologic events that lead to altered physiologic and metabolic functions and their clinical manifestations. Chapters are also included on legal issues, economic aspects, nursing, psychological issues and quality of life.
  • 2014 Springer
    Philip Rubin, Louis S. Constine, Lawrence B. Marks, editors.
    The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of ALERT Adverse Late Effects of Cancer Treatment is to offer a coherent multidisciplinary approach to the care of cancer survivors. The central paradigm is that cytotoxic multimodal therapy results in a perpetual cascade of events that affects each major organ system differently and is expressed continually over time. Essentially, radiation and chemotherapy are intense biologic modifiers that allow for cancer cure and cancer survivorship but accelerate senescence of normal tissues and increase the incidence of age-related diseases and second malignant tumors. Volume 2 of this two-volume work comprehensively documents potential late effects in all the normal tissue anatomic sites in the human body. The detection, diagnosis, management and prevention of effects are all considered in detail, and prognostic outcomes are discussed. Radiation risk factors and interactions with chemotherapy effects are clearly presented. The text is accompanied by numerous supportive illustrations and tables.
  • 2011 Thieme eNeurosurgery
    [edited by] Franco DeMonte, Michael W. McDermott, Ossama Al-Mefty.
    "This new edition of Meningiomas proves a valuable contribution to the literature on the fascinating aspects of meningioma biology, diagnosis, and management"--Provided by publisher.
  • 2010 Springer
    Moulay Alaoui-Jamali, editor.
    Overview of efficacy and limitation of standard and targeted therapy for malignant disease using lung cancer as a case study -- Overview of current TCM practice and potential impacts on conventional therapies -- Complementary and alternative medicine for cancer care in India: basic and clinical perspective -- Esophageal cancer -- Gastric cancer -- Colorectal cancer -- Liver cancer -- Pancreatic cancer -- Breast cancer -- Ovarian cancer -- Prostate cancer -- Kidney cancer -- Bladder cancer -- Brain cancer -- Complementary and alternative treatments for the management of cancer-related fatigue -- Complementary and alternative treatments for the management of cancer-related pain -- Challenges conducting clinical trials with herbal products in oncology -- Herbal product-drug interactions from a pharmacological perspective -- Patient-physician relationship: creating an optimal healing environment -- Legal issues in alternative treatment of cancer -- Intellectual property for alternative medicine -- Chemical-biology of natural products from medicinal plants for cancer therapy -- Flavonoids in cancer prevention and therapy: chemistry, pharmacology, mechanisms of action, and perspectives for cancer drug discovery -- Marine natural products and their synthetic derivatives for cancer therapy -- Natural product-like scaffolds for molecular dissection of macromolecular interactions and new therapeutic applications -- Mining natural product-derived molecules against cancer targets: the case of the androgen receptor in prostate cancer.
  • 2012 Future Med
    editors, Frank Porecca, Tamara King.
    Analgesics for cancer pain / Tamara King & Frank Porreca -- Cancer pain assessment and consensus guidelines / Brian Wilhelmi & Paul J. Christo -- Role of step 2 opioid analgesics in mild-to-moderate pain intensity treatment / Wojciech Leppert -- Opioid analgesics for severe cancer pain / Phillip Good & Janet Hardy -- Alternative opioids and administration routes / Mellar P. Davis -- Adjuvant analgesics for cancer pain / Russell K. Portenoy & Ebtesam Ahmed -- Analgesics for breakthrough pain / Sebastiano Mercadante -- Emerging analgesics and future directions : targeting bone remodeling / Flaminia Coluzzi -- Emerging analgesics and future directions : targeting neuroplasticity / Alysia N. Lozano-Ondoua & Todd W. Vanderah -- Index.
  • 2010 Atypon
    Fábio J. Ayres, Rangaraj M. Rangayyan, and J.E. Leo Desautels.
    The presence of oriented features in images often conveys important information about the scene or the objects contained; the analysis of oriented patterns is an important task in the general framework of image understanding. As in many other applications of computer vision, the general framework for the understanding of oriented features in images can be divided into low- and high-level analysis. In the context of the study of oriented features, low-level analysis includes the detection of oriented features in images; a measure of the local magnitude and orientation of oriented features over the entire region of analysis in the image is called the orientation field. High-level analysis relates to the discovery of patterns in the orientation field, usually by associating the structure perceived in the orientation field with a geometrical model. This book presents an analysis of several important methods for the detection of oriented features in images, and a discussion of the phase portrait method for high-level analysis of orientation fields. In order to illustrate the concepts developed throughout the book, an application is presented of the phase portrait method to computer-aided detection of architectural distortion in mammograms.
  • 2010 Springer
    William C. Wood, C.A. Staley, John E. Skandalakis (eds.).
  • 2009 Springer
    Donald Tindall, James Mohler, editors.
    Androgen action and modulation of prostate and prostate cancer growth : an historical perspective / Shutsung Liao ... [et al.] -- Clinical progression to castration-recurrent prostate cancer / Mark Pomerantz and Philip Kantoff -- Differential roles of androgen receptor in prostate development and cancer progression / Shuyuan Yeh ... [et al.] -- Imaging androgen receptor function in vivo / Michael Carey and Lily Wu -- Increased expression of genes converting adrenal androgens to testosterone in castration-recurrent prostate cancer / Steven P. Balk -- Androgen-metabolic genes in prostate cancer predisposition and progression / Juergen K.V. Reichardt and Ann W. Hsing -- Effect of steroid 5[alpha]-reductase inhibitors on markers of tumor regression and proliferation in prostate cancer / Lynn N. Thomas and Roger S. Rittmaster -- 5[alpha]-reductase isozymes in castration-recurrent prostate cancer / Mark A. Titus and James L. Mohler -- Improving intermittent androgen-deprivation therapy : OFF cycle and the role of steroid 5[alpha]-reductase inhibitors / Shubham Gupta, Daniel Shevrin, and Zhou Wang -- Insights from AR gene mutations / Grant Buchanan ... [et al.] -- Functional motifs of the androgen receptor / Elizabeth M. Wilson -- The role of the androgen receptor polyglutamine tract in prostate cancer : in mice and men / Diane M. Robbins -- The androgen receptor coactivator-binding interface / Eva Estébanez-Perpiñá and Robert J. Fletterick -- Co-regulators and the regulation of androgen receptor action in prostate cancer / Irina U. Agoulnik and Nancy L. Weigel -- Androgen receptor coregulators and their role in prostate cancer / Latif A. Wafa, Robert Snoek, and Paul S. Rennie -- Interaction of the androgen receptor ligand-binding domain with the n-terminal domain and with coactivators / Jan Trapman -- Multitasking and interplay between the androgen receptor domains / F.Claessens, T. Tanner, and A. Haelens -- Chromatin remodeling and androgen receptor-mediated transcription / Li Jia ... [et al.] -- Ligand-independent androgen receptor activity / Scott M. Dehm and Donald J. Tindall -- Role of IL-6 in regulating the androgen receptor / Zoran Culig and Alfred Hobisch -- The role of cyclic AMP in regulating the androgen receptor / Marianne D. Sadar -- Cellular and molecular signatures of androgen ablation of prostate cancer / Clifford G. Tepper and Hsing-Jien Kung -- Tissue levels of androgens in castration-recurrent prostate cancer / James L. Mohler and Mark A. Titus -- Unique effects of wnt signaling on prostate cancer cells : modulation of the androgen signaling pathway by interactions of the androgen receptor gene and protein with key components of the canonical wnt signaling pathway / Matthew J. Tanner ... [et al.] -- The role of foxa proteins in the regulation of androgen receptor activity / David J. DeGraff ... [et al.] -- Androgen receptor as a licensing factor for DNA replication / Donald J. Vander Griend and John T. Isaacs -- Androgen-regulated genes in the prostate / Nigel Clegg and Peter S. Nelson -- Mapping the androgen receptor cistrome / Qianben Wang and Myles Brown -- Differential regulation of clusterin isoforms by the androgen receptor Tanya K. Day, Colleen C. Nelson, and Martin E. Gleave -- Androgen regulation of prostate cancer gene fusions / Rou Wang, Scott A. Tomlins, and Arul M. Chinnaiyan -- Androgens and the lipogenic switch in prostate cancer / Johannes V. Swinnen ... [et al.] -- Molecular biology of novel targets identified through study of castration-recurrent prostate cancer / Philip A. Watson and Charles L. Sawyers -- Selenium and androgen receptor in prostate cancer / Nagalakshmi Nadiminty and Allen C. Gao.
  • 2013 Springer
    Zhou Wang, editor.
    Recent studies demonstrated a key role of the androgen receptor in the development of castration-recurrent or -resistant prostate cancer (CRPC), which is deadly and in urgent need of more effective therapies. Understanding the functions of androgen-responsive genes and their regulation and deregulation in prostate cancer progression may lead to new approaches to prevent and treat prostate cancer patients. This book provides an up-to-date review of the overall androgen-responsive gene expression program and the regulation, function, and clinical relevance of both protein coding and non-coding androgen-responsive genes. Experts in the field of androgen action and prostate cancer research discussed the importance of DNA elements, chromatin structure, cellular signaling, and cell-cell interactions in the regulation of androgen-responsive genes in the context of prostate cancer progression, including the development of CRPC. This book is intended for individuals interested in cancer endocrinology and medical and healthcare professionals involved in prostate cancer research.
  • 2010 Springer
    Rüdiger Liersch, Wolfgang E. Berdel, Torsten Kessler (eds.).
    Angiopoietins / Yvonne Reiss -- HIF-1 alpha and cancer therapy / Mei Yee Koh, Tally R. Spivak-Kroizman, Garth Powis -- Chemokines / Andreas Hippe, Bernhard Homey, Anja Meuller-Homey -- Angiogenesis inhibition in cancer therapy / Iris Appelmann ... [et al.] -- Vascular integrins : therapeutic and imaging targets of tumor angiogenesis / Curzio Ruegg, Gian Carlo Alghisi -- PDGF and vessel maturation / Carina Hellberg, Arne Ostman, C.-H. Heldin -- Lymphangiogenesis in cancer : current perspectives / Rudiger Liersch ... [et al.] -- Compounds in clinical phase III and beyond / Torsten Kessler ... [et al.] -- Metronomic chemotherapy : principles and lessons learned from applications in the treatment of metastatic prostate cancer / Urban Emmenegger ... [et al.] -- Targeting inflammatory cells to improve anti-VEGF therapies in oncology / Hans-Peter Gerber, Ezogelin Olazoglu, Iqbal S. Gerwal -- Antibody-based vascular tumor targeting / Christoph Schliemann, Dario Neri -- Caveolae and cancer / Kerri A. Massey, Jan E. Schnitzer.
  • 2013 Springer Protocols
    edited by Ricardo Martinex-Murillo, Alfredo Martinez.
    Brain tumor models to predict clinical outcome : like the Phoenix? / Lois A. Lampson -- Animal models in cancer research : assessment of severity and the application of humane endpoints / Jose M. Orellana-Muriana -- VM mouse model of glioblastoma multiforme / Thomas N. Seyfried, Laura M. Shelton, and Leanne C. Huysentruyt -- Oligodendroglioma model / Nanna Lindberg and Lene Uhrbom -- Medulloblastoma model / Jasmine Lau and William A. Weiss -- Learning about retinoblastoma from mouse models that missed / David Cobrinik -- Ependymoma models / Jesus Vaquero and Mercedes Zurita -- Meningioma models / Jessica Rainey and Randy L. Jensen -- Pituitary models / Walavan Sivakumar and William T. Couldwell -- Growth regulation of nervous system tumors : models for assessment of angiogenesis in brain tumors / Kelly Burrell [and others] -- Using genetically-engineered mouse models to understand low-grade glioma development and growth in children / Aparna Kaul, Ibrahim Hussain, and David H. Gutmann -- EGFR and tumor-suppressor function in brain cancer development / Julie Lessard and Al Charest -- Rodent glioma models : intracranial stereotactic allografts and xenografts / Hikmat Assi [and others] -- Immunotherapy of high-grade gliomas : preclinical in vivo experiments in animal models / Kristen A. Batich, Bryan D. Choi, and Duane A. Mitchell -- Assessing mechanisms of glioblastoma invasion / Stephen M. Robbins and Donna L. Senger -- Positron emission tomography (PET)-based molecular imaging / Yannic Waerzeggers [and others] -- In vivo magnetic resonance spectroscopic imaging (MRSI) and ex vivo quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS) / Rui V. Simoes [and others] -- Single photon emission computed tomography (SPECT) in small animal CNS research / Andre Constantinesco, Christian Goetz, and Philippe Choquet.
  • 2008 Springer
    edited by Beverly A. Teicher, Lee M. Ellis.
  • 2008 CRCnetBASE
    edited by Darren W. Davis and Roy S. Herbst, James L. Abbruzzese
    Part I: Angiogenesis in cancer -- Strategies to prolong the nonangiogenic dormant state of human cancer / George N. Naumov and Judah Folkman -- Vascular endothelial growth factor: basic biology and clinical implications / Napoleone Ferrara -- Angiogenesis in solid tumors / Rakesh K. Jain and Dan G. Duda -- Pathophysiologic role of VEGF in hematologic malignancies / Klaus Podar ... [et al.] -- Tumor microenvironment and angiogenesis / Cheryl H. Baker and Isaiah J. Fidler -- Part II: Targeting angiogenesis for cancer therapy -- Tyrosine kinase inhibitors of angiogenesis / Janessa J. Laskin and Alan B. Sandler -- Development of antiangiogenic monoclonal antibodies for cancer therapy / Zhenping Zhu and Daniel J. Hicklin -- Targeting fibroblast growth factor / fibroblast growth factor receptor system in angiogenesis / Marco Rusnati and Marco Presta -- Development of the VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and discovery of the next generation of angiogenesis targets / John S. Rudge ... [et al.] -- Proteinases and their inhibitors in angiogenesis / Yves A. DeClerck, Khalid Bajou, and Walter E. Laug -- Prostaglandins and COX-2: role in antiangiogenic therapy / Kristin Hennenfent, Daniel Morgensztern, and Ramaswamy Govindan -- Integrins, adhesion, and coadhesion inhibitors in angiogenesis / Abebe Akalu and Peter C. Brooks -- Conventional therapeutics with antiangiogenic activity / Christian Hafner, Thomas Vogt, and Albrecht Reichle -- Vascular disrupting agents / David J. Chaplin, Graeme J. Dougherty, and Dietmar W. Siemann -- Vascular and hematopoietic stem cells as targets for antiangiogenic therapy / Carlos Almeida Ramos, Hans-Georg Kopp, and Shahin Rafii -- Genetic strategies for targeting angiogenesis / Anita Tandle, Mijung Kwon, and Steven K. Libutti -- Identification of new targets using expression profiles / Thomas R. Burkard ... [et al.].; Part III: Translating angiogenesis inhibitors to the clinic -- Clinical trial design and regulatory issues / Ramzi N. Dagher and Richard Pazdur -- Surrogate markers for antiangiogenic cancer therapy / Darren W. Davis -- Noninvasive surrogates / Bruno Morgan and Mark A. Horsfield -- Pharmacodynamic markers in tissues / Darren W. Davis -- Blood-based biomarkers for VEGF inhibitors / Amado J. Zurita, Hua-Kang Wu, and John V. Heymach -- Part IV: Treatment of specific cancers with angiogenesis inhibitors -- Antiangiogenic therapy for colorectal cancer / Paulo M. Hoff and Everardo D. Saad -- Combined modality therapy of rectal cancer / Christopher G. Willett and Dan G. Duda -- Antiangiogenic therapy for breast cancer / Pablo M. Bedano ... [et al.] -- Antiangiogenic therapy for lung malignancies / David J. Stewart -- Antiangiogenic therapy for prostate cancer / Leslie K. Walker, Glenn Liu, and George Wilding -- Antiangiogenic therapy for hematologic malignancies / Karen W.L. Yee and Francis J. Giles -- Antiangiogenic therapy for gliomas / Heinrich Elinzano and Howard A. Fine -- Antiangiogenic therapy for Kaposi's sarcoma / Henry B. Koon, Liron Pantanowitz, and Bruce J. Dezube -- Antiangiogenic therapy for melanoma / Keith Dredge and Angus G. Dalgleish -- Sunitinib and renal cell carcinoma / Robert J. Motzer and Sakina Hoosen.
  • 2010 ClinicalKey
    [edited by] Roger Finch ... [et al.].
    1. Historical introduction -- 2. Modes of action -- 3. The problem of resistance -- 4. Pharmacodynamics of anti-infective agents: target delineation and susceptibility breakpoint selection -- 5. Antimicrobial agents and the kidneys -- 6. Drug interactions involving anti-infective agents -- 7. Antibiotics and the immune system -- 8. General principles of antimicrobial chemotherapy -- 9. Laboratory control of antimicrobial therapy -- 10. Principles of chemop rophylaxis -- 11. Antibiotic policies -- 12. Aminoglycosides and aminocyclitols -- 13. β-Lactam antibiotics : cephalosporins -- 14. β-Lactam antibiotics: penicillins -- 15. Other β-lactam antibiotics -- 16. Chloramphenicol and thiamphenicol -- 17. Diaminopyrimidines -- 18. Fosfomycin and fosmidomycin -- 19. Fusidanes -- 20. Glycopeptides -- 21. Lincosamides -- 22. Macrolides -- 23. Mupirocin -- 24. Nitroimidazoles -- 25. Oxazolidinones -- 26. Quinolones -- 27. Rifamycins -- 28. Streptogramins -- 29. Sulfonamides -- 30. Tetracyclines -- 31. Miscellaneous antibacterial agents -- 32. Antifungal agents -- 33. Antimycobacterial agents -- 34. Anthelmintics -- 35. Antiprotozoal agents -- 36. Antiretroviral agents -- 37. Other antiviral agents -- 38. Sepsis -- 39. Abdominal and other surgical infections -- 40. Infections associated with neutropenia and transplantation -- 41. Infections in intensive care patients -- 42. Infections associated with implanted medical devices -- 43. Antiretroviral therapy for HIV -- 44. Infections of the upper respiratory tract -- 45. Infections of the lower respiratory tract -- 46. Endocarditis -- 47. Infections of the gastrointestinal tract -- 48. Hepatitis -- 49. Skin and soft-tissue infections -- 50. Bacterial infections of the central nervous system -- 51. Viral infections of the central nervous system -- 52. Bone and joint infections -- 53. Infections of the eye -- 54. Urinary tract infections -- 55. Infections in pregnancy -- 56. Sexually transmitted diseases -- 57. Leprosy -- 58. Tuberculosis and other mycobacterial infections -- 59. Superficial and mucocutaneous mycoses -- 60. Systemic fungal infections -- 61. Zoonoses -- 62. Malaria -- 63. Other protozoal infections -- 64. Helminthic infections.
  • 2013 Springer Protocols
    edited by Laurent Ducry.
    Antibody-drug conjugate (ADC) clinical pipeline : a review / Ingrid Sassoon and Veronique Blanc -- Antibody-drug conjugate target selection : critical factors / Neil H. Bander -- Selecting an optimal antibody for antibody-drug conjugate therapy : internalization and intracellular localization / Jay Harper ... [et al.] -- Antibody-drug conjugate payloads / Jan Anderl ... [et al.] -- Linker technologies for antibody-drug conjugates / Birte Nolting -- In vivo testing of drug-linker stability / Pierre-Yves Abecassis and Celine Amara -- Pharmacokinetics and ADME characterizations of antibody-drug conjugates / Kedan Lin, Jay Tibbitts, and Ben-Quan Shen -- Safe handling of cytotoxic compounds in a biopharmaceutical environment / Miriam I. Hensgen and Bernhard Stump -- Micro- and mid-scale maleimide-based conjugation of cytotoxic drugs to antibody hinge region thiols for tumor targeting / James E. Stefano ... [et al.] -- Protocols for lysine conjugation / Marie-Priscille Brun and Laurence Gauzy-Lazo -- Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers / Sunil Bhakta, Helga Raab, and Jagath R. Junutula -- Enzymatic antibody modification by bacterial transglutaminase / Patrick Dennler, Roger Schibli, and Eliane Fischer -- Formulation development of antibody-drug conjugates / William J. Galush and Aditya A. Wakankar -- Conjugation process development and scale-up / Bernhard Stump and Jessica Steinmann -- Methods for conjugating antibodies to nanocarriers / Anil Wagh and Benedict Law -- Drug-to-antibody ratio (DAR) by UV/Vis spectroscopy / Yan Chen -- Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography / Jun Ouyang -- Drug-to-antibody ratio (DAR) and drug load distribution by LC-ESI-MS / Louisette Basa -- Determination of charge heterogeneity and level of unconjugated antibody by imaged cIEF / Joyce Lin and Alexandru C. Lazar -- Risk-based scientific approach for determination of extractables/leachables from biomanufacturing of antibody-drug conjugates (ADCs) / Weibing Ding.
  • 2015 Springer
    Jeffrey Wang, Wei-Chiang Shen, Jennica L. Zaro, editors.
    This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.
  • 2013 Springer
    Gail Lewis Phillips, editor.
    The concept of delivering 'magic bullets' to treat diseases was first proposed by Paul Erlich in the early 1900's. The realization of this concept for the treatment of cancer occurred in the late 1990's with the approval of monoclonal antibody therapies. The use of monoclonal antibodies conjugated (linked) to potent cytotoxic agents (antibody-drug conjugates, ADCs) for specifically delivering cytotoxics to cancer cells was an obvious extension of antibody-based therapy. ADCs have been under intense investigation for several decades; progress, however, has been limited due to toxicity or lack of improved efficacy compared to unconjugated cytotoxics. More recently, linker technology and target selection have advanced such that several ADCs and immunotoxins are undergoing clinical testing or are approved for use. This important volume gives the latest and most comprehensive information on the topic, describing different types of ADCs and immunotoxins for both hematologic and solid malignancies. Finally, the volume highlights the promise that this technology holds for diverse types of human cancer.
  • 2012 CRCnetBASE
    edited by Gordon M. Cragg, David G.I. Kingston, and David J. Newman.
    "This book covers clinically used anticancer agents that are either natural products or are clearly derived from natural product leads. The second edition includes drugs that are currently in development. In addition, the text emphasizes the applications of synthetic and medicinal chemistry to the preparation of analogs with enhanced activities. Contributors also address the potential of novel drug discovery through the use of genome mining as well as the status of advanced development candidates. For each compound of class of compounds, the text provides information on the history, structure, mechanism of action, development, synthesis, medicinal chemistry, and clinical applications"-- Provided by publisher. "The search for new lead compounds is a crucial element of modern pharmaceutical research. Natural products provided the only source of pharmaceuticals for thousands of years, and natural products have made enormous contributions to human health through compounds such as quinine, morphine, aspirin (a natural product analog), digitoxin, and many others. The potential of natural products as anticancer agents was recognized in the 1950's by the U. S. National Cancer Institute (NCI) under the leadership of the late Dr. Jonathan Hartwell, and the NCI has since made major contributions to the discovery of new naturally occurring anticancer agents through its contract and grant support, including an important program of plant and marine collections. Many, although not all, of the compound classes described in the following pages owe their origin in whole or in part to NCI support. In spite of the success of the natural products approach to anticancer drug discovery, as exemplified by the following chapters, in recent years their importance as a source of molecular diversity for drug discovery research and development has been overshadowed by newer chemical approaches currently in favor. These approaches include chemical ones which make heavy use of combinatorial chemistry, and biological ones such as manipulation of biosynthetic pathways of microbial metabolites through combinatorial biosynthetic techniques. It is thus worthwhile to review briefly the major reasons why natural products are so important. First, there is a strong biological and ecological rationale for plants and marine invertebrates to produce novel bioactive secondary metabolites"-- Provided by publisher.
  • 2014 Springer
    Stefan Grimm, editor.
    "This book discusses the emergence of a new class of genes with a specific anticancer activity. These genes, recently defined as "Anticancer Genes", are reviewed in individual chapters on their mode of action, the specific cell death signals they induce, and the status of attempts to translate them into clinical application. Anticancer Genes provides an overview of this nascent field, its genesis, current state, and prospect. It discusses how Anticancer Genes might lead to the identification of a repertoire of signaling pathways directed against cellular alterations that are specific for tumor cells."--Publisher's website.
    Also available: Print – 2014
  • 2013
    Diane Tseng.
    Mobilization of the T cell response against cancer has the potential to achieve long-lasting cures. However, it is not known how to optimally harness antigen presenting cells to achieve an effective anti-tumor T cell response. In this study, we show that anti-CD47 antibody-mediated phagocytosis of cancer by macrophages can initiate an anti-tumor T cell immune response. Using the ovalbumin model antigen system, anti-CD47 antibody-mediated phagocytosis of cancer cells by macrophages resulted in increased priming of OT-I T cells (CD8+), but did not prime OT-II T cells (CD4+). The CD4+ T cell response was characterized by a reduction in Foxp3+ regulatory T cells. Macrophages following anti-CD47-mediated phagocytosis primed CD8+ T cells to exhibit cytotoxic effector function in vivo, protecting animals from tumor challenge. We conclude that anti-CD47 antibody treatment not only enables macrophage phagocytosis of cancer, but can also initiate an anti-tumor cytotoxic T cell immune response. Anti-CD47-mediated phagocytosis of cancer cells by macrophages leads to priming of a predominant CD8+ T cell response without priming of CD4+ T cells, demonstrating differential priming of T cell responses by macrophages. Priming of effector CD8+ T cells is difficult to achieve with existing vaccines for cancer and infectious diseases. Anti-CD47-based vaccination strategies serve as a promising new strategy for overcoming this challenge for treating or preventing human disease.
  • 2011 Karger
    volume editors, Peter R. Donald, Paul D. van Helden.
    History of drug discovery : early evaluation studies and lessons learnt from them / Ahmad, Z., Makaya, N.H. and Grosset, J. -- Tuberculosis treatment trials past and present : old and new challenges / Nunn, N. -- The rifamycins : renewed interest in an old drug class / Burman, W., Dooley, K.E., and Nuermberger, E. -- Isoniazid pharmacokinetics and efficacy in adults and children / Donald, P.R. and Schaaf, H.S. -- Recent developments in the study of pyrazinamide : an update / Mitchison, D.A. and Zhang, Y. -- Experience with phase III clinical trials of antituberculosis drugs and regimens : conclusions and lessons for the future / Jindani, A. -- Tuberculosis recurrence : exogenous or endogenous? / Williams, M. ... [et al.] -- Second-line antituberculosis drugs : current knowledge, recent research findings and controversies / Schaaf, H.S., Seddon, J.A., and Caminero, J.A. -- Acquisition, transmission, and amplification of drug-resistant tuberculosis / Müller, B. ... [et al.] -- The treatment of tuberculosis in children -- Cruz, A.T. and Starke, J.R. -- Issues and challenges in the development of novel tuberculosis drug regimens / Erondu, N. and Ginsberg, A. -- Drug resistance in mycobacterium tuberculosis : molecular mechanisms and laboratory susceptibility testing / Bittger, E.C. -- The role of the mouse model in the evaluation of new antituberculosis drugs / Nuermberger, E.L. -- Current issues in tuberculosis pharmacokinetics / Egelund, E.F. and Peloquin, C.A. -- Pharmacological considerations of antitubercular agents in children / Goldman, J.L., Kearns, G.L., and Abdel-Rahman, S.M. -- Interactions between antituberculosis and antiretroviral agents / Mcilleron, H. and Khoo, S.H. -- Diabetes mellitus and tuberculosis treatment / Ruslami, R., Van Crevel, R. -- Early bactericidal activity of antituberculosis agents / Maritz, J.Z., Diacon, A.H., and Donald, P.R. -- Assessment of whole-blood bactericidal activity in the evaluation of new antituberculosis drugs / Wallis, R.S. -- Serial sputum colony counting in drug regimens / Sloan, D. and Davies, G. -- The evaluation of new antituberculosis drugs in children / Mcneeley, D.F. ... [et al.] -- A new era in tuberculosis treatment : what does the future hold? / Duncan, K.
  • 2015 Karger
    volume editors, Gerhard Rogler, Toshifumi Hibi, Hans Herfarth, Ole Haagen Nielsen.
  • 2015 Thieme eNeurosurgery
    guest editors, Ziya Gokaslan, Charles Fisher, Stefano Boriani.
    Evaluation and decision making for metastatic spine tumors / Yan Michael Li, Michael S. Dirks, Claudio E. Tatsui, and Laurence D. Rhines -- Neoplastic spinal instability / Daryl R. Fourney and Charles G. Fisher -- Major complications associated with stereotactic ablative radiotherapy (SABR) for spinal metastasis / Simon S. Lo, Arjun Sahgal, and Eric L. Chang -- En bloc resection in the treatment of spinal metastases : technique and indications / Ilya Laufer, Jean-Paul Wolinksy, and Mark H. Bilsky -- Region specific approaches / Daniel Sciubba -- Spinal reconstruction and fixation/fusion / Rajiv Saigal and Dean Chou -- Minimally invasive surgery for metastatic spine disease / Meic H. Schmidt -- Vertebral augmentation for metastatic disease / Ehud Mendel, Eric Bourekas, and Paul Porensky -- Surgical complications and avoidance / Michelle J. Clarke.
  • 2015 Thieme eNeurosurgery
    guest editors, Ziya Gokaslan, Charles Fisher, Stefano Boriani.
    Evaluation and decision making / Stefano Boriani and Charles Fisher -- Safety and efficacy of surgery for primary tumors of the spine / Daryl R. Fourney, Charles Fisher, and Stefano Boriani -- Interventional options for primary tumors / Sudhir Kathuria -- Radiation therapy for primary bone tumors / Brent Y. Kimball and Yoshiya Yamada -- Medical oncology principles for the spine oncology surgeon / Scott H. Okuno, Steven Robinson and Shreyaskumar Patel -- Spinal osteoid osteoma and osteoblastoma / Melissa Nadeau and Christian DiPaola -- ABC, giant cell / Stefano Boriani, Stefano Bandiera, Riccardo Ghermandi, Simone Colangeli, Luca Amendola, and Alessandro Gasbarrini -- Chordoma / Jackson Sui, Patricia L. Zadnik, Mari L. Groves, and Ziya L. Gokaslan -- Chondrosarcoma / Stefano Boriani, Stefano Bandiera, Riccardo Ghermandi, Simone Colangeli, Luca Amendola, and Alessandro Gasbarrini -- Osteogenic and ewing sarcomas of the spine / Derek G. Ju, Patricia L. Zadnik, and Daniel M. Sciubba -- Margins in spine tumor resection : how much is enough? is planned -- Transgression okay? / Ilya Laufer, Mari Groves, and Jean-Paul Wolinsky -- Principles behind determining the right approach / Nicolas Dea and Rowan Schouten -- Spino-pelvic reconstruction/fixation and fusion / Peter Paul Varga -- Structural graft selection and wound closure techniques -- Complications and avoidance: how to plan primary tumor resection to minimize complications and maximize outcome / Michael C. Oh, Vedat Deviren, and Christopher P. Ames.
  • 2009 Springer
    edited by Inke S. Näthke, Brooke M. McCartney.
    APC and [beta]-catenin degradation -- Nuclear APC -- APC in cell migration -- The APC-EB1 interaction -- The role of APC in mitosis and in chromosome instability -- Role of APC and its binding partners in regulating microtubules in mitosis -- The adenomatous polyposis coli tumor -- Suppressor and Wnt signaling in the regulation of apoptosis -- APC and its modifiers in colon cancer -- Tissue-specific tumour suppression by APC -- Extra-colonic manifestations of familial adenomatous polyposis coli.
    Also available: Print – 2009
  • 2015 Springer Protocols
    edited by Gil Mor and Ayesha B. Alvero.
    In Apoptosis and Cancer: Methods and Protocols, Second Edition, expert researches in the field detail the performance of molecular and cellular biology techniques for studying and detecting the activation of the apoptotic pathway. Chapters focus on assays developed to detect its activation not only in vitro but also in vivo, optimized multiplex analysis, medium- to high-throughput screens, and the cellular process. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Apoptosis and Cancer: Methods and Protocols, Second Edition aids scientists as a stand-alone resource for the execution and analysis of the described protocols and as a reference for the study and detection of apoptosis within and outside the area of cancer research.
  • 2008 Springer Protocols
    edited by Gil Mor and Ayesha B. Alvero.
    Modulation of apoptosis to reverse chemoresistance / Gil Mor, Michele K. Montagna, and Ayesha B. Alvero - - Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis / Suparna Mazumder, Dragos Plesca, and Alexandru Almasan - - Flow cytometry enumeration of apoptotic cancer cells by apoptotic rate / David Diaz ... [et al.] - - Detection of cancer-related proteins in fresh-frozen ovarian cancer samples using laser capture microdissection / Dan-Arin Silasi ... [et al.] - - Flow cytometric detection of activated caspase-3 / Richard Fox and Martine Aubert - - The chemofx® assay : an ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy / Stacey L. Brower, Jeffrey E. Fensterer, and Jason E. Bush -- Correlation of caspase activity and in vitro chemo-response in epithelial ovarian cancer cell lines / Ayesha B. Alvero, Michele K. Montagna, and Gil Mor - - Assessing expression of apoptotic markers using large cohort tissue microarrays / Elah Pick, Mary M. McCarthy, and Harriet M. Kluger -- Mitochondria potential, bax "activation," and programmed cell death / C. Michael Knudson and Nicholas M. Brown -- In vitro and in vivo apoptosis detection using membrane permeant fluorescent-labeled inhibitors of caspases / Brian W. Lee ... [et al.] - - Caspase activity assays / Andrew L. Niles, Richard A. Moravec, and Terry L. Riss - - Multiplex caspase activity and cytotoxicity assays / Andrew L. Niles, Richard A. Moravec, and Terry L. Riss - - Homogeneous, bioluminescent proteasome assays / Martha A. O'Brien ... [et al.] - - A simple method for profiling mirna expression / Jia-Wang Wang and Jin Q. Cheng - - Apoptotic caspase activation and activity / Jean-Bernard Denault and Guy S. Salvesen - - Biochemical analysis of the native trail death-inducing signaling complex / Henning Walczak and Tobias L. Haas - - Laser microdissection sample preparation for RNA analyses / Christopher J. Vega.
  • v. 1-2, 2007. Springer
    v. 2, 2007 Springer
    edited by Rakesh Srivastava.
    BCR-ABL and human cancer / Maria Pérez-Caro and Isidro Sánchez-Garcia -- Angiogenesis and cancer / Yohei Maeshima -- Metastasis: the evasion of apoptosis / Christine E. Horak ... [et al.] -- Carcinogenesis: balance between apoptosis and survival pathways / Dean G. Tang and James P. Kehrer -- Aberrations of DNA damage checkpoints in cancer / Marikki Laiho -- c-Myc, apoptosis, and disordered tissue growth / Michael Khan and Stella Pelengaris -- Role of lysophospholipids in cell growth and survival / Xianjun Fang and Sarah Spiegel -- Alternative use of signaling by the [beta] GBP cytokine in cell growth and cancer control: from surveillance to therapy / Livio Mallucci and Valerie Wells -- Control nodes linking the regulatory networks of the cell cycle and apoptosis / Baltazar D. Aguda, Wee Kheng Yio, and Felicia Ng -- Regulation of NF-[kapa]B function: target for drug development / Daniel Sliva and Rakesh Srivastava -- 5-fluorouracil: molecular mechanisms of cell death / Daniel B. Longley and Patrick G. Johnston -- Apoptosis-inducing cellular vehicles for cancer gene therapy: endothelial and neural progenitors / Gergely Jarmy ... [et al.] -- Apoptosis and cancer therapy / Maurice Reimann and Clemens A. Schmitt -- Coupling apoptosis and cell division control in cancer: the survivin paradigm / Dario C. Altieri -- Clinical significance of histone deacetylase inhibitors in cancer / Sharmila Shankar and Rakesh K. Srivastava.
  • 2016 Springer
    Christopher D. Gregory, editor.
    Foreword -- Preface -- 1. Molecular Cell Biology of Apoptosis and Necroptosis in Cancer -- 2. Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis -- 3. Micro-environmental Effects of Cell Death in Malignant Disease -- 4. Apoptotic Caspases in Promoting Cancer: Implications from Their Roles in Development and Tissue Homeostasis -- 5. Axl and Mer Receptor Tyrosine Kinases: Distinct and Non-overlapping Roles in Inflammation and Cancer? -- 6. Immunogenic Apoptotic Cell Death and Anti-cancer Immunity -- 7. Cancer Cell Death-inducing Radiotherapy -- Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity -- 8. Novel Approaches to Apoptosis-inducing Therapies -- 9. Killing Is Not Enough: How Apoptosis Hijacks Tumor-associated Macrophages to Promote Cancer Progression -- Index.
    Also available: Print – 2016
  • 2009 Springer
    George G. Chen, Paul B.S. Lai, editors.
  • 2007 Springer
    edited by David A. Gewirtz, Shawn E. Holt, Steven Grant.
    The intrinsic pathway of apoptosis -- The extrinsic pathway of apoptosis -- Evaluating the importance of apoptosis and other determinants of cell death and survival -- Mitotic catastrophe -- Autophagy and autophagic cell death -- Regulation and function of detachment-induced cell death (anoikis) in cancer progression and metastasis -- Structure and function of the telomere -- Overview of senescence -- Contributions of telomerase to tumorigenesis -- The role of telomeres in genomic instability -- Overview of the DNA damage checkpoint: ATM and ATR -- Interactions between myc- and cyclin-dependent kinase inhibitors in cancer -- Interplay between [gamma]H2AX and 53BP1 pathways in DNA double-strand break repair response -- DNA-dependent protein kinase in repair, apoptosis, telomere maintenance, and chemotherapy -- Resistance/signaling pathways -- Ceramide and multidrug resistance -- Chemo- and radiosensitization through inhibition of PI3K/Akt signaling -- The advancement of epidermal growth factor receptor inhibitors in cancer therapy -- Antimetabolites -- Topoisomerase I poisons and apoptotic topoisomerase I-DNA complexes -- Perturbations of cellular functions by topoisomerase II inhibitors: all roads lead to cell death? -- The significance of poly-targeting in apoptosis induction by alkylating agents and platinum drugs -- Contributions of apoptosis and senescence to cytotoxicity produced by microtubule-stabilizing agents -- Tyrosine kinase inhibitors -- Monoclonal antibodies in lymphomas -- Role of apoptosis in anti-angiogenic cancer therapies -- Photodynamic therapy-induced apoptosis -- Modulation of TRAIL signaling for cancer therapy.
  • 2010 Springer
    Francesco Cecconi, Marcello D'Amelio, editors.
  • 2014 Springer
    Kewal K. Jain.
    Applications of Biotechnology in Oncology collects key writings by Kewal K. Jain on the most important contributions of biotechnology to cancer research, particularly to the molecular diagnosis of cancer and drug delivery in cancer for personalized management of patients. Basics of various -omics technologies and their application in oncology are described as oncogenomics and oncoproteomics. This detailed volume also explores molecular diagnostics, nanobiotechnology, cell and gene therapies, as well as personalized oncology. With approximately one thousand selected references from recent literature on this topic and numerous tables and figures, Applications of Biotechnology in Oncology serves as an ideal reference for oncologists, scientists involved in research on cancer biology, and physicians in various specialties who deal with cancer.
  • 2012 ScienceDirect
    edited by David T. Curiel, Paul B. Fisher.
    Ch. 1. Cancer terminator viruses and approaches for enhancing therapeutic outcomes -- Ch. 2. Adenovirus strategies for tissue-specific targeting -- Ch. 3. Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds -- Ch. 4. Design of improved oncolytic adenoviruses -- Ch. 5. The development of transcription-regulated adenoviral vectors with high cancer-selective imaging capabilities -- Ch. 6. Adenovirus-based immunotherapy of cancer, promises to keep -- Ch. 7. Cancer treatment with gene therapy and radiation therapy -- Ch. 8. Oncolytic adenoviruses for cancer immunotherapy, data from mice, hamsters, and humans -- Index.
  • 2016 Springer
    Jose A. Plaza, Victor G. Prieto, editors.
  • 2006 Springer
    edited by B.J.A. Furr.
  • 2008 Springer
    edited by B.J.A. Furr.
  • 2013 Springer Protocols
    edited by Diponkar Banerjee, Sohrab P. Shah.
    Array comparative genomic hybridization : an overview of protocols, applications, and technology trends / Diponkar Banerjee -- Ultradense array CGH and discovery of micro-copy number alterations and gene fusions in the cancer genome / Ewa Przybytkowski [and others] -- Epigenomics : sequencing the methylome / Martin Hirst -- Application of array comparative genomic hybridization in chronic myeloid leukemia / Seonyang Park [and others] -- Use of cytogenetic microarrays in myelodysplastic syndrome Characterization / Lisa G. Shaffer, Blake C. Ballif, and Roger A. Schultz -- CGH protocols : chronic lymphocytic leukemia / Esteban Braggio, Rafael Fonseca, and Neil E. Kay -- Analysis of Acquired genomic copy number aberrations and regions of loss of heterozygosity in acute myelogenous leukemia genomes using affymetrix SNP 6.0 arrays and supporting software tools / Peter D. Ouillette [and others] -- Clinical applications of BAC array-CGH to the study of diffuse large B-cell lymphomas / Cristina Robledo, Juan Luis Garcia, and Jesus M. Hernandez -- Genomic profiling of mantle cell lymphoma / Melissa Rieger Menanteau and Jose A. Martinez-Climent -- Copy number analysis in EBV-positive nodal peripheral T cell lymphoma, unspecified / Kyusam Choi, Hyunjeong Ju, and Young Hyeh Ko -- Mycosis fungoides and Sezary syndrome / Blanca Espinet and Rocio Salgado -- Array CGH reveals clonal evolution of adult T-cell leukemia/lymphoma / Akira Umino and Masao Seto -- Array-CGH analysis of cutaneous anaplastic large cell lymphoma / K. Szuhai [and others] -- Genome-wide DNA profiling of HIV-related B-cell lymphomas / Andrea Rinaldi [and others] -- Array comparative genomic hybridization in osteosarcoma / Bekim Sadikovic [and others] -- Comparative genomic hybridization of Wilms' tumor / Shahrad Rod Rassekh and Evica Rajcan-Separovic -- Array-CGH in childhood MDS / Marcel Tauscher, Inka Praulich, and Doris Steinemann -- Nonfamilial breast cancer subtypes / Markus Ringner, Johan Staaf, and Goran Jonsson -- Applications of array-CGH for lung cancer / Kenneth J. Craddock, Wan L. Lam, and Ming-Sound Tsao -- Array CGH in brain tumors / Gayatry Mohapatra, Julia Sharma, and Stephen Yip -- Finding common regions of alteration in copy number data / Oscar M. Rueda, Ramon Diaz-Uriarte, and Carlos Caldas -- Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arrays / Gavin Ha and Sohrab Shah.
  • 2008 Springer
    editor, Mikhail V. Kiselevsky.
  • 2013 Springer
    edited by Sasan Karimi.
    Atlas of Brain and Spine Oncology Imaging presents a comprehensive visual review of pathologic disease variations of cancers of the brain and spine through extensive radiologic images. The focus of the book is on algorithmic strategies for identifying neoplastic pathologies commonly found in brain and spinal tumors through a visual representation of the variety of appearances that each neoplasm takes, within both benign and malignant manifestations.
  • 2015 Springer
    Mario Rietjens, Mario Casales Schorr, Visnu Lohsiriwat ; forewords by Umberto Veronesi and Jean Yves Petit.
    Back Cover Text Breast reconstructive and oncoplastic surgery can reduce the sense of mutilation resulting from oncologic surgery and meets the need to provide breast cancer treatment that will not only eradicate the cancer but also re-establish the patient?s quality of life. However, the difficulties inherent in preoperative planning and the intraoperative complexity of breast reconstruction and oncoplastic techniques represent major challenges for the breast surgeon. This atlas, intended for surgeons at every level, is an all-inclusive guide that documents surgical techniques step by step by means of a wealth of more than 1000 color photos, additional high-quality drawings and illustrations, and succinct accompanying text. Both common, established procedures and the most recently introduced techniques are covered, ensuring that readers will have at their disposal multiple approaches for breast repair, remodeling, and reconstruction. In addition to the comprehensive descriptions of techniques, preoperative planning is explained, indications and contraindications are identified, and the management of surgical complications is discussed. Tips, pitfalls, and key points are highlighted. The Atlas of Breast Reconstruction is an unprecedented tool that will increase and refine the arsenal at the oncoplastic surgeon's disposal in order to ensure that the best treatment can be offered to each individual patient.
  • 2015 Thieme-Connect
    Diethelm Wallwiener [and eight others].
  • 2010 ClinicalKey
    editor, V. Suzanne Klimberg.
    Aspiration of a breast cyst -- Incision and drainage of an abscess -- Ultrasound-guided percutaneous excisional biopsy -- Stereotactic breast biopsy -- Breast ductoscopy -- Excisional breast biopsy of palpable or nonpalpable lesions -- Needle localization breast biopsy -- Radioisotope occult lesion localization -- Cryoablation-assisted lumpectomy -- Excision followed by radiofrequency ablation -- Axillary sentinel lymph node biopsy -- Mediastinal sentinel lymph node biopsy -- Axillary lymph node dissection -- Axillary reverse mapping -- Simple mastectomy -- Simple extended and modified radical mastectomy -- Oncoplastic approaches to the partial mastectomy for breast conservation therapy -- Breast reconstruction postmastectomy with tissue expanders and alloderm -- Tissue breast reconstruction -- Utility of reduction mammoplasty techniques in oncoplastic surgery -- Chest wall resection -- Forequarter amputation -- Mammosite balloon catheter placement and other brachytherapy delivery devices -- In vivo intraoperative radiation therapy for breast cancer -- Targeted intraoperative radiation therapy (TARGIT).
  • 2008 IARC
    edited by P. Boyle and M. Smans.
    Also available: Print – 2008
  • 2015 Springer
    Junzo Kigawa, Tsunehisa Kaku, Toru Sugiyama, Steven G Silverberg.
    Clear cell carcinoma (CCC) of the ovary with its unique clinical and biological features has attracted great attention, and calls for the publication of a specialized book on the subject. This is the first atlas that has narrowed its focus to CCC. Revealed here are the typical and variable histological features of CCC and related tumors. Hundreds of high-quality photographs help the reader to recognize the pathological features and clinical manifestations of CCC and to formulate diagnoses confidently and accurately. Data are based on the international central pathological review of the JGOG/GCIG3017 clinical trial in which experts around the world participated. Using a virtual slide system, interesting and significant features of CCC were discovered in the review of 652 cases. This book provides the newest information on the categorization and classification of CCC: growth patterns (papillary, tubocystic, solid, and adenofibromatous), cell types (classical hobnail and clear cell, eosinophilic, oxyphilic, and oncocytic), stromal changes (hyalinized, necrotic, hemorrhagic, lymphocytic infiltrative, luteinized, and psammomatous calcification), presence of endometriosis and atypical endometriosis, and borderline/atypical proliferative tumors. The Atlas of Clear Cell Carcinoma of the Ovary is an invaluable diagnostic resource for pathologists and gynecologic oncologists.
  • 2015 Springer
    Tommaso Vincenzo Bartolotta, Adele Taibbi, Massimo Midiri.
    Introduction -- Benign Focal Liver Lesions -- Malignant Focal Liver Lesions -- Fatty Liver, Pseudolesions -- Other Rare Lesions -- Assessment of Therapy Response -- Impact of European Guidelines on CEUS.
  • 2015 Springer
    Joi B. Carter, Amrita Goyal, Lyn McDivitt Duncan, editors.
    The integration of clinical findings, laboratory results, and disease progression is critical for the diagnosis and treatment of patients with skin lymphoma. This atlas includes numerous clinical and histological images with diagrams, tables, and text describing each type of lymphoma in the current cutaneous classification scheme, which includes information on the recent classification scheme for cutaneous lymphoma published by the World Health Organization and the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Group. Atlas of Cutaneous Lymphomas: Classification and Differential Diagnosis includes chapters on synonyms, clinical features (presentation, prognosis, and treatment), laboratory findings (histopathology, immunophenotype, and molecular), differential diagnosis, and presentation of clinical cases for each diagnostic entity. In addition, chapters are included on T-cell lymphomas, B-cell lymphomas, ancillary techniques including immunohistochemistry and molecular tests, and a glossary of terms. This book will help clarify the classification of cutaneous lymphoma and will serve as a useful tool for physicians involved in the diagnosis and treatment of patients with cutaneous lymphoma.
  • 2010 ClinicalKey
    edited by Arthur T. Skarin ; associate editors, Kitt Schaffer, Tad Wieczorek, Janina Longtine.
    The role of molecular probes and other markers in the diagnosis of malignancy / Tad Wieczorek and Janina A. Longtine -- Radiographic evaluation of cancer / Kitt Shaffer -- Nuclear medicine in oncology / Steven Burrell and Annick van den Abbeele -- Cancer of the head and neck region / Robert Haddad ... [et al.] -- Lung cancer and tumors of the heart and mediastinum / Ravi Salgia, Ramon Blanco and Arthur T. Skarin -- Malignant mesothelioma / Pasi A. Janne, David Wu and Lucian R. Chirieac -- Cancer of the gastrointestinal tract and neuroendocrine tumors / Jeffrey A. Meyerhardt, Matthew Kulke and Jerrold R. Turner -- Cancer of the genitourinary tract / William K. Oh ... [et al.] -- Gynecologic tumors and malignancies / Michelle S. Hirsch, Karen J. Krag and Ursula A. Matulonis -- Breast cancer / Wendy Y. Chen, Susana M. Campos and Daniel F. Hayes -- Endocrine neoplasia / Peter M. Sadow, Mark A. Socinski and Francis D. Moore, Jr. -- Sarcomas of soft tissue and bone and gastrointestinal stromal tumors / Susan George ... [et al.] -- Skin cancer / Philip Friedlander ... [et al.] -- Neoplasms of the central nervous system / Elizabeth A. Maher and Ann C. McKee -- Acute and chronic leukemias / Martha Wadleigh, David M. Dorfman and Arthur T. Skarin -- Hodgkin disease and non-Hodgkin lymphomas / Eric Jacobsen, David M. Dorfman and Arthur T. Skarin -- Multiple myeloma and plasma cell dyscrasias / Noopur Raje ... [et al.] -- Solid tumors in childhood / Stephan D. Voss ... [et al.] -- AIDS-associated malignancies / Jeremy S. Abramson and David T. Scadden -- Complications of cancer / Nadine Jackson McCleary and Arthur T. Skarin -- Systemic and mucocutaneous reactions to chemotherapy / Joseph P. Eder and Arthur T. Skarin.
  • 2014 Springer
    Pinghong Zhou, Liqing Yao, Xinyu Qin, editors.
    Diagnostic Techniques in Gastrointestinal Disease -- Device and Equipment for Endoscopic Therapy -- Endoscopic Mucosal Resection (EMR) -- Endoscopic Submucosal Dissection (ESD) -- Endoscopic Resection for Submucosal Tumors -- Tunnel Endoscopic Surgery.
  • 2014 Springer
    Henryk A. Domanski, editor.
    This book covers all of the diagnostic areas where FNAC is used today. This includes palpable lesions and lesions sampled using various radiological methods, and correlations with ancillary examinations detailed on an entity-by-entity basis. As well as being a complete atlas of the facts and findings important to FNAC, this atlas is a guide to diagnostic methods that optimize health care. The interaction of the cytologist or cytopathologist with other specialists (radiologists, oncologists and surgeons) involved in the diagnosis and treatment of patients with suspicious mass lesions is emphasized and illustrated throughout. ? With contributions from experts in the field internationally and abundant colour images Atlas of Fine Needle Aspiration Cytology provides a comprehensive and up-to-date guide to FNAC for pathologists, cytopathologists, radiologists, oncologists, surgeons and others involved in the diagnosis and treatment of patients with suspicious mass lesions.
  • 2015 Ovid
    Christina A. Arnold, Dora M. Lam-Himlin, Elizabeth A. Montgomery.
  • 2013 Springer
    Ariadne M. Bach, Jingbo Zhang, editors.
    The Atlas of Genitourinary Oncological Imaging presents a comprehensive visual review of appearances for normal anatomy and oncological diseases in the genitourinary system using over 900 radiological images and illustrations. The book presents current imaging techniques and discusses the role of imaging in pre-treatment staging and post-treatment follow-up. Diseases discussed include kidney, adrenal gland, upper tract, bladder, prostate, testes, and pediatric malignancies. Individual chapters include normal anatomy, imaging techniques, and pathology of each cancer type. The staging of the malignancy and what to include in the radiology report are discussed, and expected and complicated postoperative and post-treatment findings and recurrence are presented. Dedicated chapters on interventional and radiation therapy discuss their unique role in the management and treatment of oncology of the genitourinary system. Additionally, a chapter on chemotherapy toxicities discusses drug reaction treatment therapies unique to the genitourinary system.Edited and written by radiologists from the genitourinary disease management team at Memorial Sloan-Kettering Cancer Center, the Atlas of Genitourinary Oncological Imaging is an ideal resource for radiology and urology trainees seeking a review of the basics and for practicing radiologists looking for answers to challenging cases confronted in daily practice.
  • 2014 Springer
    Oguz Akin, editor.
    This book provides a comprehensive visual review of pathologic disease variations of the five main types of gynecologic cancers: ovarian, endometrial, cervical, vaginal, and vulvar. Through the use of cross-sectional imaging modalities, including computed tomography, magnetic resonance imaging, ultrasound, and positron emission tomography, it depicts normal anatomy as well as common gynecological tumors. For each type of cancer, aspects such as primary staging, recurrence patterns, and findings from different yet complementary imaging modalities are explored. Atlas of Gynecologic Oncology Imaging presents a coherent perspective of the roles of standard and cutting-edge imaging techniques in gynecologic oncology via a multidisciplinary approach to cancer care. Featuring over 600 images, this book is a valuable resource for diagnostic radiologists, radiation oncologists, and gynecologists.
  • 2015 Springer
    Nirav Trivedi.
    Surgery for head neck cancer has evolved greatly in the recent years. Appropriate surgical resection with negative margins still remain corner-stone in achieving good oncological outcome. This atlas proposes a new concept of " The Compartment Surgery " to achieve negative margins in third dimensions which is the problem area in majority of cases. Reconstructive techniques have evolved vastly in the recent years with use of microvascular free flaps and this has significantly improved the functional outcome. Performing each step in appropriate manner cumulatively enables us to perform more complex procedures. Theme of this atlas revolves around this fact. This atlas on head and neck cancers takes a fresh stylistic approach where each surgical procedure is described in a step-wise manner through labeled high-resolution images with minimal incorporation of text. This allows the surgeons to rapidly revise the operative steps of a procedure within minutes just before they start a surgery. Head and neck has multidimensional anatomy and surgical treatment requires specific approach for each subsite. This operative atlas covers the entire spectrum of common, uncommon and rare cancers of the head and neck area. Each subsite is addressed in a separate chapter with further subdivisions for surgery of tumors with varying extent. Each procedure is demonstrated with photographs of each surgical step and line diagrams. Commonly used flaps (regional and free flaps) are demonstrated in separate chapter for reconstruction. With over 1000 images, and coverage of both the ablative and reconstructive surgical procedures, this is a technique-focused atlas in comparison to the available comprehensive texts. There are two chapters on very advanced cancers, and surgery in resource constrained surgical units making the book relevant to a wide range of cancer surgeons and fellows-in-training in varied clinical settings.
  • 2009 Springer
    Tsieh Sun, editor.
  • 2015 Springer
    Pei Hui, Natalia Buza.
    This atlas is dedicated specifically to gynecologic frozen section diagnosis and addresses professional practice gaps such as high diagnostic error rate, slow turnaround time, and inefficient communication between surgeons and pathologists at the time of intraoperative frozen section consultation of gynecologic specimens. The format of the volume is a combination of concise text and high quality gross and frozen section microscopic images, meticulously selected from the superb collection of pathology specimens of gynecologic tumors provided at Yale-New Haven Hospital in the past decades. Frequent entities with diagnostic pitfalls are balanced with less common lesions. Strategies to recognize their diagnostic features are emphasized, in addition to the impact on optimal surgical treatment of patients with gynecologic cancer. The indications, limitations, morphologic diagnostic criteria and pitfalls of frozen section consultation in gynecologic pathology are thoroughly reviewed with an ultimate goal of avoiding patient mismanagement in real-time. High quality frozen section microscopic illustrations aid the recognition of morphologic patterns and serve as quick reference during intraoperative consultation. Written by experts in the field, Atlas of Intraoperative Frozen Section Diagnosis in Gynecologic Pathology is a valuable resource for pathologists at all career/expertise levels who are involved in intraoperative consultation in their daily clinical practice.
  • 2013 Springer
    Giuseppe Micali, Marco Cusini, Pompeo Donofrio, Franco Dinotta.
    Male genital disorders represent a common issue in medical practice, especially in the dermatological setting. Correct clinical evaluation of these disorders is essential when addressing the diagnosis, which in some cases may require histopathological confirmation. Depending on the disease, early diagnosis may be not only lifesaving, but also of fundamental importance to the planning of successful treatment. This atlas introduces the most common penile diseases, along with more rarely encountered ones. It provides invaluable guidance on clinical diagnosis by highlighting prominent clinical features and presenting particular videodermatoscopy findings when these are indicative of the diagnosis. In addition, for each condition the most appropriate treatment is proposed, taking into account recent therapeutic advances of proven benefit.
  • 2007 Ovid
    Ellen Shaw de Paredes.
    Anatomy of the breast -- Techniques and positioning in mammography -- An approach to mammographic analysis -- Circumscribed masses -- Indistinct and spiculated masses -- Analysis of calcification -- Prominent ductal patterns -- Asymmetry and architectural distortion -- The thickened skin pattern -- The axilla -- The male breast -- The postsurgical breast -- The augmented breast -- Galactography -- Needle localization -- Percutaneous breast biopsy -- The roles of ultrasound and magnetic resonance imaging in breast imaging.
    Also available: Print – 2007
  • 2010 Springer
    [edited by] Shailesh Puntambekar, Miguel A. Cuesta.
  • 2014 Springer
    Piero Picci, Marco Manfrini, Nicola Fabbri, Marco Gambarotti, Daniel Vanel, editors.
    This book reflects the experience of the Rizzoli Orthopedic Institute during more than 100 years of treatment of musculoskeletal tumor and tumorlike lesions. It presents a wide range of lesions from a multidisciplinary perspective, highlighting pertinent clinical, radiological, and histological correlations. Treatment is briefly reported for each entity. In addition, the more recent biomolecular findings of use for diagnosis, prognosis, and treatment are carefully analyzed. The Rizzoli case archive spans more than a century, the first treated case dating back to 28 September 1900, and contains the original material, clinical charts, imaging, paraffin blocks, and histological slides of more than 40,000 cases, including about 29,000 bone lesions and 11,000 soft tissue lesions. This book reports the most relevant entities and reflects the improvements in knowledge of musculoskeletal tumors as presented during the yearly international course held at the Rizzoli Institute.
  • 2010 Springer
    [edited by] Armando E. Fraire ... [et al.].
    Lymphangiomatosis -- Pleuropulmonary blastoma -- Congenital pulmonary myofibroblastic tumor -- Alveolar adenoma -- Uncommon endobronchial surface tumors -- Mucous gland adenoma -- Pleomorphic adenoma -- Mucoepidermoid tumor -- Adenoid cystic carcinoma -- Inflammatory polyps -- Inflammatory pseudotumor -- Pulmonary chondroma -- Pulmonary hamartoma -- Localized fibrous tumor -- Lipomas and liposarcomas -- Cystic lymphangioma -- Lymphangioleiomyomatosis -- Epithelioid hemangioendothelioma -- Pulmonary artery sarcoma -- Synovial sarcoma -- Marginal zone B-cell lymphoma (maltoma) -- Diffuse large B-cell lymphoma -- Lymphomatoid granulomatosis -- Langerhans cell histiocytosis -- Typical and atypical carcinoids -- Teratoma -- Melanoma -- Thymoma -- Glomus tumor of the lung -- Sclerosing hemangioma -- Preinvasive disease -- Squamous cell carcinoma -- Adenocarcinoma -- Large cell carcinoma -- Small cell carcinoma -- Adenosquamous carcinoma -- Bronchioloalveolar carcinoma -- Large cell neuroendocrine carcinoma -- Sarcomatoid carcinoma -- Pulmonary blastoma -- Metastatic tumors.
  • 2015 Springer
    Constantine P. Karakousis.
    Surgical Technique in Cancer Surgery -- Intraoperative Lymphatic Mapping/Sentinel Lymphadenectomy -- Tumor in the Hand -- Tumor in the Wrist -- Tumor in the Ventral Aspect of the Forearm -- Tumor in the Dorsal Aspect of the Forearm -- Tumor in the Anterior Compartment of the Arm -- Tumor in the Dorsal Aspect of the Arm -- Tumor in the Medial Arm -- Axillary Node Dissection -- In Continuity Axillary and Supraclavicular Node Dissection -- Neck Dissection -- Tumor at the Shoulder Point -- Tumor in the Neck -- Scapulectomy -- Shoulder Disarticulation -- Forequarter Amputation -- Tumor in the Back -- Chest Wall Tumors -- Tumor in the Lower Chest Wall and Upper Abdomen -- Involvement of the Abdominal Wall by Tumor -- One-Layer Closure of the Abdominal Wall -- Midline Abdominal Wall Gaps and Incisional Hernia -- Regional Chemotherapy Infusion Via the Hepatic Artery -- Peritoneolysis in the Reconstruction of a Roux-en-Y Loop -- Hilar Hepatojejunostomy -- Hepatic Resection -- Pancreaticoduodenectomy -- Distal Pancreatectomy -- Colonic Interposition for Esophageal Replacement -- Ileal Loop Bladder-Interposition Conduit -- Resection of Mesenteric Tumors -- Dissection in the Bowel Mesentery and Its Clinical Applications -- Retroperitoneal Node Dissection -- Retroperitoneal Sarcomas -- Tumor in the Lesser Sac -- Tumor in the Right Abdomen -- Tumor in the Left Abdomen -- The T or L Incision in Resection of Tumors of the Pelvis -- Groin Dissection -- Abdominoinguinal Incision in the Resection of Pelvic Tumors and Limb Salvage -- Resection of Pelvic Tumors with Visceral Involvement -- Internal Hemipelvectomy -- The Surgical Importance of the Inferior Epigastric Vessels -- Sacral Resection -- Tumor in the Buttock Area -- Tumor in the Anterior Thigh -- Tumor in the Medial Thigh -- Tumor in the Posterior Thigh -- Popliteal Node Dissection -- Tumor in the Leg -- Tumor in the Foot -- Hip Disarticulation -- Hemipelvectomy (Hindquarter Amputation) -- Variants of Hemipelvectomy -- Central Venous Access -- Resection of Tumors of the Ischiorectal Fossa.
  • 2010 Springer
    Adekunle M. Adesina ... [et al.], editors.
    Part 1. Pilocytic astrocytoma and Pilomyxoid Astrocytoma -- Pilocytic astrocytoma and Pilomyxoid Astrocytoma / Christine Fuller and Sonia Narendra -- Pleomorphic Xanthoastrocytoma / Christine E. Fuller -- Infiltrative Astrocytomas (Diffuse Astrocytoma, Anaplastic Astrocytoma, Glioblastoma) / Christine E. Fuller -- Oligodendroglial Tumors / Christine E. Fuller -- Ependymal Tumors / Christine E. Fuller, Sonia Narendra and Ioana Tolicica -- Introduction and Overview of Brain Tumors / Adekunle M. Adesina -- Part 2. Embryonal Neuroepithelial Tumors -- Central Nervous System Primitive Neuroectodermal Tumors and Medulloepithelioma / Adekunle M. Adesina, J. Hunter and L. Rorke-Adams -- Medulloblastoma / Adekunle M. Adesina and J. Hunter -- Atypical Teratoid Rhabdoid Tumor / Adekunle M. Adesina, J. Hunter and L. Rorke-Adams -- Part 3. Tumors of the Meninges -- Meningiomas / Christine Fuller and Brian Pavlovitz -- Hemangiopericytoma and Other Mesenchymal Tumors / Christine E. Fuller -- Melanocytic Lesions / Christine E. Fuller -- Hemangioblastoma -- Christine E. Fuller -- Part 4. Tumors of Cranial and Spinal Nerves -- Schwannoma / Tarik Tihan -- Neurofibroma / Tarik Tihan -- Malignant Peripheral Nerve Sheath Tumors / Tarik Tihan -- Part 5. Neuronal and Mixed Neuronal-glial Tumors -- Desmoplastic Infantile Astrocytoma and Ganglioglioma / Adekunle M. Adesina -- Dysembryoplastic Neuroepithelial Tumor / Adekunle M. Adesina and Ronald A. Rauch -- Ganglioglioma and Gangliocytoma / Adekunle M. Adesina and Ronald A. Rauch -- Central Neurocytoma and Extraventricular Neurocytoma / Adekunle M. Adesina and Ronald A. Rauch -- Papillary Glioneuronal Tumor / M. Rivera-Zengotita, A. Illner and Adekunle M. Adesina -- Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle / M. Rivera-Zengotita and Adekunle M. Adesina -- Malignant Epithelioid Glioneuronal Tumor / M. Rivera-Zengotita, R. Rauch and Adekunle M. Adesina -- Paraganglioma / A. Rivera and Adekunle M. Adesina -- Part 6. Neurocutaneous Syndromes -- Neurofibromatosis 1 / Tarik Tihan -- Neurofibromatosis 2 / Tarik Tihan -- Von Hippel-Lindau Disease / Tarik Tihan and Adekunle M. Adesina -- Tuberous Sclerosis Complex / Tarik Tihan and Adekunle M. Adesina -- L'hermitte-Duclos Disease and Cowden Disease / T. Hidehiro, S. Hiroyoshi and Adekunle M. Adesina -- Part 7. Tumors in the Region of the Pituitary Fossa -- Pituitary Tumors / Tarik Tihan and Christine E. Fuller -- Craniopharyngioma / Tarik Tihan -- Part 8. Choroid Plexus Neoplasms -- Choroid Plexus Neoplasms / Christine E. Fuller, Sonia Narendra and Ioana Tolocica -- Part 9. Pineal Based Tumors -- Pineal Parenchymal Tumors / Tarik Tihan -- Part 10. Germ Cell Tumors -- Germ Cell Tumors / Tarik Tihan -- Part 11. Paraneoplastic Disorders -- Paraneoplastic Disorders of the Central Nervous System / Christine E. Fuller and Sonia Narendra -- Part 12. Tumours of the Haematopoietic System -- Malignant Lymphoma / Adekunle M. Adesina -- Histiocytic Tumors / A. Mukherjee and Adekunle M. Adesina -- Part 13. Interesting/Challenging Cases and Exercises in Pattern Recognition -- Case Studies / Adekunle M. Adesina, Christine E. Fuller and Lucy Rocke-Adams.
  • 2015 Springer
    Tamer Özülker, Filiz Özülker.
  • 2013 Springer
    Osman Ratib, Markus Schwaiger, Thomas Beyer, editors.
    This new project on PET/MR imaging in oncology includes digital interactive software matching the cases in the book. The interactive version of the atlas is based on the latest web standard, HTML5, ensuring compatibility with any computer operating system as well as a dedicated version for Apple iPad and iPhone. The book opens with an introduction to the principles of hybrid imaging that pays particular attention to PET/MR imaging and standard PET/MR acquisition protocols. A wide range of illustrated clinical case reports are then presented. Each case study includes a short clinical history, findings, and teaching points, followed by illustrations, legends, and comments. The multimedia version of the book includes dynamic movies that allow the reader to browse through series of rotating 3D images (MIP or volume rendered), display blending between PET and MR, and dynamic visualization of 3D image volumes. The movies can be played either continuously or sequentially for better exploration of sets of images. The editors of this state-of-the-art publication are key opinion leaders in the field of multimodality imaging. Professor Osman Ratib (Geneva) and Professor Markus Schwaiger (Munich) were the first in Europe to initiate the clinical adoption of PET/MR imaging. Professor Thomas Beyer (Zurich) is an internationally renowned pioneering physicist in the field of hybrid imaging. Individual clinical cases presented in this book are co-authored by leading international radiologists and nuclear physicians experts in the use of PET and MRI.
  • 2013 Springer
    Sumaira Z. Aasi, David J. Leffell, Rossitza Z. Lazova.
    1. How to Use This Atlas -- 2. Normal Skin -- 3. Basal Cell Carcinoma -- 4. Infiltrative Basal Cell Carcinoma -- 5. Differentiating Basal Cell Carcinoma from Normal and Benign Histologic Findings -- 6. Adnexal Tumors -- 7. Microcystic Adnexal Carcinoma -- 8. Differentiating Infiltrative Basal Cell Carcinoma from Other Tumors -- 9. Squamous Cell Carcinoma In Situ and Actinic Keratoses -- 10. Squamous Cell Carcinoma -- 11. Differentiating Squamous Cell Carcinoma from other entities -- 12. Dermatofibrosarcoma Protuberans -- 13. Other Non-melanocytic Skin Cancer -- 14. Pitfalls and Incidental Findings -- 15. Artifacts.
  • 2016 Springer
    Gabriel Zada, M. Beatriz S. Lopes, Srinivasan Mukundan Jr, Edward R. Laws Jr, editors.
    Anatomy of the Sellar and Parasellar Region -- Imaging of the Sellar Region -- Pituitary Physiology and Endocrinology -- Pathology and Molecular Biology of the Pituitary Region -- The Direct Endoscopic Endonasal Transsphenoidal Approach to the Pituitary Gland -- Transcranial and Skull Base Surgical Approaches to the Sellar and Parasellar Region -- Radiosurgery of the Sellar and Parasellar Region -- The Normal Pituitary Gland -- Pituitary Hyperplasia -- Nonfunctioning Pituitary Adenomas -- Prolactinomas -- Somatotroph (GH) Adenomas -- Corticotroph (ACTH) Adenomas -- Silent Corticotroph (ACTH) Adenomas -- Thyrotroph (TSH) Adenomas -- Gonadotroph Adenomas -- Pituitary Apoplexy -- Atypical Pituitary Adenomas -- Pituitary Carcinoma -- Ectopic Pituitary Adenomas -- Craniopharyngioma -- Rathke Cleft Cyst -- Xanthogranuloma of the Sellar Region -- Petrous Apex Cholesterol Granuloma -- Sellar Region Arachnoid Cyst -- Sellar Region Epidermoid and Dermoid Cysts -- Colloid Cyst of the Sellar Region.- Meningioma.- Hemangiopericytoma -- Schwannomas of the Sellar and Parasellar Region -- Chordoma and Chondrosarcoma -- Hemangioblastoma -- Cavernous Sinus Cavernous Hemangioma -- Optic Pathway (Opticochiasmatic) and Hypothalamic Gliomas -- Pituicytomas and Sellar Ependymomas -- Granular Cell Tumor -- Germ Cell Tumor -- Olfactory Neuroblastoma and Sellar Neuroblastoma -- Hypothalamic Hamartoma -- Plasmacytoma -- Lymphoma -- Gangliocytoma and Ganglioglioma -- Spindle Cell Oncocytoma -- Nasopharyngeal Carcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses -- Sinonasal Melanoma -- Sinonasal Adenocarcinoma -- Sinonasal Undifferentiated Carcinoma (SNUC) -- Fibrosarcoma of the Sellar Region -- Juvenile Nasopharyngeal Angiofibroma (JNA) -- Metastatic Tumors to the Pituitary Gland -- Spontaneous Abscess of the Sellar Region -- Invasive Fungal Sinusitis and Fungal Abscess of the Sella -- Mucocele and Mucopyocele -- Sellar Tuberculosis -- Neurocysticercosis of the Sellar Region -- Granulomatous Conditions -- Inflammatory Hypophysitis -- Demyelinating Diseases: Multiple Sclerosis and Neuromyelitis Optica -- Cerebral Aneurysms with Intrasellar Extension -- Arteriovenous Malformations -- Cavernous Malformations (Angiomas) of the Sellar and Suprasellar Region -- Vascular Fistulas of the Sellar and Parasellar Region -- Carotid Artery Dolichoectasia and Kissing Internal Carotid Arteries -- Sheehan's Pituitary Infarction -- Persistent Trigeminal Artery of the Sellar Region -- Meningoceles and Encephaloceles -- Empty Sella Syndrome -- Pituitary Hypoplasia and Other Midline Developmental Anomalies -- Duplication of the Pituitary Gland -- Fibrous Dysplasia -- Basilar Impression and Invagination -- Traumatic Injury, Pituitary Stalk Disruption, and Posttraumatic Anosmia -- Spontaneous, Traumatic, and Postoperative CSF Rhinorrhea -- Pseudoaneurysms of the Internal Carotid Artery in the Sellar Region -- Iatrogenic Pituitary Abscess.
  • 2011 Springer
    Ali Hendi, Juan-Carlos Martinez.
    The incidence of skin cancer has risen rapidly in recent decades, and patients often present initially to practitioners in many different specialties. Because skin cancer can vary in clinical appearance, even dermatologists may experience difficulty in reaching a clinical diagnosis. For primary care physicians and physician extenders (physician assistants, nurses, and nurse practitioners), who have had very little or no formal training in dermatology, the task can be still more daunting. In this atlas, the authors set out to provide a practical resource that will help improve the 'visual vocabulary' of physicians and physician extenders, helping them identify lesions that should be biopsied.--Abstract (excerpt).
  • 2013 Springer
    Cyril Fisher.
    Soft tissue tumors are a large and heterogeneous group of tumors and pseudotumors with a spectrum of behavior from benign to frankly malignant. This Atlas of Soft Tissue Tumor Pathology provides an overview of reactive, pseudoneoplastic, benign and intermediate neoplasms, sarcomas and related conditions arising in subcutaneous and deep soft tissues. Emphasis is placed on microscopic appearances with correlation with gross diagnostic findings where relevant. In addition, the immunohistochemical and molecular genetic features of the major soft tissue tumor subtypes are presented.
  • 2008 Springer
    J. Richard Smith, Jeremiah Healy, Giuseppe Del Priore (eds.).
  • 2016 Springer
    Dan M. Fliss, Ziv Gil.
    The Cranial Base -- Anterior Skull Base: Imaging -- Operating Room Setup in Skull Base Surgery -- Open Surgical Approaches to the Paranasal Sinuses -- The Subcranial Approach to the Anterior Skull Base -- Surgical Approaches to the Lateral Skull Base -- Approaches to the Parapharyngeal Space -- The Translabryinthine Approach to the Internal Auditory Canal and Cerebellopontine Angle -- Cancer of the Temporal Bone -- Endoscopic Approaches in Skull Base Surgery and Their Indications -- Combined Approaches to Complex Skull Base Tumors -- Microsurgical Reconstruction of Skull Base Defects -- Complications After Skull Base Surgery.
  • 2011 Springer
    Arne Heilo, Eva Sigstad, Krystyna Groeholt, editors.
    Physical and technical essentials -- Ultrasound features of thyroid lesions -- Nodular or colloid goiter, hyperplasia, and cysts -- Follicular adenoma and follicular thyroid carcinoma -- Oncocytic nodule/Hurtle cell tumors -- Follicular variant of papillary thyroid carcinoma -- Papillary thyroid carcinoma -- Medullary thyroid carcinoma -- Anaplastic carcinoma -- Lymphoma and plasmacytoma -- Thyroiditis -- Metastases -- Regional lymph node metastases.
  • 2011 Springer
    Abraham H. Dachman, Andrea Laghi, editors.
  • 2012
    Cigall Kadoch.
  • 2013 Springer
    Hong-Gang Wang, editor.
    This book covers the latest advances in the field of autophagy and cancer from the basics of the molecular machinery for autophagy induction and regulation up to current areas of interest, including modulation of autophagy and drug discovery for cancer prevention and treatment. The reader will be initially introduced to the historical context of autophagy, followed by a summary of the key players in autophagy, a discussion on the origin of autophagosomes, and an overview of signal transduction regulation of autophagy. The next chapters deal with the complex relationship between autophagy and tumorigenesis through in-depth discussions of how autophagy influences cell survival, apoptosis, inflammation, immunity, tumor microenvironment, metabolic stress, DNA damage, and genomic instability. The remaining chapters discuss how autophagy affects cancer cell response to therapy and how to best modulate autophagy for therapeutic benefit - what to target and how to target. We hope that this monograph will be an invaluable reference source for professionals, students, postdoctoral fellows, and senior scientists working in the fields of autophagy and cancer.
  • 2013
    Katherine Cynthia Fuh.
    Axl, Sky, and Mer receptor tyrosine kinases (RTKs) are increasingly implicated in a host of cellular responses including cell survival, proliferation, migration, phagocytosis, chemoresistance, and epithelial-mesenchymal transition (EMT). Furthermore, the Gas6/AXL system is implicated in several types of human cancer as well as inflammatory, autoimmune, vascular and kidney diseases. Since the discovery of Gas6/AXL in 1988 in chronic myelogenous leukemia, many more cancers have been found to express AXL. In chapter 1, I will describe my contribution to the field that includes identifying the role of AXL in metastatic ovarian cancer and validating the therapeutic target in ovarian cancer. In the second chapter, I have investigated the role of AXL in chemoresistance in ovarian cancer. Within the past decade, AXL crosstalk has emerged as a dominant pathway for ligand-independent activation. With the recent identification of AXL as an important factor in mediating tyrosine kinase inhibitor resistance, understanding this cross-talk is important. There has been a recent report of c-MET and AXL cross-talk in breast cancer. c-MET has become a potential target for cancer therapy with numerous clinical trials using c-MET inhibitors as monotherapy or in combination with other targeted agents or chemotherapy. I have further explored this cross-talk in ovarian cancer. In my final chapter, I have identified AXL expression in ovarian cancer tumors formed in a conditional genetically modified invasive ovarian cancer mouse model. In the future, AXL therapy should be further investigated in patients with metastatic ovarian cancer.
  • 2012 Springer
    Abdul Arif Khan, editor.
  • 2010 Springer
    Murat Beyzadeoglu, Gokhan Ozyigit, Cuneyt Ebruli.
    Radiation physics -- Radiobiology -- Clinical radiation oncology -- Central nervous system tumors -- Head and neck cancers -- Lung cancer -- Breast cancer -- Genitourinary system cancers -- Gynecological cancers -- Gastrointestinal system cancers -- Soft tissue sarcoma -- Skin cancer -- Lymphomas and total body irradiation.
  • 2016 Springer
    Frederick O. Stephens, Karl R. Aigner ; with contribution by Kornelia Aigner [and more].
  • 2009 Springer
    [edited by] Frederick O. Stephens, Karl R. Aigner.
  • 2010 Springer
    edited by Claudio Hetz.
    Homeostatic functions of BCL-2 proteins beyond apoptosis / Nika N. Danial, Alfredo Gimenez-Cassina, and Daniel Tondera -- Alternative functions of the BCL-2 protein family at the endoplasmic reticulum / Diego Rojas-Rivera ... [et al.] -- BH3-only proteins and their effects on cancer / Thanh-Trang Vo and Anthony Letai -- Endoplasmic reticulum stress and BCL-2 family members / Ross T. Weston and Hamsa Puthalakath -- Targeting survival pathways in lymphoma / Luca Paoluzzi and Owen A. O'Connor -- The interplay between BCL-2 family proteins and mitochondrial morphology in the regulation of apoptosis / Maria Eugenia Soriano and Luca Scorrano -- Noncanonical functions of BCL-2 proteins in the nervous system / Heather M. Lamb and J. Marie Hardwick -- Mitochondria on guard : role of mitochondrial fusion and fission in the regulation of apoptosis / Mariusz Karbowski.
    Also available: Print – 2010
  • 2015 Springer
    Luca Aldrighetti, Francesco Cetta, Gianfranco Ferla, editors ; forewords by Gennaro Nuzzo and Antonio Daniele Pinna ; in collaboration with Francesca Ratti.
    Diagnosis of benign tumors of the liver is experiencing exponential growth, mainly owing to the diffusion of more accurate imaging techniques. This monograph opens by examining the epidemiology, histopathology, and genetics of these diseases and discussing liver physiopathology. The role of imaging techniques is described, and clear guidance provided on differential diagnosis. The full range of benign liver tumors and conditions is then systematically reviewed, including liver cysts and polycystic liver disease, Caroli disease, hemangiomas, focal nodular hyperplasia, adenomas, hepatic manifestations of systemic diseases, and focal infectious diseases. Surgical indications are accurately analyzed, with a view to assisting in the avoidance of useless interventions. Transplantation, laparoscopic resection, and robotic surgical techniques are described and illustrated, emphasizing the optimization of intra- and postoperative management in order to avoid potential complications and degeneration. In these chapters, attention is drawn to the ways in which the surgical management of benign liver tumors differs from that of malignant tumors. Information is also provided on anesthesia, blood transfusion, the role of interventional radiology in patients with benign liver tumors and fast track programs for liver surgery. This book, in handy format, will prove essential reading for all who are interested in benign liver surgery and will represent an invaluable source of knowledge for general and hepatobiliary surgeons, whether in training or practice.
  • 2015 Ovid
    [edited by] Jonathan S. Berek, MD, MMS, Laurie Kraus Lacob Professor, Director, Stanford Women's Cancer Center, Stanford Cancer Institute, Chair, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, Neville F. Hacker, AM, MD, Professor of Gynaecologic Oncology, Conjoint, University of New Sourth Wales, Director, Gynaecologic Cancer Centre, Royal Hospital for Women, Sydney, Australia ; illustrations and design by Deborah Berek. MA, Tim Hengst, CMI, FAMI.
  • 2011 Springer
    Gary D. Stoner, Navindra P. Seeram, editors.
    Experimental investigations in the past 10-15 years have provided convincing evidence of the cancer preventive potential of berries. Berries and their components have been shown to reduce the malignant properties of cancer cells in culture by influencing genes associated with cancer development. In addition, diets containing freeze-dried berries have been shown to prevent cancer in animals, and recent data indicate that they also exhibit cancer preventive effects in humans.
  • 2014 Ovid
    editors, Jame Abraham, James L. Gulley, Carmen J. Allegra.
    Head and neck cancer -- Non-small cell lung cancer -- Small cell lung cancer -- Esophageal cancer -- Gastric cancers -- Biliary tract cancers -- Primary cancers of the liver -- Colorectal cancer -- Pancreatic cancer -- Anal cancer -- Other gastrointestinal tumors -- Breast cancer -- Renal cell cancer -- Prostate cancer -- Bladder cancer -- Testicular carcinoma -- Ovarian cancer -- Endometrial cancer -- Cervical cancer -- Vulvar cancer -- Sarcomas and malignancies of the bone -- Skin cancers and melanoma -- Acute leukemia -- Chronic lymphoid leukemias -- Chronic myeloid leukemia -- Chronic myeloproliferative neoplasms -- Multiple myeloma -- Non-Hodgkin lymphoma -- Hodgkin lymphoma -- Hematopoietic cell transplantation -- Carcinoma of unknown primary -- Central nervous system tumors -- Endocrine tumors -- Hematopoietic growth factors -- Infectious complications in oncology -- Oncologic emergencies and paraneoplastic syndromes -- Psychopharmacologic management in oncology -- Management of emesis -- Medical nutrition therapy -- Pain and palliative care -- Central venous access device -- Procedures in medical oncology -- Diagnosis-driven individualization of cancer care -- Basic principles of radiation oncology -- Clinical genetics -- Anticancer agents.
  • 2010 Springer
    Syed Z. Ali, Edmund S. Cibas, editors.
  • 2014 Springer
    edited by Joseph M. Herman, Timothy M. Pawlik, Charles R. Thomas, Jr.
    The second edition of this book is intended as a definitive text on biliary tract and gallbladder cancers. Specifically, it will serve as a single-source reference on the current knowledge base for the multidisciplinary management of such cancers and thus covers epidemiological, surgical, radiotherapy, and chemotherapy approaches. Akey feature is the demonstration of the impact of cutting-edge technical knowledge on treatment; for example, interventional radiology techniques, novel surgical approaches, and image-guided radiation therapy are all extensively discussed. Diagnosis is also considered in detail, with coverage of novel serum biomarkers, pathologic staging, molecular profiling, and the full range of current and emerging imaging strategies. Further chapters are devoted to epidemiology, the role of growth factor pathways and signal transduction, and histopathology and molecular pathogenesis. Experienced practitioners in a range of specialties will find this amply illustrated book to be an invaluable source of information on the newest diagnostic and treatment techniques in biliary tract and gallbladder cancer, yet it is also sufficiently concise to offer an introduction to the field for students and community practitioners.
  • 2010 Springer
    edited by John A. Milner, Donato F. Romagnolo ; forewords by David S. Alberts, Maria Lluria-Prevatt, Scott M. Lippman.
    Monitoring the burden of cancer in the United States -- Cancer biology and nutrigenomics -- Cellular cancer processes and their molecular targets -- Nutrigenetics: the relevance of polymorphisms -- Diet and epigenetics -- Nutrient signaling-protein kinase to transcriptional activation -- Dietary energy balance, calorie restriction, and cancer prevention -- Fiber and microbially generated active components -- Gut microbiota, probiotics, prebiotics and colorectal cancer -- Meats, protein and cancer -- Saturated fatty acids and cancer -- Conjugated linoleic acid and cancer -- Cancer and n-3PUFAs: the translational connection -- n-6 polyunsaturated fatty acids and cancer -- Carotenoids -- Vitamin A -- Vitamin D and cancer chemoprevention -- Folate -- Selenium -- Calcium and cancer -- Iron and cancer -- Zinc in cancer development and prevention -- Cruciferous vegetables, isothiocyanates, indoles, and cancer prevention -- Garlic and cancer prevention -- Mammary and prostate cancer chemoprevention and mechanisms of action of resveratrol and genistein in rodent models -- Cancer prevention by catechins, flavonols, and procyanidins -- Mechanisms of action of isoflavones in cancer prevention -- The anticarcinogenic properties of culinary herbs and spices -- Cancer prevention with berries: role of athocyanins -- Pomegranate -- Alcohol and cancer: biological basis -- Aryl hydrocarbon receptor-mediated carcinogenesis and modulation by dietary xenobiotic and natural ligands -- Opportunities and challenges for communicating food and health relationships to American consumers.
  • 2009 Springer
    edited by Gavin J. Gordon.
    The emergence of bioinformatics : historical perspective, quick overview and future trends / Christos A. Ouzounis -- The statistical design and interpretation of microarray experiments / Kevin K. Dobbin and Richard M. Simon -- Whole-genome analysis of cancer / Steven A. Enkemann ... [et al.] -- Bioinformatics approaches to the analysis of the transcriptome of animal models of cancer / Mark J. Hoenerhoff ... [et al.] -- Significance of aberrant expression of miRNAs in cancer cells / George A. Calin ... [et al.] -- Proteomic methods in cancer research / Scot Weinberger and Egisto Boschetti -- Comprehensive genomic profiling for biomarker discovery for cancer detection, diagnostics and prognostics / Xiaofeng Zhou ... [et al.] -- Gene expression profiling of the leukemias : oncogenesis, drug responsiveness, and prediction of clinical outcome / Lars Bullinger, Hartmut Dohner, and Jonathon R. Pollack -- Personalized medicine in the clinical management of colorectal cancer / Anthony El-Khoueiry and Heinz Josef Lenz -- PIK3CA gene alterations in human cancers / Sérgia Velho, Carla Oliveira, and Raquel Seruca.
  • 2015 Springer
    Vasilis Vasiliou, Samir Zakhari, Helmut K. Seitz, Jan B. Hoek, editors.
    In recent years, a significant amount of research has emerged connecting the link between alcohol and cancer. The field has rapidly advanced, especially since the complex connection between alcohol and cancer has several unique sub areas that are being investigated and this volume gives a comprehensive overview of these advancements.
    Also available: Print – 2015
  • 2005 Springer
    edited by Lodovico Balducci, Martine Extermann.
    Also available: Print – 2005
  • 2017 Springer
    Todd M. Zimmerman, Shaji K. Kumar, editors.
  • 2014
    Weinberg, Robert A.
    Status: Not Checked OutLane Catalog Record
    Thoroughly updated and incorporating the most important advances in the fast-growing field of cancer biology, This book is a textbook for students studying the molecular and cellular bases of cancer at the undergraduate, graduate, and medical school levels. The principles of cancer biology are presented in an organized, cogent, and in-depth manner. The clarity of writing, supported by an extensive full-color art program and numerous pedagogical features, makes the book accessible and engaging. The information unfolds through the presentation of key experiments that give readers a sense of discovery and provide insights into the conceptual foundation underlying modern cancer biology. Besides its value as a textbook, this book is a useful reference for individuals working in biomedical laboratories and for clinical professionals. Every copy of the book comes with an updated DVD-ROM containing the book's art program, a selection of movies, audio file mini-lectures, Supplementary Sidebars, and a Media Guide.
  • 2009 Springer
    Timothy Wang, James G. Fox, Andrew S. Giraud, editors.
  • 2014 CRCnetBASE
    Prakash S. Bisen, Zakir Khan, Saurabh Bundela.
    "Cancer is a class of disease or disorders characterized by uncontrolled division of cells and the ability of these cells to invade other tissues. One new approach in dealing with cancer is through apoptotic regulators, which is the process of controlling cell growth by abnormally prolonging cell survival, facilitating the accumulation of transforming mutations and promoting resistance. This book uses oral cancers as the specific means to demonstrate this technique with this particular type of cancer, which is quite prevalent (and deadly) in India and other parts of Asia, in particular"--Provided by publisher.
  • 2006 Springer
    edited by Giampietro Gasparini and Daniel F. Hayes.
    Guidelines for the design of clinical studies for the development and validation of therapeutically relevant biomarkers and biomarker-based classification systems / Richard M. Simon -- Analytical aspects of biomarker immunoassays in cancer research / C. G. J. (Fred) Sweep, Chris M. G. Thomas and Manfred Schmitt -- Tissue microarrays: state-of-the-art, pitfalls, and promises / Chungyeul Kim and Soonmyung Paik -- Gene expression profiling with DNA microarrays / Michele De Bortoli and Nicoletta Biglia -- Assays for gene amplification / Chungyeul Kim, Yongkuk Song, and Soonmyung Paik -- Cell kinetics / Maria Grazia Daidone, Rosella Silvestrini, and Dino Amadori -- Urokinase-type plasminogen activator and PAI-1 / Michael J. Duffy -- Predictive value of c-erbb-2 for endocrine therapy and chemotherapy in breast cancer / Vered Stearns -- Erb-b-2 as a therapeutic target / Robert Mass -- The epidermal growth factor receptor pathway as a selective -- Molecular-targeting treatment in human breast cancer / Fortunato Ciardiello, Teresa Troiani, and Giampaolo Tortora -- P-53 as a prognostic and predictive indicator / Daniela Kandioler and Raimund Jakesz -- Occult metastatic cells in breast cancer patients / Stephan Braun, Julia Seeber, and Christian Marth -- Circulating HER-2/neu / Allan Lipton ... [et al.] -- Circulating vascular endothelial growth factor / Roberta Sarmiento ... [et al] -- Detection of early tumor dissemination in patients with breast cancer / Debra Hawes and Richard J. Cote -- New technologies/new markers/new challenges / Daniel F. Hayes and Giampietro Gasparini -- Index.
  • 2016 Springer
    Fausto Rodriguez, Cheng-Ying Ho.
    Introduction -- Special Techniques -- Biobanking and Regulations -- Public Databases -- Biomarkers applied to specific tumor types -- Conclusions.
  • 2013 ScienceDirect
    edited by Kinam Park.
    Part I Fundamentals of biomaterials for cancer therapeutics; 1 Introduction to biomaterials for cancer therapeutics; 1.1 Introduction; 1.2 Biomaterials used in cancer therapeutics; 1.3 Materials used in anticancer formulations; 1.4 Conclusion and future trends; 1.5 References; 2 Cancer cell biology; 2.1 Introduction; 2.2 Public perception and misunderstanding of cancer cell activity; 2.3 The 'War on Cancer'; 2.4 The genetic basis of cancer; 2.5 Cancer interface with the environment; 2.6 Cancer cells as moving targets; 2.7 Conclusion and future trends; 2.8 References; 3 Targeted drug delivery for cancer therapy; 3.1 Introduction; 3.2 Current paradigm; 3.3 Challenges to current paradigm; 3.4 Conclusion and future trends; 3.5 References; Part II Synthetic vaccines, proteins, and polymers for cancer therapeutics; 4 Chemical synthesis of carbohydrate-based vaccines against cancers; 4.1 Introduction; 4.2 Semi-synthetic vaccines; 4.3 Fully synthetic vaccines; 4.4 Conclusion and future trends; 4.5 References; 5 Generating functional mutant proteins to create highly bioactive anticancer biopharmaceuticals; 5.1 Introduction; 5.2 Artificial proteins for cancer therapy; 5.3 How to create functional mutant proteins as beneficial therapeutics; 5.4 Mutant TNF(alpha) for cancer therapy; 5.5 Conclusion and future trends; 5.6 Sources of further information and advice; 5.7 References; 6 Polymer therapeutics for treating cancer; 6.1 Introduction; 6.2 Polyamines and polyamine analogs; 6.3 Polymeric P-glycoprotein (Pgp) inhibitors; 6.4 Conclusion and future trends; 6.5 Acknowledgment; 6.6 References; Part III Theranosis and drug delivery systems for cancer therapeutics; 7 Nanotechnology for cancer screening and diagnosis; 7.1 Introduction; 7.2 Nanotechnology for cancer diagnosis; 7.3 Nanotechnology-based biosensing platforms; 7.4 Nanotechnology for biosensing -- early detection of cancer; 7.5 Nanotechnology for cancer imaging; 7.6 Concerns with using nanomaterials; 7.7 Conclusion and future trends; 7.8 References; 8 Synergistically integrated nanomaterials for multimodal cancer cell imaging; 8.1 Introduction; 8.2 Nanomaterial-based multifunctional imaging probes; 8.3 Nanoparticles with exogenous imaging ligands; 8.4 Nanoparticles with endogenous contrast; 8.5 Cocktail injection; 8.6 Conclusion; 8.7 References; 9 Hybrid nanocrystal as a versatile platform for cancer theranostics; 9.1 Introduction; 9.2 Imaging modality; 9.3 Developing theranostic systems; 9.4 Hybrid nanocrystal as theranostic platform; 9.5 Conclusion; 9.6 Acknowledgment; 9.7 References; 10 Embolisation devices from biomedical polymers for intra-arterial occlusion and drug delivery in the treatment of cancer; 10.1 Introduction; 10.2 Biomedical polymers and embolisation agents; 10.3 Particulate embolisation agents; 10.4 Drug-eluting embolisation beads; 10.5 Polymer structure, form and property relationships; 10.6 Experience with drug-eluting embolisation beads; 10.7 Conclusions and future trends; 10.8 Acknowledgement; 10.9 References; 11 Small interfering RNAs (siRNAs) as cancer therapeutics; 11.1 Introduction; 11.2 Prerequisites for siRNAs cancer therapeutics; 11.3 Delivery systems of anticancer siRNAs; 11.4 Current challenges for clinical trials; 11.5 Conclusion; 11.6 Acknowledgement; 11.7 References; 12 Reverse engineering of the low temperature-sensitive liposome (LTSL) for treating cancer; 12.1 Introduction; 12.2 What is reverse engineering?; 12.3 Investigating the thermal-sensitive liposome's performance-in-service; 12.4 Defining the function of the liposome; 12.5 Component design: mechanism of action; 12.6 Selecting the most appropriate material when designing the Dox-LTSL; 12.7 Analysis of materials performance in the design; 12.8 Specification sheet; 12.9 Production; 12.10 Prototypes; 12.11 Further development; 12.12 Conclusion and future trends; 12.13 Acknowledgements; 12.14 References; 13 Gold nanoparticles (GNPs) as multifunctional materials for cancer treatment; 13.1 Introduction; 13.2 Physical properties of gold nanoparticles; 13.3 Surface chemistry of GNPs; 13.4 GNPs as vehicles for drug delivery; 13.5 GNPs in biomedical imaging and theranostics; 13.6 GNPs as radiosensitizing agents; 13.7 Challenges in the development of GNPs as therapeutic agents; 13.8 Conclusion and future trends; 13.9 Acknowledgments; 13.10 Bibliography; 14 Multifunctional nanosystems for cancer therapy; 14.1 Introduction; 14.2 Design of multifunctional nanosystems; 14.3 Illustrative examples of multifunctional nanosystems for tumor-targeted therapies; 14.4 Polymeric nanosystems; 14.5 Lipid nanosystems; 14.6 Hybrid nanosystems; 14.7 Regulatory and clinical perspectives; 14.8 Conclusions; 14.9 References; Part IV Biomaterial therapeutics and cancer cell interaction; 15 Biomaterial strategies to modulate cancer; 15.1 Introduction; 15.2 Understanding cancer with biomaterials; 15.3 Molecular markers for cancer; 15.4 Biomaterials for cancer therapy; 15.5 Conclusion; 15.6 References; 16 3D cancer tumor models for evaluating chemotherapeutic efficacy; 16.1 Introduction; 16.2 Efforts to fight cancer; 16.3 Preclinical drug evaluation in cellular and animal models; 16.4 In vivo environment; 16.5 2D vs 3D culture systems; 16.6 3D tumor models; 16.7 Methods to culture multicellular tumor spheroids; 16.8 Conclusion; 16.9 References; 17 Nanotopography of biomaterials for controlling cancer cell function; 17.1 Introduction;17.2 The influence of surface topography and roughness of PLGA on cancer cells: creation of nanoscale PLGA surfaces; 17.3 The influence of nanoscale PLGA topographies on surface wettability and surface free energy; 17.4 The influence of PLGA nanotopographies on protein adsorption; 17.5 The impact of PLGA surface nanopatterns on cancer cell functions; 17.6 The impact of nanopatterns and LBL monolayers on cell functions; 17.7 Conclusions; 17.8 References; Index.
  • 2010 Springer
    Michael F. Ochs, John T. Casagrande, Ramana V. Davuluri, editors.
  • 2016 Ovid
    Cyril Fisher, Elizabeth A. Montgomery, Khin Thway.
    Biopsy techniques, diagnostic methods, and reporting -- Benign and intermediate fibrosing lesions -- Cellular benign and intermediate lesions of fibroblasts and myofibroblasts -- Cutaneous spindle cell lesions -- Intra-abdominal spindle cell lesions -- Smooth muscle tumors -- Myofibroma, myopericytic tumors, myoepithelioma, and myofibroblastoma -- Tumors of specialized lower genital tract mesenchyme -- Benign nerve sheath tumors -- Spindle cell sarcomas -- Epithelioid tumors of soft tissue -- Soft tissue lesions with clear or granular cells -- Pleomorphic soft tissue tumors -- Small round cell tumors -- Benign adipose tissue lesions -- Liposarcoma -- Superficial vascular lesions and mimics of vascular lesions -- Deep vascular lesions -- Osteochondroid lesions of soft tissue -- Superficial myxoid lesions -- Deep myxoid lesions -- Plexiform soft tissue tumors -- Soft tissue tumors with giant cells.
  • 2013 CRCnetBASE
    editors, Victor R. Preedy, Vinood Patel.
    Functional optical imaging-based biosensors / Pablo Iglesias and Jose A. Costoya -- Use of a surface plasmon resonance (SPR) biosensor to characterize zwitterionic coatings on SiO2 for cancer biomarker detection / Norman D. Brault, Shaoyi Jiang, and Qiuming Yu -- Microcantilever-based biosensor array for tumor angiogenic marker detection / Riccardo Castagna and Carlo Ricciardi -- Electrochemical DNA biosensors at the nanoscale / Rosa Letizia Zaffino ... [et al.] -- Aptamer-based biosensors for cancer studies / Ilaria Palchetti and Marco Mascini -- Fluorescent biosensors for cancer cell imaging and diagnostics / May C. Morris -- Electrical and electrochemical immunosensor for cancer study / Seung Yong Lee and Seung Yong Hwang -- Multifunctional nanobiosensors for cancer / Dai-Wen Pang and Er-Qun Song -- Silicon nanowire biosensor for cancer markers / Yang-Kyu Choi and Chang-Hoon Kim -- DNA-electrochemical biosensors and oxidative damage to DNA : application to cancer / Victor Constantin Diculescu and Ana Maria Oliveira Brett -- Asparaginase-based asparagine biosensors and their application to leukemia / Neelam Verma and Kuldeep Kumar -- Breast cancer detection using surface plasmon resonance-based biosensors / Chii-Wann Lin and Chia-Chen Chang -- Detection of miRNA with silicon nanowire biosensors / Guo-Jun Zhang -- Biosensors for BCR-ABL activity and their application to cancer / Yusuke Ohba ... [et al.] -- Optical fiber nanobiosensor for single living cell detections of cancers / Xin Ting Zheng and Chang Ming Li -- Microfluidic biosensors for thyroglobulin detection and application to thyroid cancer / Seokheun Choi and Junseok Chae -- Optical biosensors and applications to drug discovery and development in cancer research / Carlo Bertucci and Angela De Simone -- Single-chain fragment variable recombinant antibodies and their applications in biosensors for cancer diagnosis / Xiangqun Zeng and Ray Mernaugh -- DNA biosensor for rapid detection of anticancer drugs / Sigen Wang and Ruili Wang -- Using UV light to engineer biosensors for cancer detection : the case of prostate specific antigen / Maria Teresa Neves-Petersen, Antonietta Parracino, and Steffen B. Petersen.
  • 2013 Springer
    Jean-Louis Prugnaud, Jean-Hugues Trouvin, editors.
    Biologicals' Characteristics / K. Ho and J.-H. Trouvin -- From the Biosimilar Concept to the Marketing Authorisation / M. Pavlovic and J.-L. Prugnaud -- Immunogenicity / J.-L. Prugnaud -- Substitution and Interchangeability / J.-L. Prugnaud -- G-CSFs: Onco-Hematologist's Point of View / D. Kamioner -- The Oncologist's Point of View / C. Chouaïd -- Biosimilars: Challenges Raised by Biosimilars: Who is Responsible for Cost and Risk Management? / F. Megerlin.
  • 2012 Springer
    Mauro Bologna, editor.
    Central Nervous System Tumors / Paolo Aloisi, Francesco Martella, Davide Cerone and Giampiero Porzio -- Head and Neck Tumours / Keith D. Hunter and Robert Bolt -- Thyroid Cancer / Laura D. Locati, Angela Greco, Maria Grazia Borrello, Maria Luisa Carcangiu and Paolo Bossi, et al. -- Targeted Therapies for Non-small-Cell Lung Cancer / Giulio Metro and Lucio Crinò -- Non-Hodgkin's Lymphomas / Roberta Zappasodi and Massimo Di Nicola -- Leukemias / Lia Ginaldi and Massimo De Martinis -- Breast Cancer / Nadia Rucci, Luca Ventura and Anna Teti -- Oesophago-Gastric Cancer / Alex M. Reece-Smith, Simon L. Parsons and Sue A. Watson -- Colorectal Cancer / David N. Church, Rachel Susannah Midgley and David J. Kerr -- Hepatocellular Carcinoma / Yasunori Minami and Masatoshi Kudo -- Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma / Laura S. Schmidt -- Bladder Cancer / Andrea Tubaro, Daniele Santini, Cosimo De Nunzio, Alice Zoccoli and Michele Iuliano -- Biomarkers in Prostate Cancer / Mauro Bologna and Carlo Vicentini -- Ovarian Cancer / Jessica Wangui Oribabor, Allison Ambrosio, Cesar M. Castro and Michael J. Birrer -- Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer / Annekathryn Goodman, Leslie S. Bradford and Leslie A. Garrett -- Biotargets in Sarcomas: The Past, Present, and a Look into the Future / Vivek Subbiah and Razelle Kurzrock -- Melanoma and Other Skin Cancers / Kim H. T. Paraiso, Jobin K. John and Keiran S. M. Smalley -- Molecular Pathology of Cancer Metastasis: Suggestions for Future Therapy / Adriano Angelucci and Edoardo Alesse -- Current and Future Developments in Cancer Therapy Research: miRNAs as New Promising Targets or Tools / Marilena V. Iorio, Patrizia Casalini, Claudia Piovan, Luca Braccioli and Elda Tagliabue.
  • 2010 Springer
    edited by Cheryl T. Lee and David P. Wood.
  • 2011 Springer
    Vinata B. Lokeshwar, Axel S. Merseburger, Stefan H. Hautmann, editors.
  • 2009 Springer
    Felix Bronner, Mary C. Farach-Carson, (eds.).
  • 2010 ClinicalKey
    edited by Andrew L. Folpe, Carrie Y. Inwards.
    Bone and Soft Tissue Pathology: A Volume in the Diagnostic Pathology Series, by Andrew L. Folpe, MD and Carrie Y. Inwards, MD, packs today's most essential bone and soft tissue pathology know-how into a compact, high-yield format! The book's pragmatic, well-organized approach, complemented by abundant full-color, high-quality illustrations and at-a-glance tables, makes it easy to access the information you need to quickly and accurately identify pathology specimens. Best of all, Expert Consult functionality provides online access to the full text of the book, downloadable illustrations for your personal use, and more. The result is a practical, affordable reference for study and review as well as for everyday clinical practice. Includes access to the complete contents online, fully searchable, downloadable illustrations for your personal use, and more, allowing you to consult the text a quick, convenient manner. Reviews normal histology before examining abnormal findings, enabling you to conveniently compare their characteristics in one place at one time. Covers both neoplastic and non-neoplastic conditions of bone and soft tissue to equip you to meet a wide range of diagnostic challenges. Uses a consistent, user-friendly format to explore each entity's clinical features, pathologic features (gross and microscopic), ancillary studies, differential diagnoses, and prognostic and therapeutic considerations ... making it easy to locate specific information on a particular entity. Features abundant boxes and tables throughout that enhance the presentation and accessibility of the material. Offers nearly 1,000 full-color, high-quality illustrations that demonstrate the key features of a wide variety of pathologic lesions to facilitate greater accuracy in identification of specimens.
  • 2015 ClinicalKey
    [edited by] Dominique Heymann.
    Epidemiology of primary bone tumors and economical aspects of bone metastases -- Tumor: bone interactions: there is no place like bone -- Stem cell niches in the bone: bone marrow organ and their significance for hematopoietic and non-hematopoietic cancer -- Deregulation of osteoblast differentiation in primary bone cancers -- Contribution of osteoclasts to the bone: tumor niche -- Involvement of osteocytes in cancer bone niche -- Role of mesenchymal stem cells in bone cancer; initiation, propagation and metastasis -- Gap junction in bone remodeling and in primary bone tumors: osteosarcoma and Ewing sarcoma -- Macrophages and pathophysiology of bone cancers -- Cytokines and bone cancers -- Technical aspects: how do we best prepare bone samples for proper histological analysis? -- Bone remodeling markers and bone cancer -- Cancer stem cells in representative bone tumors: osteosarcoma, Ewing sarcoma and metastases from breast and prostate carcinomas -- Homeobox genes from the Dlx family and bone cancers -- MicroRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors -- Hypoxia and angiogenesis: from primary tumor to bone metastasis -- Modeling osteosarcoma: in vitro and in vivo approaches -- Stemness markers of osteosarcoma -- Molecular pathology of osteosarcoma -- Gene and proteomic profiling of osteosarcoma -- Ewing sarcoma family of tumors -- Biology of Ewing sarcoma -- Osteoclast-rich lesions of bone: a clinical and molecular overview -- Markers for bone sarcomas -- Margins and bone tumors: what are we talking about? -- Cytogenetics of bone tumors -- Genetic aspects of bone tumors -- Cytogenetic and molecular genetic alterations in bone tumors -- Genetics of giant cell tumors of bone -- Mammalian models of bone sarcomas -- Zebrafish models for studying bone cancers: mutants, transgenic fish and embryos -- Imaging of bone sarcomas -- New therapeutic targets in Ewing sarcoma: from pre-clinical proof-of-concept to clinical trials -- Therapeutic approaches for bone sarcomas -- Chondrosarcoma of bone: diagnosis and therapy -- Apoptosis and drug resistance in malignant bone tumors -- Giant cell tumors of bone -- EMT process in bone metastasis -- Histopathology of skeletal metastases -- Disseminated tumor cells in bone marrow of cancer patients -- MicroRNA-mediated regulation of bone metastasis formation: from primary tumors to skeleton -- Myeloma and osteoclast relationship -- In vivo models used in studies of bone metastases -- Interventional radiologic techniques in management of bone tumors -- Diagnosis of bone metastases in urological malignancies : an update -- Pre-clinical molecular imaging of "the seed and the soil" in bone metastasis -- Mechanisms and management of bone cancer pain -- Bone cancer: current opinion in palliative care -- Involvement of sympathetic nerves in bone metastasis -- Pain control with palliative radiotherapy in patients with bone metastases -- Cellular and molecular actions of bisphosphonates -- The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood [gamma delta] T cells for the treatment of bone cancer metastasis -- Systemic treatment of bone metastases in castration-resistant prostate cancer (CRPC): pre-clinical to clinical point of view -- A multi-targeted approach to treating bone metastases -- Bone metastases in prostate cancer: pathophysiology, clinical complications, actual treatment, and future directions -- Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases -- Bone metastases : current status of bone-targeted treatments -- Bone metastases, clinical trials II: zoledronic acid and denosumab in the prevention of bone metastases.
  • 2010 ScienceDirect
    edited by Dominique Heymann.
    Chapter 1. Epidemiology of Primary Bone Tumors and Economical Aspects of Bone Metastases / Esther I. Hauben, Pancras C.W. Hogendoorn -- Chapter 2. Tumor-Bone Cell Interactions in Bone Metastases / Pierrick G.J. Fournier, Lauren K. Dunn, Gregory A. Clines, Theresa A. Guise -- Chapter 3. Early Bone Metastasis-Associated Molecular and Cellular Events / Philippe Clézardin -- Chapter 4. Regulation of Osteoblast Differentiation and Bone Cancers by Wnt and PTH Signaling Pathways / Julia Billiard, John A. Robinson, Ramesh A. Bhat, Bheem M. Bhat, Richard J. Murrills, Peter V.N. Bodine -- Chapter 5. Osteoclast Differentiation and Function / Luis Filgueira -- Chapter 6. Immunoregulation of Osteoclast Differentiation in Multiple Myeloma Bone Disease / Maria Grano, Giacomina Brunetti, Silvia Colucci -- Chapter 7. Facts and Hypothesis on Osteolytic Lesions Related to Normal and Tumoral Epithelial Dental Cell Differentiation / Blandine Ruhin, Frédéric Lézot, Aymann Bouattour, Sonia Ghoul-Mazgar, Ariane Berdal, Vianney Descroix -- Chapter 8. The Role of the Interleukin-6 Family of Cytokines in Bone Remodeling and Bone Cancer / Frédéric Blanchard, Emmanuelle David, Bénédicte Brounais -- Chapter 9. Proteases and Therapeutic Approaches of Bone Tumors / Velasco C. Ruiz, Y. Fortun, D. Heymann, M. Padrines -- Chapter 10. Bone Remodeling Markers and Bone Cancer / Markus J. Seibel -- Chapter 11. Cytogenetic and Molecular Genetic Alterations in Bone Tumors / Suvi Savola, Tom Böhling, Sakari Knuutila -- Chapter 12. Cytogenetics of Bone Tumors / Jiyun Lee, Mallory Martin, Shibo Li -- Chapter 13. Genetic Aspects of Bone Tumors / Shamini Selvarajah, Maria Zielenska, Jeremy A. Squire, Paul C. Park -- Chapter 14. Proteomics of Bone Cancer / Stephanie Byrum, Eric R. Siegel, Sudeepa Bhattacharyya, Larry J. Suva -- Chapter 15. Genomic and Proteomic Profiling of Osteosarcoma / Tsz-Kwong Man, Pulivarthi H. Rao, Ching C. Lau -- Chapter 16. Molecular Pathology of Osteosarcoma / Walter C. Bell, Gene P. Siegal -- Chapter 17. Technical Aspects: How Do We Best Prepare Bone Samples for Proper Histological Analysis? / Daniel Chappard -- Chapter 18. Osteoclast-rich Lesions of Bone: A Clinical and Molecular Overview / Adrienne M. Flanagan, Roberto Tirabosco, Panagiotis D. Gikas -- Chapter 19. Recent Advances in the Biology of Bone Tumors and New Diagnostic Tools / Gonzague de Pinieux, Corinne Bouvier -- Chapter 20. Ewing's Sarcoma Family of Tumors / Joseph D. Khoury -- Chapter 21. The Histopathology of Skeletal Metastases / Ping Tang, David G. Hicks -- Chapter 22. Interventional Radiologic Techniques and their Contribution to the Management of Bone Tumors / Robert G. Jones, Eric J. Heffernan, Faisal Rashid, Peter L. Munk -- Chapter 23. Imaging of Bone Metastases / Nieroshan Rajarubendra, Nathan Lawrentschuk -- Chapter 24. Diagnosis of Skeletal Metastases in Malignant Extraskeletal Cancers / Holger Schirrmeister, Coskun Arslandemir -- Chapter 25. Pain Control with Palliative Radiotherapy in Bone Metastases / Alysa Fairchild, Amanda Hird, Edward Chow -- Chapter 26. Mechanisms and Management of Bone Cancer Pain / Ma'ann C. Sabino, Denis R. Clohisy -- Chapter 27. Malignant Skeletal Pain: Mechanisms and Potential Therapeutic Opportunities / Monica Herrera, Juan Miguel Jimenez-Andrade, Marina Vardanyan, Patrick W. Mantyh -- Chapter 28. Animal Models of Malignant Primary Bone Tumors and Novel Therapeutic Approaches / Julie Rousseau, François Lamoureux, Gaëlle Picarda, François Gouin, Valérie Trichet, Françoise Rédini -- Chapter 29. In vivo Models Used in Studies of Bone Metastases / Ingunn Holen, Michelle A. Lawson -- Chapter 30. Cytokine Gene Therapy in Bone Remodeling / Carl D. Richards, David Smyth -- Chapter 31. Non-surgical Treatment of Chondrosarcoma: Current Concepts and Future Perspectives / Eric L. Staals, Emanuela Palmerini, Stefano Ferrari, Mario Mercuri -- Chapter 32. Mechanistic Role of RANKL in Cancer-induced Bone Diseases and Development of a Targeted Therapy to Inhibit this Pathway / William C. Dougall -- Chapter 33. Chondrosarcoma of Bone: Diagnosis and Therapy / Arne Streitbuerger, Jendrik Hardes, Georg Gosheger -- Chapter 34. Current Status of Immunotherapy for Osteosarcoma and its Future Trends / Kanji Mori, Kosei Ando, Yoshitaka Matsusue, Dominique Heymann -- Chapter 35. Bisphosphonates, Bone Health and the Clinical Biology of Bone Metastases from Breast Cancer / Alexander H.G.Paterson -- Chapter 36. A Multi-targeted Approach to Treating Bone Metastases / Robert D. Loberg, Kenneth J. Pienta -- Chapter 37. Bone Metastases of Prostatic Cancer: Pathophysiology, Clinical Complications, Actual Treatment and Future Directions / Sara De Dosso, Fernanda G. Herrera, Dominik R. Berthold -- Chapter 38. Apoptosis and Drug Resistance in Malignant Bone Tumors / Udo Kontny.
  • 2012 Springer
    Dimitra Anagnostou, Estella Matutes, editors.
    1. New Insights in the Development of Human B Lymphocytes / Bianca Blom -- 2. The Aging Lymphocyte / Hector F. Valenzuela, Rita B. Effros -- 3. The Bone Marrow Microenvironment and Its Impact in Acute and Chronic B Cell Malignancies / Jan A. Burger -- 4. The Expanding Diagnostic Role of Flow Cytometry in Bone Marrow Studies of Patients with Lymphomas and Plasma Cell Disorders / Anna Porwit -- 5. The Application of Molecular Techniques on Bone Marrow Trephines / Falko Fend, Leticia Quintanilla-Martínez -- 6. Residual Disease Assessment and Its Role in Monitoring Lymphoid and Plasma Cell Neoplasms / Konnie M. Hebeda -- 7. Reporting of Bone Marrow Lymphoid Infiltrates / Yi-Hua Chen, LoAnn Peterson -- 8. Janus-Faced Lymphoid Infiltrates / Dimitra Anagnostou -- 9. Singularities in Pediatric Bone Marrow Lymphoid Processes / Sophia L. Yohe, Robert W. McKenna -- 10. Bone Marrow Involvement in Primary Mature B and T Cell Leukemias / Ayoma D. Attygalle -- 11. A Step Forward in the Diagnosis of B-Cell Lymphomas in the Bone Marrow / Ahmet Dogan, Mine Hekimgil -- 12. New Insights in Waldenström's Macroglobulinemia / Meletios A. Dimopoulos, Evangelos Terpos -- 13. Bone Marrow in Hodgkin Lymphoma and Mimickers / Stefano A. Pileri, Elena Sabattini -- 14. Misleading Features of Bone Marrow Involvement by Peripheral T-Cell Lymphomas / Philippe Gaulard, Sylvia Hoeller -- 15. Systemic Mastocytosis Associated with Lymphoproliferative Disorders (SM-AHNMD) / Hans-Peter Horny, Karl Sotlar, Peter Valent.
  • 2009 Springer
    edited by Dimitrios Kardamakis, Vassilios Vassiliou and Edward Chow.
    Focusing on the field of metastatic bone disease, this volume: describes the molecular and cellular mechanisms involved in the formation of bone metastases, comments on the role of angiogenesis, and, deals with various aspects of imaging modalities applied for the detection and evaluation of bone metastases.
  • 2014 Springer
    Dimitrios Kardamakis, Vassilios Vassiliou, Edward Chow, editors.
    The second edition of this book serves both as an introductory and reference book focusing on the field of metastatic bone disease. Featuring contributions from experts in the field, this volume describes the molecular and cellular mechanisms involved in the formation of bone metastases, presents the newer advances made in the understanding of the clinical picture and symptoms of patients, analyses the role of bone markers in research and clinical practice and deals with all aspects of imaging modalities applied for the detection and evaluation of bone metastases. Moreover, the use of all available treatment methods, such as radiotherapy, surgery and systemic treatments for the management of patients with metastatic bone disease is discussed in detail. Overall this volume presents a thorough overview of all aspects of metastatic bone disease and provides a comprehensive and concise information resource for researchers, oncologists, orthopaedic surgeons and clinicians dealing with patients with metastatic bone disease.
  • 2005 Springer
    edited by Gurmit Singh, Shafaat A. Rabbani.
    Overview / Sadmeet Singh and Gurmit Singh -- Parathyroid hormone-related peptide and malignancy / David Goltzman -- Vitamin D and vitamin D analogs in cancer / Richard Kremer and Shafaat A. Rabbani -- Role of TGF and IGF in tumor progression and bone metastases / Erin Giles and Gurmit Singh -- Biologic and therapeutic implications of osteomimicry and epithelial/mesenchymal transition in prostate cancer / Wen-Chin Huang, Valerie Odero-Marah, and Leland W.K. Chung -- The roles of immune-cell derived matrix metalloproteinases in tumor growth and metastasis / Kristina A. Szabo and Gurmit Singh -- Contribution of osteopontin to the development of bone metastasis / Alison L. Allan ... [et al.] -- The role of interleukin-11 in osteolytic bone metastasis / Ryan R. Simon ... [et al.] -- Cell adhesion moleculars in tumor metastasis / Sujata Persad ... [et al.] -- Antithrombotics in tumor growth and metastasis / Shaker A. Mousa -- Challenges and strategies in the analysis of multiple events in oncology / Pierre P. Major and Richard J. Cook -- Integrins : novel targets for the treatment of bone metastasis / Graham C. Parry ... [et al.] -- Bone metastasis and pathological fractures : bone tissue engineering as a novel therapy / Laurie A. McDuffee, Nigel Colterjohn, and Gurmit Singh -- Role of photodynamic therapy for bone metastasis / Shane Burch and Albert J.M. Yee -- Docetaxel for metastatic cancer and its role in combination therapies for advanced prostate cancer / Ellen K. Wasan ... [et al.] -- The use of tetracyclines for bone metastasis / Eric Seidlitz, Zeina Saikali, and Gurmit Singh -- Role of bisphosphonates in skeletal metastases / Arif Hussain and Fred Saad -- Radiation treatment of bone metastases / Edward Chow, Jackson Wu, and Elizabeth Toni Barnes.
    Also available: Print – 2005
  • 2013 Springer
    Patrick P. Lin, Shreyaskumar Patel, editors.
    Multidisciplinary approach to the management of sarcomas of bone / Bryan S. Moon -- Bone sarcoma imaging / John E. Madewell ... [et al.] -- Percutaneous image-guided biopsy for diagnosis of bone sarcomas / Kamran Ahrar -- Orthopedic oncologic surgical specimen management and surgical pathology / A. Kevin Raymond and Alexander J. Lazar -- Osteosarcoma / Patrick P. Lin and Shreyaskumar Patel -- Ewing sarcoma / Patrick P. Lin ... [et al.] -- Chondrosarco / Alan W. Yasko, Vinod Ravi, and Ashleigh Guadagnolo -- Rare bone sarcomas / Valerae O. Lewis ... [et al.] -- Skeletal reconstruction after bone sarcoma resection / Christopher P. Cannon and David W. Chang -- Soft tissue reconstruction after bone sarcoma resection / Scott D. Oates -- Bone sarcomas in the growing child / Valerae O. Lewis and David W. Chang -- Perioperative management of patients with bone sarcomas / Janie Rutledge, Mark S. Pilarczyk, and Alan W. Yasko -- Rehabilitation in orthopedic oncology / Benedict Konzen and Christopher P. Cannon -- Follow-up evaluation and surveillance after treatment of bone sarcomas / Colleen M. Costelloe and Patrick P. Lin.
  • 2012 Springer
    Jim S. Wu, Mary G. Hochman.
    Introduction to Bone Tumors -- How to Evaluate a Bone Lesion -- Imaging Modalities -- Cartilage Tumors -- Osseous Tumors -- Fibrous Tumors -- Miscellaneous Tumors -- Bone Metastases -- Bone Tumor Mimickers -- Cases.
  • 2011 Springer
    Irene M.Ghobrial, Paul G. Richardson, Kenneth C. Anderson, editors.
    Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways. This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.
  • 2010 Springer
    edited by M.A. Hayat.
  • 2007 Springer
    edited by Jeffrey J. Raizer, Lauren E. Abrey.
    Also available: Print – 2007
  • v. 1, 2014 ClinicalKey
    edited by M.A. Hayat.
    With an annual rate of more than 12 million global diagnoses and 7.6 million deaths, the societal and economic burden of cancer cannot be overstated. Brain metastases are the most common malignant tumors of the central nervous system, yet their incidence appears to be increasing in spite of the advancement of cancer therapies. While much is known about primary cancers (including primary brain tumors), less work has been done to uncover the roots of metastatic disease. This volume fills that gap, serving as the first reference to focus primarily on the link between primary cancers and brain metastases. This link is explored for the most common cancer types -- lung, breast, and melanoma. Additionally, biological background as well as therapy for CNS metastases is addressed. Age and gender related trends are also discussed, as is the use of biomarkers for early detection.
  • v.2, 2015 ClinicalKey
    [edited by] M.A. Hayat.
    Brain metastases are the most common malignant tumors of the central nervous system, yet their incidence appears to be increasing in spite of the advancement of cancer therapies. While much is known about primary cancers (including primary brain tumors), less work has been done to uncover the roots of metastatic disease. Brain Metastases from Primary Tumors fills that gap, serving as the first two-part reference to focus primarily on the link between primary cancers and brain metastases. This link is explored for the most common cancer types - lung, breast, and melanoma. Additionally, biological background as well as therapy for CNS metastases is addressed. Age- and gender-related trends are also discussed, as is the use of biomarkers for early detection.
  • 2015 Thieme-Connect
    [edited by] Rajan Jain, Marco Essig.
    Conventional morphologic imaging : MRI remains the workhorse -- Benjamin Cohen, Inna Nutanson, and Girish M. Fatterpekar -- Response assessment in neuro-oncology / Tom Mikkelsen and Tobias Walbert -- Going beyond the conventional morphologic imaging : an overview of functional imaging techniques / Marco Essig and Cem Calli -- Perfusion imaging : DSC MR perfusion / Marco Essig, Joseph Puig Alcantara, and Cem Cali -- Perfusion imaging : dynamic contrast enhanced T1-weighted MRI (DCE-MRI) perfusion / David Fussell and Robert J. Young -- Perfusion imaging : arterial spin labeling / S. Ali Nabavizadeh, Suyash Mohan, Jeffrey M. Pollock -- Perfusion imaging : CT perfusion / Brent Griffith and Rajan Jain -- Diffusion weighted imaging for gliomas / Benjamin M. Ellingson, Bryan Yoo, and Whitney B. Pope -- Diffusion tensor imaging / Bram Stieltjes and Peter Neher -- Functional MRI and diffusion tensor imaging with tractography / Anna Knobel and Robert J. Young -- Metabolic imaging : MR spectroscopy / Isabella Björkman-Burtscher and Pia C. Sundgren -- Molecular imaging : PET and SPECT / Asim K. Bag and Samuel E. Almodóvar -- It's not just the tumor : treatment effects / Brent Griffith and Rajan Jain -- It's not just the tumor : CNS paraneoplastic syndromes and cerebrovascular complications of cancers / Prashant Nagpal and Rajan Jain -- Image guided neurosurgery : intraoperative MRI / Ian Y. Lee -- On the horizon : ultra-high-field MR / Steffen Sammet and Alexander Radbruch -- On the horizon : tumor genomics / Rivka R. Colen, Faisal Tai, and Pascal O. Zinn -- On the horizon : going beyond the conventional MR contrast agents / Josep Puig and Wilson B. Chwang -- On the horizon : molecular imaging / Sanath Kumar, Meser M. Ali, and Ali Syed Arbab.
  • 2016 Springer
    Elke Hattingen, Ulrich Pilatus, editors.
    Brain tumor imaging -- MR imaging of brain tumors -- MR spectroscopic imaging -- MR perfusion imaging -- Diffusion-weighted methods -- Advanced MR methods in differential diagnosis of brain tumors -- PET imaging of brain tumors -- Advanced imaging modalities and treatment of gliomas: radiation therapy -- Advanced imaging modalities and treatment of gliomas: neurosurgery -- Future methods in tumor imaging.
  • 2006 Springer
    by Davide Schiffer.
  • 2011 ScienceDirect
    2011 ClinicalKey
    Kaye, Andrew H.; Laws, Edward R.
    Meet the increasing need for effective brain tumor management with the highly anticipated revision of Brain Tumors by Drs. Andrew H. Kaye and Edward R. Laws. Over the past decade, enormous advances have been made in both the diagnosis and the surgical and radiotherapeutic management of brain tumors. This new edition guides you through the latest developments in the field, including hot topics like malignant gliomas, functional brain mapping, neurogenetics and the molecular biology of brain tumors, and biologic and gene therapy. You'll also have easy access to the complete contents online, with links to PubMed and a downloadable image library, at www.expertconsult.com. Benefit from the knowledge and experience of Drs. Andrew H. Kaye and Edward R. Laws, globally recognized experts in the field of neurosurgery, as well as many other world authorities.
  • 2013 Springer
    Mahesh K. Shetty, editor ; foreword by Edward L. Trimble.
    Burden of Breast and Gynecological Cancers in Low-Resource Countries -- Breast Cancer: Pathology, Cytology, and Core Needle Biopsy Methods for Diagnosis -- Gynecological Cancers: Pathology and Cytological Methods for Diagnosis of Gynecological Cancers -- Screening and Early Diagnosis of Breast Cancer: Proven Methodology and an Optimized Strategy for Developing Countries -- HPV and Cervical Cancer -- Screening for Cervical Cancer in Low-Resource Countries -- Ovarian Cancer Screening and Early Detection in Low- and Middle-Income Countries -- Endometrial Cancer: Risk Factors and Early Diagnosis in Low-Resource Countries -- Breast and Gynecologic Cancer Prevention in Low-Resource Countries -- Combined Screening for Breast and Gynecological Cancers Using Mobile Clinics: The Barretos Experience (Brazil) -- Cost-Effectiveness of Screening for and Early Diagnosis of Breast and Gynecological Cancers in Low-Income Countries -- Challenges for Breast and Gynecological Cancer Control by Early Detection in Less-Developed Countries -- Funding for Global Healthcare Intervention: Initiatives Aimed at Controlling Cancer in Women in Low-Resource Countries -- Coordinated Training on Early Detection and Diagnosis of Breast Cancer Across Different Levels of Health Workers: An Example from Peru -- Telemedicine in Cancer Control Programs in Developing Countries -- Breast Cancer Screening and Cervical Cancer Prevention in Developing Countries: Strategies for the Future -- Well Woman Clinic Concept: An Integrated Approach for Screening and Early Diagnosis of Breast and Gynecological Cancers in Developing Countries.
  • 2011 ClinicalKey
    edited by Lisa Jacobs, Christina A. Finlayson.
    The normal breast and benign diseases of the breast / Samia Nawaz -- Ductal and lobular proliferations : preinvasive breast disease / Meenakshi Singh and Jon V. Rittenbach -- Invasive breast cancer / Michael D. Stamatakos -- Risk factors and risk assessment / Nancy S. Goldman and Constance R. Ziegfeld -- Genetics / Jennifer E. Axilbund, Amy L. Gross, and Kala Visvanthan -- Strategies for risk reduction / Anna Voltura and Lisa Jacobs -- Nutrition and lifestyle / Lisa Ware Corbin -- Radiologic techniques for early detection and diagnosis / John M. Lewin -- Screening of high-risk patients / James P. Borgstede and Brian Bagrosky -- Minimally invasive breast biopsy / Steve H. Parker, Terese I. Kaske, and Judy L. Chavez -- Surgical biopsy / Elizabeth Prier -- Surgical therapy of early breast cancer / Michael Ford and Christina A. Finlayson -- Breast reconstruction after mastectomy / Alex Colque, Hanjoon Song, and Erica D. Anderson -- Oncoplastic surgical techniques for the partial mastectomy / Chin-Yau Chen, Kristine E. Calhoun, and Benjamin O. Anderson -- Axillary management / M. Catherine Lee and Michael S. Sabel -- Radiation oncology / Richard Zellars, Timothy George, and Lee Myers -- Neoadjuvant therapy / Susanne Briest and Vered Stearns -- Cost-effective staging of breast cancer / Virginia F. Borges and Lara Hardesty -- Adjuvant systemic therapy / Anthony D. Elias, Daniel Bowles, and Peter Kabos -- Surveillance and detection of recurrence of breast cancer / Peter Kabos and Virginia F. Borges -- The use of molecular profiles in the management of breast cancer / Anthony D. Elias -- Partial breast irradiation / Rachel Rabinovitch -- Breast cancer and pregnancy / Scott W. McGee and Donald C. Doll -- Mammary ductoscopy / Edward R. Sauter.
  • 2008 Springer
    E. Bombardieri, G. Bonadonna, L. Gianni (eds.) ; with contributions by R. Agresti ... [et al.].
  • 2005 Thieme Book
    László Tabár, Tibor Tot, Peter B. Dean.
    Also available: Print – 2005
  • 2011 Springer
    Zsuzsanna Kahan, Tibor Tot, editor.
    The volume raises attention to the need of a completely new approach to breast cancer based on the knowledge collected on early breast cancer in the past two decades. The chapters are contributed by experts of all the fields participating in the clinical research and care of breast cancer. The practical importance of such a book is underlined by the increasing number of breast cancer cases, and also the increasing proportion of early stage-cases. The ultimate goal of the book is to point to the heterogeneous nature of the disease which is more striking and has more importance in care at the very early stages than at the more advanced stages. The book recommends the utilisation of all the information provided by multimodality imaging and special pathological methods, a new classification system and therapeutic guidelines since early breast cancers should not be treated based on experience obtained with palpable tumors. No similar book has been yet released to the market. The book is written for all the members of the team participating in the diagnosis and treatment of breast cancer (radiologists, pathologists, surgeons, clinical and radiation oncologists), but may be useful for medical students and residents too. The chapters are illustrated with didactic pictures, and special emphasis is given to provide a peep into the practice of the special procedures for the careful examination and individualized therapy of each case.
  • 2011 Springer
    Tibor Tot, editor.
    The theory of the sick lobe states that breast carcinoma is a lobar disease developing most often within a single lobe, meaning that, at an early stage, breast carcinoma occupies a limited, anatomically well-defined portion of the breast. This theory unites observed patterns from the genetic, developmental and morphological perspectives, into an overall concept. "Breast Cancer: A Lobar Disease," presents this hypothesis and its consequences. The body of evidence, pro and contra, generated in recent years will be presented in this volume. The chapters, all authored by leading experts.
  • 2014 Springer
    Darius S. Francescatti, Melvin J. Silverstein, editors.
    Breast Cancer: A New Era in Management provides a compendium of succinct analysis of the many facets involved in the present day management of the breast cancer patient. The text provides the clinician or student with basic foundational knowledge in the rapidly expanding areas of expertise that are required for both the diagnosis and treatment of the breast cancer patient. Each topic, whether diagnostic or therapeutic, is presented in a straightforward fashion incorporating as part of each topic a description of the historical clinical landmarks leading to the present day, their present day position in the care of the breast patient, and finally, an assessment of possible future application and adaptation in clinical practice. Emphasis is placed on clear and concise explanations of each topic presented in stepwise fashion from fundamental elements to the more complex. Breast Cancer: A New Era in Management will act as a ready reference for the practicing surgeon and students seeking practical information on a particular clinical topic or scenario.
  • 2011 Springer
    Patricia A. Thomas, editor.
    Overview -- Common benign conditions of low concern -- Benign conditions associated with a risk for the subsequent development of cancer -- Precursor lesions and noninvasive cancers -- Breast cancer -- Things pathologists must always consider -- Nuances and details of the pathology report.
  • 2013 NIEHS
    report of the Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC).
    The large and increasing burden of breast cancer demands innovative research and bold new approaches to uncover the intricate combination of factors inside and outside the body that lead to the disease. Based on our review of the state of the science, current programs and investments by federal agencies and nongovernmental organizations, and relevant communication efforts and policies, the IBCERCC offers seven recommendations to highlight the urgent need for coordinated, targeted efforts to identify and mitigate the environmental causes of breast cancer.
  • 2015 Springer
    Jonathan Strauss, William Small, Gayle E. Woloschak, editors.
    Breast Cancer Biology for the Radiation Oncologist is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entity, with all treatment decisions being based on clinical and pathologic risk factors. We are now beginning to understand that biological subtypes of breast cancer may have different risks of recurrence as well as different intrinsic sensitivity to radiotherapy. Multi-gene arrays that have for years been used to predict the risk of distant recurrence and the value of systemic chemotherapy may also have utility in predicting the risk of local recurrence. Additionally, the targeted agents used to treat breast cancer may interact with radiotherapy in ways that can be beneficial or undesirable. All of these emerging issues of central importance to radiation oncologists are extensively discussed in this book, and practical treatment recommendations based on available clinical evidence are presented whenever possible.
  • 2007 Springer
    edited by Dihua Yu, Mien-Chie Hung.
    Overview of resistance to systemic therapy in patients with breast cancer / Ana Maria Gonzalez-Angulo, Flavia Morales-Vasquez and Gabriel N. Hortobagyi -- Roles of multidrug resistance genes in breast cancer chemoresistance / M. Tien Kuo -- Therapy-induced apoptosis in primary tumors / David J. McConkey -- Cell cycle deregulation in breast cancer: insurmountable chemoresistance or achilles' heel? / Laura Lambert and Khandan Keyomarsi -- p53, BRCA1 and breast cancer chemoresistance / Kimberly A. Scata and Wafik S. El-Deiry -- Integrin-mediated adhesion: tipping the balance between chemosensitivity and chemoresistance / Mary M. Zutter -- Insulin-like growth factors and breast cancer therapy / Xianke Zeng and Douglas Yee -- EGF receptor in breast cancer chemoresistance / Robert B. Dickson and T.B. Deb -- Molecular mechanisms of ErbB2-mediated breast cancer chemoresistance / Ming Tan and Dihua Yu -- Estrogen receptors in resistance to hormone therapy / Matthew H. Herynk and Suzanne A.W. Fuqua -- Novel approaches for chemosensitization of breast cancer cells: the E1A story / Yong Liao, Dihua Yu and Mien-Chie Hung.
    Also available: Print – 2007
  • 2010 Springer
    Christopher I. Li, editor ; foreword by Janet R. Daling.
    Global burden of breast cancer / Jacques Ferlay ... [et al.] -- Breast cancer biology and clinical characteristics / Amanda I. Phipps and Christopher I. Li -- In situ breast cancer / Brian L. Sprague and Amy Trentham-Dietz -- Endogenous hormones / Amanda I. Phipps and Christopher I. Li -- Exogenous hormones / Christopher I. Li and Elisabeth F. Beaber -- Reproductive factors / Mats Lambe -- Physical activity and anthropometric factors / Katherine D. Henderson, Jennifer Prescott, and Leslie Bernstein -- Diet and nutrition / Martin Lajous and Shumin M. Zhang -- Environmental and occupational exposures / Amanda I. Phipps ... [et al.] -- Shift work and circadian disruption / Scott Davis and Dana K. Mirick -- Non-hormonal medications and chronic diseases / Patricia F. Coogan -- Male breast cancer / Ian S. Fentiman -- Inherited predisposition: familial aggregation and high risk genes / Kathleen E. Malone and Kerryn W. Reding -- Common genetic susceptibility loci / Mikkel Z. Oestergaard and Paul Pharoah -- Mammographic density as a potential surrogate marker for breast cancer / Norman F. Boyd, Lisa J. Martin, and Salomon Minkin -- Breast cancer screening / Karla Kerlikowske -- Principles of breast cancer therapy / Allison W. Kurian and Robert W. Carlson -- Breast cancer outcomes / Graham A. Colditz and Courtney Beers.
  • 2015 Springer
    Nicoletta Biglia, Fedro Alessandro Peccatori, editors.
    Epidemiology.- Managing breast cancer in young women -- Impact of breast cancer treatment on fertility.- Fertility preservation and ART -- Breast cancer during pregnancy.- Pregnancy after breast cancer -- Reproductive issues in BRCA mutation carriers.
  • 2008 ClinicalKey
    Marie Tartar, Christopher E. Comstock, Michael S. Kipper.
    Through a case-based approach, this book illustrates the best practices for all facets of breast cancer imaging - from screening of asymptomatic patients to cancer staging, identifying metastases, and assessing efficacy of treatment - in a succinct, practical source. Contributing authors from a wide range of subspecialties provide well-rounded guidance to meet the needs of today₂s multidisciplinary work environment. Presents multidisciplinary discussions on the advantages and/or limitations of all available modalities. Includes advice from leading experts on cross-sectional imaging, breast imaging, and PET/CT, with input from radiation oncology, medical oncology, and breast surgery, to span the complete spectrum of care from screening to diagnosis to treatment, reflecting today₂s team approach to patient care. Covers all imaging modalities to help you correlate disease presentations on mammography, CT, MR, US, and PET images. Offers a very practical, clinical, concise approach to the subject in a case-based format. Provides over 1,000 high-resolution images of disease appearance for comparison with the findings you encounter in your practice.
  • 2009 Springer
    edited by Antonio Giordano, Nicola Normanno.
  • 2006 Springer
    senior editor, Christopher Kwesi O. Williams ; editors, Olufunmilayo I. Olopade and Carla I. Falkson.
    Status: Not Checked OutLane Catalog Record
    Burden of breast cancer in developing and developed countries -- Genetics of breast cancer in women of African Descent: an overview -- Biology of breast cancer: molecular and pathologic features of ductal neoplasia of the breast: racial considerations -- Screening and early detection of breast cancer in women in Africa and the Middle East -- Breast cancer at diagnosis in women of Africa and the Middle East -- Breast cancer aggressiveness in women of African descent -- Radiotherapy of breast cancer -- Adjuvant therapy of breast cancer -- Endocrine therapy of breast cancer -- Palliative care for breast cancer in the African-American population -- Outcome of African American women with breast cancer in cooperative group clinical trials -- Traditional medicine in breast cancer management with a focus on the Chinese integrative approach -- Impact of culture, education and socio-economic status -- Barriers to successful management of breast cancer.
    Also available: Print – 2006
  • 2006 MyiLibrary
    [edited by] Martine J. Piccart ... [et al.].
  • 2013 Springer
    Aamir Ahmad, editor.
    This volume comprehensively covers recent prrogress in breast cancer research. In an effort to successfully treat breast cancer, it is imperative to fully understand the disease with all its heterogeneity ; understand the factors that influence the metastasis of breast cancer to distant organs making it lethal and understand the underlying processes that lead to the phenomenon of drug-resistance making the disease particularly incurable. The book explores all of these issues, including the phenomenon of epithelial-mesenchymal-transition, cancer stem cells as well as microRNAs in an attempt to better understand the disease in connection to its heterogeneity, metastasis, drug-resistance as well as to propose novel signaling pathways for therapeutic intervention. The profiling of tumors to molecularly classify breast cancers is also investigated so that customized targeted therapies can be developed -- source other than Library of Congress.
  • 2008 Springer
    Kelly K. Hunt ... [et al.], editors ; foreword by John Mendelsohn.
  • 2016 Springer
    Lida Mina, Anna Maria Storniolo, Hal Douglas Kipfer, Cindy Hunter, Kandice Ludwig.
    1. Introduction to breast cancer: The Magnitude of the problem -- 2. Risk Factors for Breast Cancer -- 3. Defining the population at elevated risk for Breast Cancer: Risk Models -- 4. Genetic predisposition and Genetic screening -- 5. The BRCA patient population -- 6. Women with benign proliferative breast disease -- 7. Approach to Imaging -- 8. Chemoprevention -- 9. Lifestyle and Breast Cancer -- 10. Obesity and Inflammation -- 11. Conclusion/the Future/ Komen Tissue Bank/Clinical Trials.
  • 2005 Springer Protocols
    edited by Susan A. Brooks, Adrian Harris.
    Breast tissue banking: collection, handling, storage, and release of tissue for breast cancer research / Linda Snell and Peter H. Watson -- Frozen biopsy collection and storage: frozen biopsy samples / Russell Leek -- Serial biopsies/fine-needle aspirates and their assessment / Irene Boeddinghaus and Stephen R.D. Johnson -- Breast tissue microarrays / Robert J. Springall and Cheryl E. Gillett -- Preparation of tumor homogenates for subsequent preparation of cytosols, membrane fractions, RNA, and DNA / Naomi Robertson and Russell Leek -- Isolation of RNA from tumor samples: single-step guanidinium acid-phenol method / Naomi Robertson and Russell Leek -- Isolation of DNA from tumor samples / Naomi Robertson and Russell Leek -- Laser-assisted microdissection and isolation of DNA and RNA / Ulrich Lehmann and Hans Kreipe -- Fluorescence in situ hybridization and comparative genomic hybridization / Patricia Gorman and Rebecca Roylance -- Fluorescence in situ hybridization assessment of c-myc gene amplification in breast tumor tissues / Jan K. Blancato, Mary Steele Williams, and Robert B. Dickson -- Detection of HER2 gene amplification by fluorescence in situ hybridization in breast cancer / John M.S. Bartlett, and Amanda Forsyth -- In situ hybridization combined with immunohistochemistry to localize gene expression / Rosemary Jeffery, Toby Hunt, and Richard Poulsom -- Quantitation of RNA by ribonuclease protection assay / John W. Moore -- Identification of steroid hormone-regulated genes in breast cancer / Bruce R. Westley and Felicity E.B. May -- Sequencing of the tumor suppressor gene TP 53 / Barbro Linderholm, Torbjörn Norberg, and Jonas Bergh -- Expression profiling using cDNA microarrays / Chris Jones ... [et al.] -- Gene expression analysis using filter cDNA microarrays / Peter Simpson ... [et al.] -- Immunohistochemistry / Cheryl E. Gillett -- Detection of aberrant glycosylation in breast cancer using lectin histochemistry / Tracey M. Carter and Susan A. Brooks -- SDS-PAGE and western blotting to detect proteins and glycoproteins of interest in breast cancer research / Chloe Osborne and Susan A. Brooks -- Breast cancer proteomics using two-dimensional electrophoresis: studying the breast cancer proteome / Miriam V. Dwek and Sarah L. Rawlings -- Procedures for the quantitative protein determination of urokinase and its inhibitor PAI-1 in human breast cancer tissue extracts using ELISA / Manfred Schmitt ... [et al.] -- Methods to analyze the effects of the urokinase system on cancer cell adhesion, proliferation, migration, and signal transduction events / Ute Reuning ... [et al.] -- Phospho-specific antibodies as a tool to study in vivo regulation of BRCA1 after DNA damage / Kum Kum Khanna, Magtouf Gatei, and Gordon Tribbick -- Models of hormone resistance in vitro and in vivo / Jennifer MacGregor Schafer and V. Craig Jordan -- Generation of genetically modified embryonic stem cells for the development of knockout mouse animal model systems / Stephen D. Robinson, Stephen Wilson, and Kairbaan M. Hodivala-Dilke -- In vivo xenograft models of breast cancer metastatsis / Ursula Valentiner, Susan A. Brooks, and Udo Schumacher -- Neoadjuvant endocrine therapy models / Juliette Murray, William R. Miller, and J. Michael Dixon -- Primary mouse endothelial cell culture for assays of angiogenesis / Louise E. Reynolds and Kairbaan M. Hodivala-Dilke. Traditional and established indicators of prognosis and treatment success / Derek E. Roskell and Ian D. Buley -- Sentinel lymph node biopsy in breast cancer / Celia Chao and Kelly M. McMasters -- Pathological evaluation of axillary sentinel lymph nodes in breast cancer / Michael Z. Gilcrease and Aysegul Sahin -- Measurement of estrogen receptor status by immunocytochemistry in paraffin wax sections / Bharat Jasani ... [et al.] -- Markers of apoptosis / Falzul H. Sarkar and Yiwei Li -- Quantitative angiogenesis in breast cancer / Stephen B. Fox --
  • 2010 Springer
    Edward R. Sauter, Mary B. Daly, editors.
    Part I. Prevention -- Risk Factors / Polly A. Newcomb and Karen J. Wernli -- Lifestyle Factors and Risk of Breast Cancer: A Review of Randomized Trial Findings / Garnet L. Anderson -- Breast Cancer Chemoprevention / Mary B. Daly -- Surgical Management of Inherited Susceptibility to Breast Cancer / Francis Freisinger and Susan M. Domchek -- Part II. Early Detection -- Clinical Breast Examination and Breast Self-Examination / William H. Goodson -- Mammography / Barbara C. Cavanaugh and Sorcha McNally -- Current Status and Future Prospects in Breast Carcinoma of Positron Emission Tomography / Sandip Basu, Joshua I. Rosenbaum and Abass Alavi -- Breast MRI / Barbara C. Cavanaugh and Sorcha McNally -- Genetic and Molecular Approaches to Imaging Breast Cancer / Eric Wickstrom and Mathew L. Thakur -- Intraductal Approaches: Nipple Aspirate Fluid to Assist in Breast Cancer Detection / Edward R. Sauter -- Intraductal Approaches: Mammary Ductoscopy and Ductal Lavage to Assist in the Diagnosis of Breast Cancer / William C. Dooley -- Blood Markers / Mark W. Duncan -- Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis and Dimitris Mavroudis.
  • 2015 Springer
    Mahesh K Shetty, editor.
    This book presents the current trends and practices in breast imaging. Topics include mammographic interpretation; breast ultrasound; breast MRI; management of the symptomatic breast in young, pregnant, and lactating women; breast intervention with imaging pathological correlation; the postoperative breast; and current and emerging technologies in breast imaging. It emphasizes the importance of fostering a multidisciplinary approach in the diagnosis and treatment of breast diseases. Featuring more than 800 high-resolution images and showcasing contributions from leading authorities in the screening, diagnosis, and management of the breast cancer patient, Breast Cancer Screening and Diagnosis is a valuable resource for radiologists, oncologists, and surgeons. Mahesh K. Shetty is a Clinical Professor of Radiology at Baylor College of Medicine and the chief physician at the Woman?s Center for Breast Care & MRI at The Woman?s Hospital of Texas.
  • 2008 Springer
    edited by M.A. Hayat.
  • 2009 ClinicalKey
    [edited by] Kirby I. Bland, Edward M. Copeland III.
    The Breast: Comprehensive Management of Benign and Malignant Diseases, 4th Edition, by Kirby I. Bland, MD, and Edward M. Copeland, III, MD, is a surgical reference that offers the most comprehensive, up-to-date resource on the diagnosis and management of, and rehabilitation following, surgery for benign and malignant diseases of the breast. With its multidisciplinary approach, sweeping updates, new contributors, and authoritative guidance, you₂ll have exactly what you need to inspire patient confidence and provide the best possible outcomes. Best of all, this new edition comes to you in print and online for easy, convenient access to the absolute latest advances. Features multidisciplinary advice from experts in surgery, radiation and medical oncology, pathology, molecular biology, pharmacokinetics, and genetics for a well-rounded perspective to enhance patient outcomes. Includes more than 1,500 figures and tables that offer high quality depictions of surgery and treatment procedures. Offers step-by-step guidance through both text and clinical boxes that makes the material relevant to everyday practice. Provides cross-referencing between chapters, as well as references to carefully selected journal articles, that makes further research easier.
  • 2008 ClinicalKey
    Ira J. Bleiweiss, Shabnam Jaffer, Susan R. Drossman.
    Introduction and general considerations -- Well-circumscribed solid lesions -- Well-circumscribed solid lesions with heterogeneous radiodensity -- Largely cystic lesions -- Partially solid, partially cystic lesions -- Well-circumscribed solid malignancies -- Irregular densities -- Spiculated architectural distortion -- Architectural distortion -- Introduction to stereotactic core biopsies for calcifications -- Calcium oxalate crystals -- Linear high-density calcifications -- Clustered low-density granular calcifications -- Linear and branching calcifications -- Miscellaenous unusual and rare lesions -- Complications and follow-up: after the core biopsy -- Postscript.
  • 2015 Springer
    Adam I. Riker, editor.
    Breast Disease: Comprehensive Management provides a clear, concise source of information in order to make real-life, evidence-based decisions for all aspects of breast disease, both benign and malignant. The volume provides the latest breakthroughs in breast cancer research, ranging from paradigm shifts in the surgical management of the axilla, the changing role of adjuvant and neoadjuvant chemotherapy, the impact of molecular medicine in decision-making and the controversial role of prophylactic mastectomy in our era. Within select chapters, ℓ́ℓHow I do itℓ́ℓ clinical scenarios are supplied and described in very practical terms. Also included at the end of each chapter are synoptic questions with detailed answers, akin to the self-assessment (SESAP) format questions and answers. These questions provide a basis for continuous medical education (CME) for the practicing physician and surgeon, further in surgical oncology and breast surgery, medical oncologists, radiation oncologists, and breast radiologists enhancing a focused approach to the management of breast disease in preparation for the American Board of Surgery certification and re-certification for the general surgeon. This title is of great value to general surgeons, breast surgeons, surgical oncologists, general surgery residents, and fellows
  • 2016 Springer
    Adnan Aydiner, Abdullah İğci, Atilla Soran, editors.
    Breast anatomy and physiology -- 2. Benign diseases of the breast -- 3. Benign breast tumors -- 4. Epidemiology, risk factors, and prevention -- 5. Breast imaging and image-guided biopsy techniques -- 6. Lobular carcinoma in situ -- 8. Biology and genetics of breast cancer -- 9. Clinical aspects of estrogen and progesterone receptros and ERBB2 testing -- 10. Prognostic and predictive factors of invasive breast cancer -- 11. Gene arrays, prognosis, and therapeutic interventions -- 12. Bone marrow micrometastases and circulating tumor cells -- 13. Pathology of breast cancer -- 14. Intraoperative pathological examination of breast lesions -- 15. Fibroepithelial tumors of the breast -- 16. Mesenchymal tumors of the breast -- Index.
  • 2016 Springer
    Adnan Aydiner, Abdullah İgci, Atilla Soran, editors.
    1. Biopsy techniques in non-palpable or palpable breast lesions -- 2. Evaluation of patients for metastases prior to primary therapy -- 3. Staging of breast cancer -- 4. Surgical treatment of early-stage breast cancer -- 5. Evaluation of axillary nodes -- 6. Breast reconstruction -- 7. Adjuvant systemic therapy: endocrine therapy -- 8. Adjuvant systemic chemotherapy for HER2-negative disease -- 9. Adjuvant therapy for HER2-positive early breast cancer -- 10. Post-mastectomy adjuvant radiotherapy (PMRT) -- 11. Adjuvant radiation therapy after peroperative chemotherapy -- 12. Breast-conserving therapy: hypofractionated and conventional whole-breast irradiation and accelerated partial-breast irradiation -- 13. Preoperative therapy for operable breast cancer -- 14. Neoadjuvant hormonal therapy in breast cancer -- 15. Systermic therapy for locally advanced breast cancer -- 16. Systemic therapy for inflammatory breast cancer -- 17. Surgical management of operable breast cancer after neoadjuvant systemic therapy -- 18. Surgical management of locally advanced breast cancer -- 19. Surgical management of inflammatory breast cancer -- 20. Occult primary breast cancer with axillary metastases -- 21. Breast cancer in older women -- 22. Breast cancer in young women (premenopausal breast cacner) -- 23. Male breast cancer -- 24. Breast cancer in pregnancy -- 25. Paget's disease of the breast -- 26. Phyllodes tumors of the breast -- 27. Nonepithelial malignancies of the breast -- 28. Surveillance of patients following primary therapy -- 29. Surgery for the primary tumor in patients with de novo stage IV breast cancer -- 30. Local-regional recurrence after breast-conservation treatment or mastectomy -- 31. Treatment of metastic breast cancer: chemotherapy -- 32. Treatment of metastatic breast cancer: chemotherapy -- 33. Treatment of HER2-overexpressing metastatic breast cancer -- 34. End-of-life considerations in patients with breast cancer -- 35. Angiogenesis inhibition in breast cancer -- 36. Tyrosine kinase inhibitors -- 37. Neurological metastases -- 38. Ocular metastases -- 39. Management of malignant pleural effusions in breast cancer -- 40. Management of discrete pulmonary nodules -- 41. Management of isolated liver metastasis -- 42. Bone-directed therapy and breast cancer: bisphosphonates, monoclonal antibodies, and radionuclides -- 43. The local management of bone metastases -- 44. A review of local and systemic therapy in breast cancer -- 45. Decision pathways in breast cancer management -- 46. Nursing care and management -- 47. Psychosocial adaptation during and after breast cancer -- 48. Breast cancer-related lymphedema (BCRL) -- 49. Reproductive issues in breast cancer -- 50. Onco-cardiology for breast cancer -- Index.
  • 2015 Springer
    Radhakrishna Selvi.
    It is challenging enough to be able to make a diagnosis in mammography, but the newer standards of care demand more than just providing a diagnosis. This book is an excellent resource to improve the understanding of breast diseases, recognize and manage problems encountered in breast imaging and clinical management of the breast diseases. With forty four chapters, this volume is divided into six sections on screening of breast cancer, imaging modalities, benign breast disorders, interventional procedures, pathological considerations and breast cancer. Breast Diseases: Imaging and Clinical Management is a crisp volume on clinical and multimodality breast imaging with emphasis on interventional procedures, pathology and the entire spectrum of breast cancers.
  • 2015 Thieme Book
    2015 Thieme-Connect
    Richard G. Barr.
    "Elastography is a noninvasive imaging technique that detects tumors based on their stiffness compared to normal tissue. It uses ultrasound technology and can be performed during an ultrasound examination of the breast. It can dramatically reduce the number of breast biopsies performed. This book introduces the techniques of breast elastography followed by a detailed description for each of the techniques, highlighting their pros and cons. This is followed by a section on how to perform each of the techniques. The third section discusses the methods of interpretation for each technique, and the final section presents cases studies highlighting the pros and cons of each technique and how to avoid pitfalls in interpretation. It is written to appeal to the beginner as well as the experienced user"--Provided by publisher.
  • 2014 Springer
    Brendon J. Coventry, editor.
    Written by internationally acclaimed specialists, Breast, Endocrine and Surgical Oncology provides pertinent and concise procedure descriptions spanning benign and malignant problems and minimally invasive procedures. Complications are reviewed when appropriate for the organ system and problem, creating a book that is both comprehensive and accessible. Stages of operative approaches with relevant technical considerations are outlined in an easily understandable manner. The text is illustrated throughout by photographs that depict anatomic or technical principles. Forming part of the series, Surgery: Complications, Risks and Consequences, this volume Breast, Endocrine and Surgical Oncology provides a valuable resource for all general surgeons and residents in training. Other healthcare providers will also find this a useful resource.
  • 2011 ClinicalKey
    Lawrence W. Bassett [and others] [editors].
    History of Breast Imaging -- Epidemiology of Breast Cancer -- Screening Results, Controversies, and Guidelines -- Mammography and Digital Equipment -- Computer-Aided Detection -- Positioning in Mammography -- Clinical Image Evaluation -- Mammography Quality Control : Digital and Screen-Film -- Ultrasound Equipment -- Ultrasound Indications and Interpretation -- Magnetic Resonance Equipment and Techniques -- Magnetic Resonance Imaging : Indications and Interpretation -- BI-RADS, Reporting, and Communication -- The Normal Breast -- Benign Cystic Lesions of the Breast -- Solid Benign Lesions of the Breast -- Proliferative Lesions -- Typical Benign Calcifications -- High-Risk Breast Diseases -- Infectious and Inflammatory Diseases of the Breast -- Ductal Carcinoma in Situ and Paget's Disease -- Invasive Ductal Carcinomas -- Invasive Lobular Carcinoma -- Other Malignant Breast Diseases -- The Effect of Neoadjuvant Chemotherapy and Radiation Therapy on Breast Tissue -- American College of Radiology Appropriateness Criteria -- Appropriate Management of Masses -- Appropriate Management of Calcifications -- Image-Guided Percutaneous Biopsy -- Galactography -- Presurgical Needle Localization -- Specimen Processing in Pathology -- Post-Biopsy Management -- The Conservatively Treated Breast -- The Augmented Breast -- Reduction Mammoplasty -- The Mammography Quality Standards Act and Accreditation -- The Medical Audit : Statistical Basis of Clinical Outcomes Analysis -- Coding and Billing in Breast Imaging -- Medical-Legal Aspects of Breast Imaging and Intervention -- Emerging X-Ray-Based and Nuclear Technologies -- Ultrasound-Based Technologies Including Elastography and Automated Whole Breast Scanning -- Recent Advances in Magnetic Resonance Spectroscopy in the Breast -- Minimally Invasive Percutaneous Breast Cancer Ablation.
  • 2012 ClinicalKey
    Cecilia M. Brennecke.
    Effectively prepare for certification, recertification, and practice with Breast Imaging: Case Review, 2nd Edition! Case studies illustrate how to make confident, final diagnoses through accurate pattern recognition, clinical correlation, and differential diagnosis. It's an ideal way to test and deepen your knowledge of all essential topics in breast imaging. Consult this title on your favorite e-reader with intuitive search tools and adjustable font sizes. Elsevier eBooks provide instant portable access to your entire library, no matter.
  • 2007 Ovid
    Daniel B. Kopans.
    Breast anatomy and basic histology, physiology, and pathology -- A pathologist's overview of the pathology of breast disease / Joseph Rabban -- Epidemiology, etiology, risk factors, and survival from breast cancer -- Screening for breast cancer -- Radiation risk -- Staging breast cancer -- Ductal carcinoma in situ and early-stage breast cancer: detection, diagnosis, and prognostic indicators -- Mammography: equipment and basic physics -- Quality assurance and quality control / Debra Deibel -- Mammographic positioning -- A systematic approach to breast imaging -- Mammography and the normal breast -- Interpreting the mammogram -- Benign lesions -- Probably benign findings appropriately managed with short-interval follow-up -- Suspicious lesions and lesions with a high probability of malignancy -- Breast ultrasound -- The altered breast: pregnancy, lactation, abscess, post biopsy changes, mastectomy, radiation, and implants -- The male breast -- Magnetic resonance imaging of the breast / Carol A. Hulka and Daniel B. Kopans -- Evaluating women with lumps, thickening, discharge or pain: imaging women with signs or symptoms that might indicate breast cancer -- Image sequencing: problems and solutions in breast evaluation -- Histological, pathological and imaging correlation -- Interventional procedures in the breast -- The breast imaging report: data management and the breast imaging audit -- The medical-legal problem and breast imaging -- Digital mammography -- Digital breast tomosynthesis -- Cytopathology.
    Also available: Print – 2007
  • 2013 ClinicalKey
    Viriginia Molleran, Mary C. Mahoney.
    Breast MRI is a comprehensive, practical resource entirely devoted to this state-of-the-art technique, which has emerged as a valuable adjunct to the conventional imaging modalities in the detection of primary and recurrent breast cancer. This brand-new medical reference book utilizes an atlas-type format that showcases numerous examples of each aspect of breast MRI, equipping you with the latest knowledge on effective breast image interpretation. Compare your breast imaging findings to a wealth of breast MRI examples that capture the characteristic clinical presentation of both normal and diseased patients. Apply the most up-to-date information available on all aspects of breast MRI, including MRI-guided biopsy, breast cancer screening with MRI, MRI features of benign and malignant lesions, and MRI in the evaluation of newly diagnosed breast cancer.Take advantage of an image-rich, atlas-type format that offers the visual clarity you need for accurate interpretation.Access the full text and images online at Expert Consult.
  • 2008 Springer
    R. Edward Hendrick.
  • 2012 ClinicalKey
    David J. Dabbs.
    Normal Breast and Developmental Disorders -- Reactive and Inflammatory Conditions of the Breast -- Infections of the Breast -- Epidemiology of Breast Cancer -- Patient Safety in Breast Pathology -- Gross Examination of Breast Specimens -- Sentinel Lymph Node Biopsy -- Breast Imaging Modalities for Pathologists -- Predictive and Prognostic Marker Testing in Breast Pathology: Immunophenotypic Subclasses of Disease -- Molecular-based Testing in Breast Disease for Therapeutic Decisions -- Diagnostic Immunohistology of the Breast -- Fibroepithelial Lesions -- Papilloma and Papillary Lesions -- Adenosis and Microglandular Adenosis -- Nipple Adenoma (Florid Papillomatosis of the Nipple) -- Radial Scar -- Myoepithelial Lesions of the Breast -- Fibrocystic Change and Usual Epithelial Hyperplasia of Ductal Type -- Columnar Cell Alterations, Flat Epithelial Atypia, and Atypical Ductal Epithelial Hyperplasia -- Molecular Classification of Breast Carcinoma -- Lobular Neoplasia and Invasive Lobular Carcinoma -- Ductal Carcinoma In Situ -- Invasive Ductal Carcinoma of No Special Type and Histologic Grade -- Triple-Negative and Basal-like Carcinoma -- Metaplastic Breast Carcinoma -- Apocrine Carcinoma of the Breast -- Paget's Disease of the Breast -- Pathology of Neoadjuvant Therapeutic Response of Breast Carcinoma -- Special Types of Breast Carcinoma: Tubular Carcinoma, Mucinous Carcinoma, Cribriform Carcinoma, Invasive Micropapillary Carcinoma, and Medullary Carcinoma -- Rare Breast Carcinomas: Adenoid Cystic Carcinoma, Neuroendocrine Carcinoma, Secretory Carcinoma, Carcinoma with Osteoclast-like Giant Cells, Lipid-Rich Carcinoma, and Glycogen-Rich Clear Cell Carcinoma -- Mesenchymal Neoplasms of the Breast -- Neoplasia of the Male Breast -- Breast Tumors in Children and Adolescents -- Tumors of the Mammary Skin -- Hematopoietic Tumors of the Breast -- Metastatic Tumors in the Breast.
  • 2014 ClinicalKey
    edited by J. Michael Dixon.
    The role of imaging in breast diagnosis including screening and excision of impalpable lesions / A. Robin M. Wilson and R. Douglas Macmillan -- Pathology and biology of breast cancer / Rajendra S. Rampaul ... [et al.] -- Nipple discharge and the role of ductoscopy in breast diseases / Sarah Tang and Gerald Gui -- Breast-conserving surgery : the balance between good cosmesis and local control / J. Michael Dixon -- Techniques of mastectomy : tips and pitfalls / R. Douglas Macmillan -- Oncoplastic procedures to allow breast conservation and a satisfactory cosmetic outcome / Richard M. Rainsbury ... [et al.] -- The axilla : current management including sentinel node and lymphedema / Anees B. Chagpar -- The genetics of breast cancer, risk-reducing surgery, and prevention / D. Gareth, R. Evans and Ava Kwong -- Breast reconstruction / Mark Schaverien and Cameron Raine -- Breast cancer treatments of uncommon diseases / Daniel Xavier Choi and Monica Morrow -- Treatment of ductal carcinoma in situ / Nicola L.P. Barnes and Nigel J. Bundred -- The role of adjuvant systemic therapy in patients with operable breast cancer / Rosalie Fisher and Ian Smith -- Locally advanced breast cancer / Douglas J.A. Adamson and Alastair M. Thompson -- Metastatic disease and palliative care / John Dewar and Pamela Levack -- The role of adjuvant radiotherapy in the management of breast cancer / Ian Kunkler -- Psychosocial issues in breast cancer / Lesley Fallowfield and Valerie Jenkins -- Benign breast disease / Steven Thrush and J. Michael Dixon -- Litigation in breast surgery / Tim Davidson and Tom Bates.
  • 2011 Springer
    Frederick M. Dirbas, Carol E.H. Scott-Conner (eds.).
    Pt. 1. Fundamentals -- pt. 2. Biologic principles -- pt. 3. Initial evaluation of the patient -- pt. 4. Common presenting complaints and concerns -- pt. 5. Diagnostic techniques -- pt. 6. Breast cancer overview -- pt. 7. Breast surgery : management of the primary tumor -- pt. 8. Breast surgery : sentinel node biopsy and axillary dissection -- pt. 9. Breast surgery : special issues -- pt. 10. Cytology and pathology -- pt. 11. Systemic therapy for breast cancer -- pt. 12. Radiation therapy of the breast -- pt. 13. The breast cancer survivor.
    Also available: Print – 2011
  • 2013 Springer
    Alexander N. Sencha, Elena V. Evseeva, Mikhail S. Mogutov, Yury N. Patrunov.
    Diagnosis of breast cancer: modern aspects -- Technique of breast ultrasound -- Ultrasound of the normal breast -- Ultrasound diagnosis of breast cancer -- Classification of breast masses -- Ultrasound features of different types of breast cancer -- Differential diagnosis of breast diseases -- Age-related changes in breast structure: breast ultrasound in children and adolescents -- Breast pathology in men -- Ultrasound examination of regional lymph nodes -- Ultrasound examination after breast surgery -- Recurrent breast cancer.
  • 2013 Springer
    Erle S. Robertson, editor.
    This volume aims to bring together efforts with a patient-oriented focus from physicians to diagnostics and clinical implications of the disease as mostly seen in the equatorial African setting. However, the chapters cover the breadth of studies on Burkitt's lymphoma with some clues for the potential future of Burkitt's lymphoma research that can have therapeutic benefits for patients. This text explore a range of topics associated with Burkitt's lymphoma, including molecular biology, diagnosis, its association with AIDS and Malaria, immune responses, therapeutic approaches and a unique view from the bedside. This volume is comprehensive and unique and represents the most up-to-date clinical and research activities on Burkitt's lymphoma.
  • 2008 IARC
    Also available: Print – 2008
  • 2013
    Asian & Pacific Islander American Health Forum.
  • 2016 Springer
    Mikel San-Julian.
    History of surgery for limb bone tumors -- Non-Surgical Treatment Of Pediatric Bone Sarcomas -- Molecular Biology of Pediatric Bone Sarcomas -- Limb Salvage in Skeletally Immature Patients with Extremity Sarcoma -- Location of Sarcomas Within Bone: The Growth Plate -- A Histological Study of the Barrier Effect of the Physis Against Metaphyseal Osteosarcoma -- Growth Plate Involvement in Malignant Bone Tumours: Relationship Between Imaging Methods and Histological Findings -- Consequences of Delayed Diagnosis -- Imaging-Based Indications for Resection with Epiphyseal Preservation -- Conservation of the Epiphysis While Removing Metaphyseal Bone Tumors: Epiphysiolysis Before Excision -- Complications of the technique and solutions -- Clinical Results -- Other Techniques for Epiphyseal Preservation -- Worldwide Experience with the Cañadell Technique -- Questions and Answers.
  • 2006 Springer
    edited by Leon P. Bignold.
  • 2013 Karger
    volume editor, Martine Extermann.
    Chronic mechanistic target of rapamycin inhibition : preventing cancer to delay aging, or vice versa? / Sharp, Z.D.; Curiel, T.J.; Livi, C. -- Senescent cells and their secretory phenotype as targets for cancer therapy / Velarde, M.C.; Demaria, M.; Campisi, J. -- Cancer vaccination at older age / Gravekamp, C. -- Immunology of aging and cancer development / Fulop, T. ... [et al.] -- Metabolic syndrome and cancer : from bedside to bench and back / Extermann, M. -- Frailty : a common pathway in aging and cancer / Balducci, L. -- Targeting age-related changes in the biology of acute myeloid leukemia : is the patient seeing the progress? / Vey, N. -- Comprehensive geriatric assessment in oncology / Mohile, S.G.; Magnuson, A. -- Pharmacology of aging and cancer : how useful are pharmacokinetic tests? / Lichtman, S.M. -- Surgery in older cancer patients : recent results and new techniques : worth the investment? / Van Leeuwen, B.L.; Huisman, M.G.; Audisio, R.A. -- Organizing the geriatrician/oncologist partnership : one size fits all? practical solutions / Holmes, H.M.; Albrand, G. -- Geriatric oncology nursing : beyond standard care / Overcash, J. -- Exercise for older cancer patients : feasible and helpful? / Klepin, H.D.; Mohile, S.G. ; Mihalko, S. -- Aging and cancer : addressing a nation's challenge / Brochot, J.-M.; Le Quellec-Nathan, M.; Buzyn, A.
  • 2012 Wiley
    [edited by] Keith Bellizzi, Margot Gosney.
    pt. I. Cancer and aging in context -- pt. II. Strategies for cancer prevention in older adults -- pt. III. Cancer screening guidelines for older adults -- pt. IV. Cancer treatment -- pt. V. Common cancers in the elderly -- pt. VI. Cancer survivorship and aging -- pt. VII. End-of-life care -- pt. VIII. Emerging issues.
  • 2010 Springer
    Nathan A. Berger, editor.
    1. Obesity and Cancer Epidemiology -- 2. Obesity and Cancer: Epidemiology in Racial/Ethnic Minorities -- 3. Obesity and Cancer in Asia -- 4. Genetic Epidemiology of Obesity and Cancer -- 5. Obesity and Cancer: Overview of Mechanisms -- 6. Caloric Restriction and Cancer -- 7. Physical Activity and Cancer -- 8. Energy Balance, Cancer Prognosis, and Survivorship -- 9. Behavior, Energy Balance, and Cancer: An Overview -- 10. Geographic and Contextual Effects on Energy Balance-Related Behaviors and Cancer.
  • 2016 Springer
    Edmund S. Sabanegh, Jr., editor.
    1. Demographics of cancer in the reproductive age male -- 2. Demographics of cancer in the reproductive age female -- 3. Physiology of spermatogenesis: opportunities for disruption -- 4. Fertility assessment in the male -- 5. Fertility assessment in the female -- 6. Fertility conditions associated with cancer development -- 7. Chemotherapy and fertility -- 8. Radiation therapy and fertility -- 9. Sperm banking for cancer patients --10.Fertility preservation strategies in the male cancer patient -- 11. Fertility preservation in the female cancer patient -- 12. Cancer treatment in pregnancy -- 13. Surgical approaches for sperm harvest in the azoospermic cancer patient -- 14. Stem cells and fertility -- 15. The role of assisted reproduction in the cancer patient -- 16. Third party reproduction -- Index.
  • 2010 Springer
    Manuel L. Penichet, Erika Jensen-Jarolim, editors.
  • 2014 Wiley
    edited by Dr. Yusuke Hiraku, Dr. Shosuke Kawanishi, Dr. Hiroshi Ohshima.
    Infection, inflammation, and cancer: overview / Hiroshi Ohshima, Noriyuki Miyoshi, and Susumu Tomono -- Stem cell theory and inflammation-related cancer / Toshihiko Tanno and William Matsui -- Epithelial-mesenchymal transition: a link between cancer and inflammation / Jonas Fuxe and Mikael C.I. Karlsson -- Role of nitrative DNA damage in inflammation-related carcinogenesis / Yusuke Hiraku and Shosuke Kawanishi -- Lipid peroxidation-derived DNA adducts and the role in inflammation-related carcinogenesis / Helmut Bartsch and Urmila Jagadeesan Nair -- Level of inflammation-related DNA adducts in human tissues / Tomonari Matsuda, Pei-Hsin Chou, and Haruhiko Sugimura -- Toll-like receptors: role in inflammation and cancer / Sarang Tartey and Osamu Takeuchi -- Inflammasomes and inflammation / Kaiwen W. Chen, Ayanthi A. Richards, Alina Zamoshnikova, and Kate Schroder -- Activation-induced cytidine deaminase: an intrinsic genome modulator in inflammation-associated cancer development / Hiroyuki Marusawa and Tsutomu Chiba -- MicroRNA and inflammation-related cancer / Zhaojian Gong, Zhaoyang Zeng, Pranab Behari Mazumder, Jian Ma, Ming Zhou, Xiayu Li, Xiaoling Li, Wei Xiong, Yong Li, and Guiyuan Li -- Inflammation as a niche for tumor progression / Futoshi Okada -- Human papillomavirus and cervical cancer / Kurt J. Sales -- Hepatitis viruses and hepatocellular carcinoma / Wai-Kay Seto, Ching-Lung Lai, and Man-Fung Yuen -- Epstein-Barr virus and nasopharyngeal carcinoma / Xiaoying Zhou, Xue Xiao, Fu Chen, Tingting Huang, and Zhe Zhang -- Barrett's esophagus and esophageal cancer / Albert Roessner and Angela Poehlmann -- Asbestos-induced chronic inflammation and cancer / Andrea Napolitano, Sandro Jube, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, and Haining Yang -- Nanomaterials / Yiqun Mo, Rong Wan, David J. Tollerud, and Qunwei Zhang -- Inflammatory pathways of radiation-induced tissue injury / Danae A. Laskaratouu, Ifigeneia V. Mavragani, and Alexandros G. Georgakilas -- Photocarcinogenesis and inflammation / Chikako Nishigori -- Chemoprevention of colorectal cancer by anti-inflammatory agents / Michihiro Mutoh, Mami Takahasi, and Keiji Wakabayashi -- Nutraceuticals and colon cancer prevention / Deepak Poudyal and Lorne J. Hofseth -- Cancer chemoprevention by targeting cox-2 using dietary phytochemicals / Kyung-Soo Chun and Young-Joon Surh -- Regulation of inflammation-associated intestinal diseases with phytochemicals / Akira Murakami.
  • 2008 Springer
    A. Surbone, F. Peccatori, N. Pavlidis (eds.)
    Also available: Print – 2008
  • 2011 Springer
    editor, John P. Mulhall ; associate editors, Luca Incrocci, Irwin Goldstein and C. Rosen.
    Functional Anatomy of the Male Sex Organs -- Functional Anatomy of the Female Sex Organs -- Physiology of Libido -- Physiology of Orgasm -- Physiology of Female Genital Sexual Arousal -- Physiology of Erection -- Physiology of Ejaculation -- Classifying Female Sexual Dysfunction -- Hypoactive Sexual Desire Disorder -- Disorders of Female Sexual Arousal -- Disorders of Female Orgasm -- Sexual Pain Disorders -- Erectile Dysfunction: Prevalence and Pathophysiology -- Androgen Deficiency -- Peyronie?s Disease -- Disorders of Ejaculation and Male Orgasm -- Priapism -- The Sexual Health Interview: Male -- The Sexual Health Interview: Female -- Communication About Sexuality and Cancer -- Validated Questionnaires in Female Sexual Function Assessment -- Validated Questionnaires in Male Sexual Function Assessment -- Evaluation of the Female with Sexual Dysfunction -- Evaluation of Male Sexual Dysfunction -- The Impact of Cancer on the Partner?s Sexuality -- Gay and Lesbian Patients with Cancer -- The Impact of a Cancer Diagnosis on Sexual Health -- Breast Cancer -- Gynecological Cancers -- Pelvic Surgery for Urological Cancers -- Pelvic Radiation in Men -- Pelvic Radiation in Women -- Impact of Chemotherapy and Hormone Therapy on Female Sexual Health -- Impact of Androgen Deprivation Therapy on Men?s Sexual Health -- Colorectal Cancer -- Stem Cell Transplant --Sexual Health in the Terminally Ill -- Survivorship: An Overview -- Nutriceuticals in Sexual Health -- Medical Treatments for Sexual Problems in Women -- Surgical Treatments for Sexual Problems in Women -- Sex Therapy in Female Sexual Dysfunction -- Erectile Dysfunction: Pharmacological Therapy -- Erectile Dysfunction: Devices -- The Management of Premature Ejaculation -- Testosterone Therapy in the Male Cancer Patient -- Sex Therapy in Male Sexual Dysfunction -- Restoring Intimacy in Relationships Affected by Cancer -- Dating and Disclosure for Cancer Survivors.
  • 2007 CRCnetBASE
    E.J. Hoffman.
  • 2016 Springer
    David M. Langenau, editor.
    Part 1. Powers of the zebrafish model. Uncharted waters: zebrafish cancer models navigate a course for oncogene discovery / Craig J. Ceol and Yariv Houvras -- The toolbox for conditional zebrafish cancer models / Marie Mayrhofer and Marina Mione -- Approaches to inactivate genes in zebrafish / John M. Parant and Jing-Ruey Joanna Yeh -- Tumor suppressors in zebrafish: from TP53 to PTEN and beyond / Jeroen den Hertog -- Identifying novel cancer therapies using chemical genetics and zebrafish / Michelle Dang, Rachel Fogley, and Leonard I. Zon -- Genomic approaches to zebrafish cancer / Richard M. White -- Transcriptomic analyses in zebrafish cancer models for global gene expression and pathway discovery / Xiaoqian Huang, Ira Agrawal, Zhen Li, Weiling Zheng, Qingsong Lin, and Zhiyuan Gong -- zebrafish discoveries in cancer epigenetics / Yelena Chernyavskaya, Brandon Kent, and Kirsten C. Sadler -- Lymphatics, cancer and zebrafish / Jonathan W. Astin and Philip S. Crosier -- In vivo imaging of cancer in zebrafish / Myron S. Ignatius, Madeline Hayes, and David M. Langenau -- Imaging cancer angiogenesis and metastasis in a zebrafish embryo model / C. Tulotta, S. He, W. van der Ent, L. Chen, A. Groenewoud, H. P. Spaink, and B. E. Snaar-Jagalska -- Allograft cancer cell transplantation in zebrafish / John C. Moore and David M. Langenau -- The zebrafish xenograft platform: evolution of a novel cancer model and preclinical screening tool / Jaime Wertman, Chansey J. Veinotte, Graham Dellaire, and Jason N. Berman -- Automation of technology for cancer research / Wietske van der Ent, Wouter J. Veneman, Arwin Groenewoud, Lanpeng Chen, Claudia Tulotta, Pancras C.W. Hogendoorn, Herman. P. Spaink, and B. Ewa Snaar-Jagalska -- part 2. Cancer models in fish. zebrafish models of human leukemia: technological advances and mechanistic insights / Nicholas R. Harrison, Fabrice J.F. Laroche, Alejandro Gutierrez, and Hui Feng -- Zebrafish Rhabdomyosarcoma / Michael Phelps and Eleanor Chen -- Baiting for cancer: using the zebrafish as a model in liver and pancreatic cancer / Katie L. Hwang and Wolfram Goessling -- Focusing the spotlight on the zebrafish intestine to illuminate mechanisms of colorectal cancer / Viola H. Lobert, Dmitri Mouradov, and Joan K. Heath -- zebrafish Melanoma / Charles K. Kaufman -- Neuroblastoma and its zebrafish model / Shizhen Zhu and A. Thomas Look -- zebrafish germ cell tumors / Angelica Sanchez and James F. Amatruda -- Malignant peripheral nerve sheath tumors / Adam D. Durbin, Dong Hyuk Ki, Shuning He, and A. Thomas Look -- Xiphophorus and medaka cancer models / Manfred Schartl and Ronald B. Walter.
    Also available: Print – 2016
  • 2012 Springer
    Erle S. Robertson, editor.
    Peyton Rous: A Centennial Tribute to the Founding Father of Cancer Virology -- Viruses and Cancer: A Historical Perspective - HBV and Prevention of a Cancer -- Virus-Mediated Cell Proliferation -- Viral-Encoded Genes and Cancer -- Oncogenic Viruses and Cancer Transmission -- DNA Viruses and Cancer: Taking a Broader Look -- Herpesviruses and Cancer -- Lymphocryptoviruses: EBV and Its Role in Human Cancer -- Nonhuman Primate Gamma-herpesviruses and Their Role in Cancer -- Rhadinoviruses: KSHV and Associated Malignancies -- Retroperitoneal Fibromatosis Herpesvirus and Kaposi's Sarcoma-Like Tumors in Macaques -- Murine Gammaherpesvirus-Associated Tumorigenesis -- Marek's Disease Virus-Induced T-Cell Lymphomas -- Polyomaviruses and Cancer -- Polyomavirus SV40: Model Infectious Agent of Cancer -- BK Polyomavirus and Transformation -- Polyomavirus JC and Human Cancer: Possible Role of Stem Cells in Pathogenesis -- Merkel Cell Polyomavirus -- Human Papillomaviruses and Cancer -- Tumorigenesis by Adenovirus Type 12 E1A -- Overview of Hepatitis Viruses and Cancer -- Hepadnaviruses and Hepatocellular Carcinoma -- Hepatitis C Virus and Hepatocellular Carcinoma -- Human and Animal Retroviruses: HIV-1 Infection Is a Risk Factor for Malignancy -- HTLV-1 and Oncogenesis -- Human T-Cell Leukemia Virus Type 2 (HTLV-2) Biology and Pathogenesis -- Mechanisms of Oncogenesis by Avian and Murine Retroviruses -- Rous Sarcoma Virus: Contributions of a Chicken Virus to Tumor Biology, Human Cancer Therapeutics, and Retrovirology -- Mouse Mammary Tumor Virus and Cancer -- Jaagsiekte Sheep Retrovirus and Lung Cancer -- Small RNAs and Their Role in Herpesvirus-Mediated Cancers -- Viral Malignancies in HIV-Associated Immune Deficiency.
  • 2014 Springer
    edited by Eric C. Schirmer, Jose I. de las Heras.
    Nuclear envelope (NE) defects have been linked to cancer biology since the mid-1800s, but it was not until the last few years that we have begun to understand these historical links and to realize that there are myriad ways that the NE impacts on tumorigenesis. The NE is a complex double membrane system that encloses the genome while providing structural support through the intermediate filament lamin polymer and regulating protein/ mRNA trafficking and signaling between the nucleus and cytoplasm via the nuclear pore complexes (NPCs). These functions already provide some mechanisms for NE influences on cancer biology, but work in the past few years has elucidated many others. Lamins and many recently identified NE transmembrane proteins (NETs) have been now shown to function in DNA repair, regulation of cell cycle and signaling, apoptosis, cell migration in metastasis, and nuclear architecture and morphology. This volume presents a comprehensive overview of the wide range of functions recently identified for NE proteins and their relevance in cancer biology, providing molecular mechanisms and evidence of their value as prognostic and diagnostic markers, and suggesting new avenues for the treatment of cancer. Indeed some of these recent links are already yielding promising therapies, such as the current clinical trial of selective inhibitors of the nuclear export factor exportin in certain types of leukemia, melanoma and kidney cancer.
    Also available: Print – 2014
  • 2014 CRCnetBASE
    edited by Debmalya Barh, Angelo Carpi, Mukesh Verma, Mehmet Gunduz.
    "According to the American Cancer Society report, "by 2030, the global cancer burden is expected to nearly double, growing to 21.4 million cases and 13.2 million deaths." Early diagnosis improves treatment efficacy and quality of life as well as reduces the cost for disease management. However, the development of molecular markers for early cancer diagnosis is always a challenge. Some fundamental principles in medical practice are (a) primum non nocere, a Latin phrase that means "first, do no harm," and (b) even when a patient's prognosis is poor, the physician must do his or her best for improving quality of the patient's life. Therefore, noninvasive or minimally invasive cancer diagnostic methods are of choice that can avoid complications of biopsy and other unfavorable impacts on patient's health. In this context, patients' easily collectable biospecimens such as blood, serum, plasma, urine, stool, sputum, saliva, etc., based molecular markers having high specificity and sensitivity in early diagnosis are emerging rapidly and in many instances such markers are also emerging as next-generation prognostic indicators and personalized therapeutics and precision medicine. Several patents have been filed and/or granted on such markers, and a number of health-care companies and authorities currently use or focus on the development of such markers. The significance of clinical validation approaches of several markers has been discussed in different chapters. This book, Cancer Biomarkers: Noninvasive Early Diagnosis and Prognosis, reflects the rapid expansion of important scientific, technological, clinical, and translational aspects of noninvasive or minimally invasive molecular cancer biomarkers and their applications along with other conventional markers"-- Provided by publisher.
  • 2012 Springer
    Egidio Del Fabbro, Akio Inui, Florian Strasser ; contributors: David Blum, Hajime Suzuki.
  • 2013 Future Med
    editors, Josep M. Argilés, Silvia Busquets.
    Cancer cachexia / Josep M. Argilés & Sílvia Busquets -- Prevalence and clinical features of cancer cachexia / Neil Johns, Richard J.E. Skipworth, Kenneth C.H. Fearon & James A. Ross -- Pathogenesis of cancer cachexia / Fabio Penna, Francesco M. Baccino & Paola Costelli -- Current medications for cancer cachexia / Clelia Madeddu, Antonio Macciò, Maria Chiara Cau, Roberto Serpe & Giovanni Mantovani -- Latest developments in cachexia drug discovery : clinical trials / Josep M. Argilés, Francisco Javier López-Soriano, Britta Stemmler & Sílvia Busquets -- Comorbidities and prognosis / Alessandro Laviano, Gianluca Di Lazzaro Giraldi & Serena Rianda -- Index.
  • 2016 Springer
    Michael Silbermann, editor.
    Medical Care in Countries in Transition -- How to Prioritize Cancer Care for Countries in Transition -- Cancer Trends and Risk Factors in Morocco -- The Magic of Dreams: Conflicts and Quandaries Within Multicultural Societies in Transition -- Modeling Integrative Oncology for the Arab Population in Northern Israel -- Cancer Care in Palestine -- Influx of Foreign Refugees to Jordan and its Overall Burden on Cancer Care -- Caring For Children With Cancer In A Country Conflicted With Massive Refugee Migration: Jordan as an Example -- Challenges and Future Trends for Cancer Care in Egypt -- Cancer Care in Lebanon, New Trends and Challenges -- Cancer Care in an economically torn country: Cyprus -- Cancer Care in a Country Undergoing Transition: Turkey. Current Challenges and Trends for the Future -- Cancer Care in Sudan: Current Situation and Challenges -- Cancer care in Countries in Transition in Africa; the case of Uganda -- Cancer Care in Pakistan -- Cancer Care in India -- Cancer Care in Afghanistan -- Kazakhstan -- An overview of cancer care in societies in transition- Global perspectives: UAE Experience -- Cancer care in countries in transition: The Islamic Republic of Iran -- Cancer Care in Regions/Societies in Transition in the Gulf States: Sultanate of Oman -- Challenges and prospects in cancer care in Georgia -- Romania: Attempting to Catch up the European standards of care for cancer patients -- Recent challenges and achievements in cancer care in Latin American societies -- Caring for Refugees with Cancer: A Case for Training of US Oncology Professionals -- University of Texas MD Anderson Cancer Center Experience caring for patients from countries undergoing political-social conflict -- Forty Years Fast Forward: Vietnamese Refugees in the United States with Comments on their Cancer Care -- The current state of cancer care in North America -- Application of genetic testing for childhood cancers in emerging countries -- Cancer Care among Immigrants to North America -- Promoting Cancer Nursing Education, Training and Research in Countries in Transition.
  • 2014 CRCnetBASE
    edited by Satya Prakash Gupta.
    "Cancer-causing viruses, also called oncoviruses, play a key role in the development of certain cancers. They contribute to genetic changes that disrupt the cell cycle machinery, interfering with functions such as cell growth. Cancer-Causing Viruses and Their Inhibitors presents a plethora of research from internationally reputed contributors who discuss different types of oncoviruses, their mechanisms of invasion and growth, and their life cycles. The book begins with an overview of the oncoviruses discovered to date and includes a brief description of their structures, genotypes, replication, and mechanisms of infection leading to cancers. It then explores several of these viruses in detail, including: Human T-cell leukemia virus type 1 (HTLV-1), Hepatitis C virus (HCV), Epstein-Barr virus (EBV), Human papilloma virus (HPV), Human herpes virus 8 (HHV-8)/Kaposi's sarcoma-associated herpes virus (KSHV), Human immunodeficiency virus (HIV/AIDS), Oncolytic viruses. This book is an essential reference for those working in virology, oncology, and biotechnology. The discoveries presented will enable researchers and clinicians to optimize both historical and current approaches to anti-viral therapies"--Provided by publisher.
  • 2011 Springer Protocols
    edited by Ian A. Cree.
    Xenotransplantation of breast cancers -- Feeder layers: Co-culture with nonneoplastic cells -- Drug design and testing: Profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3h]-thymidine incorporation assay -- Transfection and DNA-mediated gene transfer -- Analysis of drug interactions -- Development of rituximab-resistant B-NHL clones: An in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy -- Proteomic evaluation of cancer cells: Identification of cell surface proteins -- Measuring gene expression from cell cultures by quantitative reverse-transcriptase polymerase chain reaction -- Expression analysis of homeobox genes in leukemia/lymphoma cell lines -- Flow cytometric DNA analysis of human cancers and cell lines -- Angiogenesis assays -- Cell migration and invasion assays -- Molecular breakpoint analysis of chromosome translocations in cancer cell lines by long distance inverse-PCR -- Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay -- Purification of annexin V and its use in the detection of apoptotic cells -- Real-time cytotoxicity assays -- Differential staining cytotoxicity assay: A review -- Cell sensitivity assays: The ATP-based tumor chemosensitivity assay -- Cell sensitivity assays: The MTT assay -- Cellular chemosensitivity assays: An overview -- Isolation of endothelial cells from human tumors -- Isolation of inflammatory cells from human tumours -- Establishment and culture of leukemia-lymphoma cell lines -- Isolation and culture of ovarian cancer cells and cell lines -- Isolation and culture of squamous cell carcinoma lines -- Isolation and culture of melanoma and naevus cells and cell lines -- Isolation and culture of colon cancer cells and cell lines -- Generation of lung cancer cell line variants by drug selection or cloning -- Quality assurance and good laboratory practice -- Elimination of mycoplasmas from infected cell lines using antibiotics -- Detecting mycoplasma contamination in cell cultures by polymerase chain reaction -- Cell culture contamination -- Cytogenetic analysis of cancer cell lines -- Online verification of human cell line identity by STRDNA typing -- Characterization and authentication of cancer cell lines: An overview -- Storage of cell lines -- Principles of cancer cell culture -- Cancer biology.
  • 2014 Springer Protocols
    edited by Martha Robles-Flores, Universidad Nacional Autónoma de México, México D.F., México.
    Use of Biguanides to Improve Response to Chemotherapy -- Evaluating Response to Metformin/Cisplatin Combination in Cancer Cells Via Metabolic Measurement and Clonogenic Survival -- Quantifying the Autophagy-Triggering Effects of Drugs in Cell Spheroids with Live Fluorescence Microscopy -- Interdependency Between Genetic and Epigenetic Regulatory Defects in Cancer -- Experimental Strategies to Manipulate the Cellular Levels of the Multifunctional Factor CTCF -- Use of Serum-Circulating miRNA Profiling for the Identification of Breast Cancer Biomarkers -- Prostate Cancer Detection Using a Non-Invasive Method for Quantifying mi RNAs -- DNA Methylation Analysis of Steroid Hormone Receptor Genes -- Control of Oncogenic mi RNA Function by Light-Activated mi RNA Antagomirs -- Methods for the Study of Long Non-Coding RNA in Cancer Cell Signaling -- Microvesicles as Mediators of Intercellular Communication in Cancer -- In Vivo Rat Model to Study Horizontal Tumor Progression -- An In Vivo Model to Study the Effects of Tumoral Soluble Factors on the Vascular Permeability in Mice -- Use of the Tumor Repressor DEDD as a Prognostic Marker of Cancer Metastasis -- Zebrafish-Based Systems Pharmacology of Cancer Metastasis -- A Flow Cytometry-Based Assay for the Evaluation of Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Cancer Cells -- Gene Disruption Using Zinc Finger Nuclease Technology.
  • 2014 CRCnetBASE
    edited by Kasirajan Ayyanathan, PhD.
  • 2013 Springer
    William C.S. Cho, editor.
    Cancer is one of the leading killers in the world and the incidence is increasing, but most cancer patients and cancer survivors suffer much from the disease and its conventional treatments' side effects. In the past, clinical data showed that some complementary and alternative medicine (CAM) possessed anticancer abilities, but some clinicians and scientists have queried about the scientific validity of CAM due to the lack of scientific evidence. There is great demand in the knowledge gap to explore the scientific and evidence-based knowledge of CAM in the anticancer field. With this aim, a book series is needed to structurally deliver the knowledge to readers. Throughout the past decade, the cancer chemopreventive potencies and treatment effects of a number of natural dietary agents present in different food sources have been evaluated by various experiments. Some of them have progressed to early clinical trials. This volume is a specialized book presenting the research evidence relevant to the use of specific diet therapy in cancer chemoprevention and treatment. We begin with lessons learned from dietary resveratrol as an effective agent with anticancer properties against malignancies, followed examples of flavonoids from fruits and vegetables in the prevention and treatment of cancer. Evidence for the beneficial influence of diet enriched with flax seed oil and green tea on cancer will be reviewed. Soy food intake may enhance the effects on anticancer treatment for breast cancer, whereas lycopene-rich foods may possess chemopreventive efficacy. There are also discussions on the contribution of the cancer preventive effects of the antioxidant-rich foods and Mediterranean diet. In addition, the modulation of proteasome pathways by nutraceuticals is highlighted. Finally, we close the book with a discussion on the attenuation of cell survival signaling by bioactive phytochemicals in the prevention and therapy cancer.
  • 2011 Ovid
    [edited by] Bruce A. Chabner, Dan L. Longo.
    Clinical strategies for cancer treatment: the role of drugs -- Target identification and drug discovery -- Clinical drug development and marketing approval -- Principles of pharmacokinetics -- Delivering anticancer drugs to brain tumors -- Pharmacogenetics -- Physical barriers to drug delivery -- Antifolates -- 5-fluoropyrimidines -- Cytidine analogues -- Purine antimetabolites -- Hydroxyurea -- Antimitotic drugs -- Alkylating agents -- Platinum analogues -- Bleomycin and other antitumor antibiotics -- Topoisomerase I-targeting drugs -- Topoisomerase II inhibitors: anthracyclines -- Topoisomerase II inhibitors: the epipodophyllotoxins -- Asparaginase -- Proteasome inhibitors -- Histone deacetylase inhibitors in oncology -- Differentiating agents -- Arsenic trioxide -- Antibodies -- Inhibitors of tumor angiogenesis -- Epidermal growth factor receptor inhibitors -- HER2 inhibitors -- Molecular targeted drugs -- Signaling inhibitors: IGFR, PI3K pathway, embryonic signaling inhibitors, and mitotic kinase inhibitors -- Cytokine therapy for cancer -- Cancer vaccines -- Adoptive cellular therapies -- Thalidomide and its analogs in the treatment of hematologic malignancies, including multiple myeloma, and solid tumors -- Hormonal therapy of breast cancer -- Hormone therapy for prostate cancer -- Drug therapy of pain in cancer patients -- Hematopoietic growth factors -- Antinausea medications -- Bisphosphonates and other bone-targeted therapies -- Intravenous access and catheter management -- Late effects of cancer chemotherapy -- Infertility after cancer chemotherapy.
  • 2006 Ovid
    editors Bruce A. Chabner, Dan L. Longo.
    Clinical strategies for cancer treatment: the role of drugs / Bruce Chabner -- Preclinical aspects of cancer drug discovery and development / Paula Krosky ... [et al.] -- Pharmacokinetics / Jerry Collins, Jeffrey G. Supko -- Infertility after cancer chemotherapy / Angela Bradbury, Richard L. Schilsky -- Carcinogenesis of anticancer drugs / Laawrence S. Blaszkowsky, Charles Erlichman -- Antifolates / Brian P. Monahan, Carmen J. Allegra -- 5-Fluoropyrimidine / Jean L. Grem -- Cytidine analogues / David P. Ryan, Rocio Garcia-Carbonero, Bruce A. Chabner -- Purine antimetabolites / Kenneth R. Hande -- Hydroxyurea / Luis Paz-Ares, Ross C. Donehower, Bruce A. Chabner -- Antimicrotubule agents / Eric K. Rowinsky -- Clinical and high-dose alkylating agents / Kenneth D. Tew, O. Michael Colvin, Roy B. Jones -- Nonclassic agents / Henry S. Friedman, Steven D. Averbuch, Joanne Kurtzberg -- Cisplatin, Carboplatin, and oxaliplatin / Eddie Reed -- Bleomycin / John s. Lazo, Bruce A. Chabner -- Antitumor antibiotics / Edwin W. Willems, Kees Nooter, Jaap Verweij -- Topoisomerase I-targeting drugs / Alex Sparreboom, William C. Zamboni -- Anthracyclines and anthracenediones / James H. Doroshow -- Topoisomerase II inhibitors: the epipodophyllotoxins, acridines, and ellipticines / Yves Pommier, François Goldwasser -- Asparaginase / Bruce A. Chabner, Alison M. Friedmann -- Delivering anticancer drugs to brain tumors / Maciej M. Mrugala, Tracy T. Batchelor, Jeffrey G. Supko -- Food and drug administration role in oncology product development / Thomas G. Roberts Jr. -- Central venous catheters: care and complications / Rachel P. Rosovsky, David J. Kuter -- Pharmacogenetics / Jeanne Fourie, Robert B. Diasio -- New targets for anticancer therapeutics / A. Dimitrios Colevas ... [et al.] -- Bisphosphonates / Matthew R. Smith -- Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma, and solid tumors / Paul Richardson ... [et al.] -- Inhibitors of tumor angiogenesis / Anaadriana Zakarija, William J. Gradishar -- Proteasome inhibitors / Owen A. O'Connor -- Molecular targeted drugs and growth factor receptor inhibitors / Jeffrey W. Clark -- Antibody therapies of cancer / David A. Scheinberg ... [et al.] -- Interferons / Daniel J. Lindner ... [et al.] -- Adoptive cellular therapies / Carl H. June -- Cancer vaccines / Glenn Dranoff -- Hematopoietic growth factors / William P. Petros -- Interleukins / Gheath Alatrash ... [et al.] -- Harmonal therapy for breast cancer / Peter F. Lebowitz, Sandra M. Swain.
  • 2012 Springer
    Terry Priestman.
    A simple introduction explaining the broad principles underlying chemotherapy, this book gives trainees a framework within which they can place the specific aspects of cancer chemotherapy they encounter in their everyday experience. The first part of this book is unique in explaining the recent developments in the field in terms of their point of action in the natural history of cancer. The second and third sections contain a more straightforward description of practical aspects of chemotherapy, and the current place of drug treatment in everyday cancer management, including the outcomes of that treatment.
  • 2008 Springer
    Terry Priestman.
  • 2007 Springer
    edited by Stanley P.L. Leong.
    Historical perspective and evolving concerns for human research / Bernard Lo and Nesrin Garan -- Cancer trials and the Institutional Review Board (IRB) / Scott Kurtzman and Zita Lazzarini -- NCI's cancer therapy evaluation program: a commitment to treatment trials / Jeffrey S. Abrams, Anthony Murgo and Michaele C. Christian -- Practical guide for cancer clinical investigators / Steven Hirschfeld -- The role of cooperative groups in cancer clinical trials / Ann M. Mauer, Elizabeth S. Rich and Richard L. Schilsky -- The advocate role in clinical study development and partnering with patient advocates in your local institution / Barbara Parker -- The National Breast Cancer Coalition: setting the standard for advocate collaboration in clinical trials / Fran Visco -- The role of the principal investigator in cancer clinical trials / Stanley P.L. Leong -- The audit process and how to ensure a successful audit / Y. Nancy You, Lisa Jacobs, Elizabeth Martinez and David M. Ota -- The privacy rule (HIPAA) as it relates to clinical research / John M. Harrelson and John M. Falletta -- The Commission on Cancer, American College of Surgeons' response to HIPAA / E. Greer Gay -- Ethical and legal issues in the conduct of cancer clinical trials / Gerianne J. Sands and Peggy A. Means -- The role of the Office of Research Integrity in cancer clinical trials / Peter Abbrecht, Nancy Davidian, Samuel Merrill and Alan R. Price -- Strategies for the administration of a clinical trial infrastructure: lessons from a comprehensive cancer center / Leonard A. Zwelling and Carleen A Brunelli -- The clinical research process: building a system in harmony with its users / Greg Koski -- Cancer research and clinical trial in action: an important exercise before you embark on your study / Stanley P.L. Leong, Larry Carbone and Scott Kurtzman.
    Also available: Print – 2007
  • 2014 Wiley
    edited by Syed A. Abutalib, MD, Assistant Director, Hematology and Hematopoietic Cell Transplantation, Midwestern Regional Medical Center, Cancer Treatment Centers of America, Zion, IL, USA, USA, Maurie Markman, MD, Senior Vice President of Clinical Affairs, National Director of Medical Oncology, Center, Cancer Treatment Centers of America, Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA.
    Section 1 Malignant hematology and hematopoietic cell transplantation -- Part 1 Acute lymphoblastic leukemia in adults -- Part 2 Acute myeloid leukemia in adults -- Part 3 Myelodysplastic syndromes and related disorders -- Part 4 Myeloproliferative neoplasms -- Part 5 Chronic lymphocytic and other leukemias -- Part 6 Hodgkin Lymphoma -- Part 7 Non-Hodgkin's lymphomas -- Part 8 Plasma cell neoplasms and related disorders -- Part 9 Special issues in hematology -- Part 10 Special issues in hematopoietic cell transplantation -- Section 2 Oncology -- Part 1 Central nervous system tumors -- Part 2 Head and neck cancers and thoracic malignancies -- Part 3 Breast cancer -- Part 4 Gastrointestinal oncology -- Part 5 Genitourinary oncology -- Part 6 Skin malignancies -- Part 7 Gynecological malignancies -- Part 8 Sarcomas -- Part 9 Multidisciplinary approach: consultation with surgical oncology team -- Part 10 Multidisciplinary approach: consultation with radiation oncology team -- Part 11 Hereditary cancer syndromes and genetic testing in oncology -- Part 12 Special issues in hematology and oncology.
  • 2011 Springer Protocols
    by Lynda J. Campbell.
    [Publisher-supplied data] Cytogenetic studies of malignancy have become an essential tool in the clinical management of cancer patients. Cancer Cytogenetics: Methods and Protocols presents eminently practical key cytogenetic and FISH techniques for every stage of diagnostic service. Experts in the field describe detailed cytogenetic analysis methods, fluorescence in situ hybridization and array methods currently being applied to investigate and diagnose different varieties of cancer. Written in the highly successful Methods in Molecular Biology series format, chapters contain introductions to their respective topics, lists of the necessary materials and reagents, and step-by-step, readily reproducible laboratory protocols. The authors of the various chapters have also provided extensive notes to guide individuals who are new to these methods through the pitfalls that bedevil all such testing. Authoritative and accessible, Cancer Cytogenetics: Methods and Protocols serves as an ideal guide to scientists of all backgrounds, allowing them to either establish new techniques in their laboratories or find the different variations of standard methods helpful in improving their results.
  • 2006 Springer
    edited by Beverly A. Teicher.
    Also available: Print – 2006
  • v. 1-2, 2009 Springer Protocols
    v. 2, 2009 Springer Protocols
    edited by Mukesh Verma.
    v. 1. Host susceptibility factors -- v. 2. Modifiable factors.
  • 2009 CRCnetBASE
    edited by Trygve Tollefsbol.
    The role of epigenetics in cancer / Trygve O. Tollefsbol -- DNA hypomethylation in cancer / Peter L. Molloy -- DNA hypermethylation in oncogenesis / J. Tyson DeAngelis ... [et al.] -- Imprinting alterations in tumorigenesis / Jeremiah Bernier-Latmani and Phillip Shaw -- Proteins that modulate DNA methylation aberrations in cancer / Sabrina L. Walthall ... [et al.] -- The role of DNA methylation in cancer progression / Sang-Woon Choi and Simonetta Friso -- Alterations in histone acetylation in tumorigenesis / Sabita N. Saldanha and Trygve O. Tollefsbol -- Histone methylation and the initiation of cancer / Shi Huang -- The role of sirtuins in aging and tumorigenesis / Xiaohong Zhang ... [et al.] -- Proteins that alter histone modifications in cancer / Ada Ao and Jianrong Lu -- Dietary and environmental influences on histone modifications in cancer / Sabita N. Saldanha ... [et al.] -- Noncoding RNAs in cancer / Maciej Szymanski and Jan Barciszewski -- Cancer-linked DNA hyper- and hypomethylation: chromosome positional effects / Melanie Ehrlich -- Chromatin remodeling and cancer / Sari Pennings and Richard R. Meehan -- Poly-ADP-ribosylation in cancer / Rajeshwar N. Sharan -- Polycomb group proteins in tumorigenesis / Hanneke E.C. Niessen and Jan Willem Voncken -- Cancer and aging: the epigenetic connection / Craig A. Cooney -- DNA methylation in tumor diagnosis / Kavitha Ramachandran, Edna Gordian, and Rakesh Singal -- DNA methylation profiles as prognostic markers for cancer / Sam Thiagalingam and Panagiotis Papageorgis -- Diagnosing cancer using histone modification analysis / Mukesh Verma and Deepak Kumar -- Histone modifications in cancer biology and prognosis / Matthew A. McBrian, David B. Seligson, and Siavash K. Kurdistani -- Histone deacetylase inhibitors in cancer therapy / Aaron M. Sargeant ... [et al.] -- Methylation changes in neoplasia: diagnostic and therapeutic implications / Eleftheria Hatzimichael, Justin Stebbing, and Tim Crook -- Clinical trials and approved drugs for epigenetic cancer therapy / Debby M.E.I. Hellebrekers and Manon van Engeland -- Future directions in epigenetic cancer research / Jacob Peedicayil.
    Also available: Print – 2009
  • 2012 Springer Protocols
    edited by Ramona G. Dumitrescu, Mukesh Verma.
    Epigenetic markers of early tumor development / Ramona G. Dumitrescu -- Epigenetics of solid cancer stem cells / Alok Mishra and Mukesh Verma -- DNA methylation and histone modifications in breast cancer / Ramona G. Dumitrescu -- DNA methylation changes in prostate cancer / Wolfgang Goering, Michael Kloth, and Wolfgang A. Schulz -- DNA methylation in promoter region as biomarkers in prostate cancer / Mihi Yang and Jong Y. Park -- Epigenetics of bladder cancer / Wun-Jae Kim and Yong-June Kim -- Epigenetics in myeloid malignancies / Stefan Deneberg -- The epigenetics of brain tumors / Adrian M. Dubuc [and others] -- DNA methylation changes in cervical cancers / Qiang Lu, Dehua Ma, and Shuping Zhao -- Epigenetics of colon cancer / Sharad Khare and Mukesh Verma -- Promoter methylation in head and neck tumorigenesis / Jesena K. Stephen [and others] -- Epigenome and DNA methylation in oral squamous cell carcinoma / Mario Pérez-Sayáns García and Abel García-García -- Clinical implications of epigenetic alterations in human thoracic malignancies : epigenetic alterations in lung cancer / Keiko Shinjo and Yutaka Kondo -- The role of microRNAs in the management of liver cancer / Krishna K. Banaudha and Mukesh Verma -- Epigenetics in ovarian cancer / L.M.S. Seeber and P.J. van Diest -- DNA methylation in pancreatic cancer : protocols for the isolation of DNA and bisulfite modification / Katja Biewusch [and others] -- Detection and analysis of DNA methylation by pyrosequencing / Hilary A.A. Colyer [and others] -- Screening for miRNA expression changes using quantitative PCR (Q-PCR) / Richard N. Armstrong, Hilary A.A. Colyer, and Ken I. Mills -- Genome-wide methylation analysis / Alexander Unterberger, Adrian M. Dubuc, and Michael D. Taylor -- Microarray for epigenetic changes : gene expression arrays / Hilary A.A. Colyer, Richard N. Armstrong, and Ken I. Mills -- Detecting DNA methylation using the methylated CpG island amplification and microarray technique / Hilary A.A. Colyer, Margaret Dellett, and Ken I. Mills -- Nutrigenomics : implications for breast and colon cancer prevention / Gabriela Riscuta and Ramona G. Dumitrescu -- Dietary and lifestyle factors of DNA methylation / Unhee Lim and Min-Ae Song -- Diet, epigenetics, and cancer / L. Joseph Su -- Role of epigenetics in cancer health disparities / Sulma I. Mohammed, Sanya Springfield, and Rina Das -- Multifactorial etiology of gastric cancer / Jovanny Zabaleta -- Epigenetic epidemiology for cancer risk : harnessing germline epigenetic variation / Kevin Brennan and James M. Flanagan -- Epigenetic biomarkers in cancer epidemiology / Mukesh Verma.
  • 2015 Springer Protocols
    edited by Mukesh Verma.
    Cancer epigenetics : an introduction / Rajnee Kanwal, Karishma Gupta, and Sanjay Gupta -- Community resources and technologies developed through the NIH roadmap epigenomics program / John S. Satterlee ... [et al.] -- Epigenome-wide association studies (EWAS) : past, present, and future / James M. Flanagan -- Epigenetic biomarkers in liver cancer / Krishna K. Banaudha and Mukesh Verma -- Cancer type-specific epigenetic changes : gastric cancer / Danielle Queiroz Calcagno, Marília de Arruda Cardoso Smith, and Rommel Rodriguez Burbano -- Beyond the island : epigenetic biomarkers of colorectal and prostate cancer / Andrea J. Savio and Bharati Bapat -- Prostate cancer epigenome / Swathi Chinaranagari ... [et al.] -- CpG island hypermethylation as a biomarker for the early detection of lung cancer / Yujin Kim and Duk-Hwan Kim -- Analysis of DNA methylation in pancreatic cancer : an update / Christian Pilarsky and Robert Grützmann -- Epigenetics of urothelial carcinoma / Wolfgang A. Schulz ... [et al.] -- Epigenetics of prostate cancer / Tawnya C. McKee and James V. Tricoli -- Methylation profile landscape in mesothelioma : possible implications in early detection, disease progression, and therapeutic options / Xinbo Zhang ... [et al.] -- Techniques to access histone modifications and variants in cancer / Monica Tyagi ... [et al] -- Single base resolution analysis of 5-methylcytosine and 5-hydroxymethylcytosine by RRBS and TAB-RRBS / Maria A. Hahn ... [et al.] -- Quantitative DNA methylation analysis for epigenotyping of colorectal cancer / Atsushi Kaneda and Koichi Yagi -- Histone modifications associated with cancer cell migration and invasion / Miki Hieda, Nariaki Matsuura , and Hiroshi Kimura -- Aberrant epigenetic modifications in radiation-resistant head and neck cancers / Hon-Yi Lin, Tim Hui-Ming Huang, and Michael Wing-Yan Chan -- Cancer-associated infectious agents and epigenetic regulation / Vidya Vedham and Mukesh Verma -- Toxicoepigenomics and cancer : implications for screening / Mukesh Verma -- Human papilloma virus (HPV) modulation of the HNSCC epigenome / Josena K. Stephen and Maria J. Worsham -- Epigenetic regulation of HIV, AIDS, and AIDS-related malignancies / Mukesh Verma -- Epigenetics of colorectal cancer / Wenji Yan and Mingzhou Guo -- Epigenetics in breast and prostate cancer / Yanyuan Wu, Marianna Sarkissyan, and Jaydutt V. Vadgama -- Epigenetic inhibitors / Mukesh Verma and Hirendra Nath Banerjee -- Use of epigenetic modulators as a powerful adjuvant for breast cancer therapies / Aurore Claude-Taupin ... [et al.] -- Epigenetic approaches in glioblastoma multiforme and their implication in screening and diagnosis / Gwyneth Hyman ... [et al.] -- Detection of circulatory microRNAs in prostate cancer/ Anvesha Srivastava ... [et al.] -- Identification and characterization of small-molecule inhibitors of lysine acetyltransferases / Daiqing Liao -- Epigenetic regulation in biopsychosocial pathways / Kristin Litzelman and Mukesh Verma -- Viral epigenetics / Barry I. Milavetz and Lata Balakrishnan -- P53 tumor suppression network in cancer epigenetics / Alok Mishra, Daniel J. Brat, and Mukesh Verma -- Promoter hypermethylation as a biomarker in prostate adenocarcinoma / Jong Y. Park -- Sequencing the cancer methylome / Austin Y. Shull ... [et al.] -- Global DNA methylation profiling technologies and the ovarian cancer methylome / Jessica Tang ... [et al.] -- Recent progress in the discovery of epigenetic inhibitors for the treatment of cancer / Sharad K. Verma -- At the crossroad between obesity and gastric cancer / Jone Garai ... [et al.] -- Detection of epigenetic aberrations in the development of hepatocellular carcinoma / Yujing Zhang -- Specific type epigenetic changes in cervical cancers / Shuping Zhao -- Epigenetics in head and neck cancer / Syeda Marriam Bakhtiar, Amjad Ali, and Debmalya Barh -- Epigenetic therapy for colorectal cancer / Vivek Vaish ... [et al.] -- Epigenetics of gastric cancer / Mingzhou Guo and Wenji Yan.
  • 2013
    Craig Patrick Giacomini.
    Recurrent gene fusions and chromosomal translocations have long been recognized for their roles in oncogenesis. This dissertation employs genomic approaches to discover and characterize novel gene fusions in several cancer types. First we developed a "breakpoint analysis" pipeline for gene fusion discovery and applied this method to a collection of nearly 1,000 human cancer samples profiled on DNA microarrays. This approach led to the discovery and characterization of twelve new gene fusions in diverse cancer types including angiosarcoma, pancreatic cancer, and colon cancer. Separately, we performed RNA Sequencing on a series of 36 breast cancer specimens and used a suite of computational tools developed in-house to discover ~350 candidate gene rearrangements. Notably, we discovered recurrent fusions of the sterile 20 (STE20)-like kinase TAOK1, and functional studies suggest that these fusions encode potent oncoproteins that drive breast carcinogenesis. Many of the alterations discovered in this dissertation represent the first gene fusions reported to date in the corresponding cancer type, and many represent potentially druggable targets with therapeutic implications for patients.
  • 2010 Springer
    Boris Pasche, editor.
    Also available: Print – 2010
  • 2010 Springer
    Andrei Thomas-Tikhonenko, editor.
  • 2014 ScienceDirect
    edited by Graham Dellaire, Jason N. Berman, Robert J. Arceci.
    Cancer Genomics addresses how recent technological advances in genomics are shaping how we diagnose and treat cancer. Built on the historical context of cancer genetics over the past 30 years, the book provides a snapshot of the current issues and state-of-the-art technologies used in cancer genomics. Subsequent chapters highlight how these approaches have informed our understanding of hereditary cancer syndromes and the diagnosis, treatment and outcome in a variety of adult and pediatric solid tumors and hematologic malignancies. The dramatic increase in cancer genomics research and ever-increasing availability of genomic testing are not without significant ethical issues, which are addressed in the context of the return of research results and the legal considerations underlying the commercialization of genomic discoveries. Finally, the book concludes with "Future Directions", examining the next great challenges to face the field of cancer genomics, namely the contribution of non-coding RNAs to disease pathogenesis and the interaction of the human genome with the environment. Tools such as sidebars, key concept summaries, a glossary, and acronym and abbreviation definitions make this book highly accessible to researchers from several fields associated with cancer genomics.Contributions from thought leaders provide valuable historical perspective to relate the advances in the field to current technologies and literature.
  • 2014 Springer Protocols
    edited by Narendra Wajapeyee.
    Genome-Wide Mapping Of RNA Pol-II Promoter Usage In Mouse Tissues By Chip-Seq -- Using Native Chromatin Immunoprecipitation To Interrogate Histone Variant Protein Deposition In Embryonic Stem Cells -- Reduced Representation Bisulfite Sequencing To Identify Global Alteration In The DNA Methylation -- A High-Throughput Microrna Expression Profiling System -- Using Pooled Mir30-Shrna Library For Cancer Lethal And Synthetic Lethal Screens -- Genome-Wide RNA Interference Screening To Identify Regulators Of Epigenetic Silencing Of A Tumor Suppressor Gene -- A Diphtheria Toxin Negative Selection In RNA Interference Screening -- Cancer Metabolism: Crosstalk Between Signaling And O-Glcnacylation -- Targeted Genome Modification Via Triple Helix Formation -- Synthesis Of Stabilized Alpha-Helical Peptides -- Arginine-Grafted Biodegradable Polymer: A Versatile Transfection Reagent For Both DNA And Sirna -- Using Laco Arrays To Monitor DNA Double-Strand Break Dynamics In Live Schizosaccharomyces Pombe Cells -- Zebrafish As A Platform To Study Tumor Progression -- Clonal Screens To Find Modifiers Of Partially Penetrant Phenotypes In C. Elegans -- Serum Profiling Using Protein Microarrays To Identify Disease Related Antigens -- Interrogation Of In Vivo Protein-Protein Interactions Using Transgenic Mouse Models And Stable Isotope Labeling -- New Biophysical Methods To Study The Membrane Activity Of Bcl-2 Proteins -- Purification Of Recombinant 2XMBP Tagged Human Proteins From Human Cells -- Computational Analysis In Cancer Exome Sequencing -- Matrix Factorization Methods For Integrative Cancer Genomics -- Computational Methods For DNA Copy-Number Analysis Of Tumors.
  • 2007 Springer Protocols
    edited by Paul B. Fisher.
    Reciprocal subtraction differential RNA display (RSDD) : an efficient technology for cloning differentially expressed genes / Devanand Sarkar, Dong-chul Kang, and Paul B. Fisher -- Cloning differentially expressed genes using rapid subtraction hybridization (RaSH) / Habib Boukerche ... [et al.] -- The application of differential display as a gene profiling tool / Ken Chien-Neng Chang ... [et al.] -- Serial analysis of gene expression (SAGE) / Fred van Ruissen and Frank Baas -- Gene expression profile analysis of tumors / Katia Basso and Riccardo Dalla-Favera -- cDNA microarray and bioinformatic analysis of nuclear factor [kappa]B related genes in squamous cell carcinoma / Zhong Chen ... [et al.] -- Gene profiling uncovers retinoid target genes / Yan Ma ... [et al.] -- Complete open reading frame (C-ORF) technique : rapid and efficient method for obtaining complete protein coding sequences / Dong-chul Kang and Paul B. Fisher -- Chromatin immunoprecipitation assays : molecular analysis of chromatin modification and gene regulation / Piyali Dasgupta and Srikumar P. Chellappan -- Manipulating genes and gene copy number by bacterial artificial chromosome transfection / Stephanie F. Phelps, Sharon Illenye, and Nicholas H. Heintz -- Molecular cytogenetic applications in analysis of the cancer genome / Pulivarthi H. Rao, Subhadra V. Nandula, and Vundavalli V. Murty -- Monitoring methylation and gene expression in cancer / Hetty Carraway and James Herman -- The use of phage display peptide libraries for basic and translational research / Renee Brissette and Neil I. Goldstein -- Yeast and mammalian two-hybrid systems for studying protein-protein interactions / Shu-ichi Matsuzawa and John C. Reed -- Ribonomic and short hairpin RNA gene silencing methods to explore functional gene programs associated with tumor growth arrest / Timothy E. Baroni ... [et al.] -- Surface-epitope masking (SEM) : an immunological subtraction approach for developing monoclonal antibodies targeting surface-expressed molecules / Neil I. Goldstein and Paul B. Fisher -- Approaches for monitoring signal transduction changes in normal and cancer cells / Paul Dent ... [et al.] -- PKR in innate immunity, cancer, and viral oncolysis / Siddharth Balachandran and Glen N. Barber -- Analysis of transformation and tumorigenicity using mouse embryonic fibroblast cells / Hong Sun and Reshma Taneja -- Analysis of growth properties and cell cycle regulation using mouse embryonic fibroblast cells / Hong Sun, Neriman Tuba Gulbagci, and Reshma Taneja -- Reverse phase protein microarrays for monitoring biological responses / Virginia Espina ... [et al.] -- Protein crystallization / Champion Deivanayagam, William J. Cook, and Mark R. Walter.
  • 2007 Springer
    edited by Ivan Damjanov, Fang Fan.
  • 2013 Springer
    Ivan Damjanov, Fang Fan, editors.
    This is the second edition of a practice-oriented, well-illustrated manual on the microscopic grading of tumors. After an introduction on the history and basic tenets of tumor grading, subsequent chapters focus on specific organ systems. In each case, the most widely used system for grading common tumors is presented and discussed. Throughout, careful attention is paid to the principles of microscopic tumor grading, ancillary methods to improve grading, and the latest techniques used in evaluating tumors and formulating prognosis.
  • 2015 Springer
    Nima Rezaei, editor.
    Specific Organ Tumors: General Considerations On Immunotherapy -- Vaccination Of Human Solid Tumors: Recent Progress In The Clinical Setting -- Immunotherapy For Pediatric Solid Tumors -- Immunopathology Of Hematological Cancers And Immunotherapy Of Leukemia And Multiple Myeloma -- Immunopathology Of Lymphoma And Immunotherapy Of Hodgkin's Disease And Non-Hodgkin's Lymphoma -- Cancer-Testis Antigens As Targets For The Immunotherapy Of Hematological Malignancies -- Tumor Immunology And Immunotherapy Of Gastrointestinal Tract Cancers -- Immunology And Immunotherapy Of Colorectal Cancer -- Immunopathology Of Hepatobiliary Tumors And Immunotherapy Of Liver Cancers -- Immunology And Immunotherapy Of Pancreatic Tumors -- Immunology Of Cutaneous Tumors And Immunotherapy For Melanoma -- Immunopathology Of Head And Neck Tumors And Immunotherapy Of Squamous Cell Carcinoma -- Immunopathology And Immunotherapy Of Oral Cancers -- Immunopathology Of Bone And Connective Tissue Cancers And Immunotherapy Of Sarcomas -- Immunopathology Of Central Nervous System Cancers And Immunotherapy Of Brain Tumors -- Immunology And Immunotherapy Of Pulmonary Tumors -- Immunopathology Of Urinary System Cancers And Immunotherapy Of Renal And Bladder Cancers -- Immunopathology Of Cancers Of Male And Female Genitalia Organs And Immunotherapy Of Cervical And Prostate Cancer -- Immunology And Immunotherapy Of Ovarian Cancer -- Revisiting Immunology For Breast Cancer -- Immunology And Immunotherapy Of Graft Versus Host Disease.
  • 2015 Springer
    Nima Rezaei, editor.
    Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. The rapid flow of studies in the field of cancer immunology during the last decade has increased our understanding of the interactions between the immune system and cancerous cells. In particular, it is now well known that such interactions result in the induction of epigenetic changes in cancerous cells and the selection of less immunogenic clones as well as alterations in immune responses. Understanding the cross-talk between nascent transformed cells and cells of the immune system has led to the development of combinatorial immunotherapeutic strategies to combat cancer. This volume is focused on interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. Notably, the principal focus is very much on clinical aspects, the aim being to educate clinicians on the clinical implications of the most recent findings and novel developments in the field. This is to be hoped that this translational book will be comprehensible, cogent and of special value for researchers and clinicians who wish to extend their knowledge on cancer immunology.
  • 2011 Springer
    Glenn Dranoff, Editor.
    Immune infiltration in human cancer : prognostic significance and disease control / Wolf H. Fridman ... [et al.] -- Subversion and coercion : the art of redirecting tumor immune surveillance / John B. Mumm and Martin Oft -- STAT3 : a target to enhance antitumor immune response / Heehyoung Lee ... [et al.] -- Biology and clinical observations of regulatory T cells in cancer immunology / Michele W. Teng ... [et al.] -- Concepts and ways to amplify the antitumor immune response / Bent Rubin and Jean Edouard Gairin -- Angiogenesis and the tumor vasculature as antitumor immune modulators : the role of vascular endothelial growth factor and endothelin / Lana E. Kandalaft ... [et al.] -- Adoptive cellular therapy / Stephen A. Grupp and Carl H. June -- Dendritic cell subsets as vectors and targets for improved cancer therapy / Karolina Palucka ... [et al.] -- Identification of human idiotype-specific T cells in lymphoma and myeloma / Jinsheng Weng ... [et al.] -- Modulation of CTLA-4 and GITR for Cancer Immunotherapy / Francesca Avogadri ... [et al.] -- Immunobiology of cancer therapies targeting CD137 and B7-H1/PD-1 cosignal pathways / Shengdian Wang and Lieping Chen -- LAG-3 in cancer immunotherapy / Monica V. Goldberg and Charles G. Drake -- Immunologically active biomaterials for cancer therapy / Omar A. Ali and David J. Mooney -- Erratum : Identification of human idiotype-specific T cells in lymphoma and myeloma / Jinsheng Weng ... [et al.].
    Also available: Print – 2011
  • 2015 Springer
    Nima Rezaei, editor.
    This translational book describes in detail the clinical application of novel approaches in cancer immunotherapy with the aim of educating clinicians in the implications of the most recent research and new developments in the field. The scope is broad, encompassing, for example, prognostic biomarkers for personalized cancer treatment, strategies for targeting tumor immunosuppression, gene therapy, virus-based vaccines, targeting of cancer stem cells, hematopoietic stem cell transplantation, the role of T lymphocytes in cancer immunotherapy, use of monoclonal antibodies, and many more innovative approaches. Clinical immunologists, hematologists, and oncologists in particular will find the book to be of value in expanding their knowledge. ℗ℓ The book is the second in a three-volume series, Cancer Immunology, which offers an up-to-date review of cancer immunology and immunotherapy. The remaining volumes focus on the immunopathology of cancers and cancer immunotherapy for organ-specific tumors. In total the series, designed for both clinicians and researchers, includes contributions from more than 250 scientists working at leading universities and institutes from across the world.
  • 2013 Springer
    Tyler J. Curiel, editor.
    This volume is a comprehensive discussion of the major factors affecting tumor immunology and a discussion of all major anti-cancer immunotherapeutic agents approved by the Food and Drug Administration of the United States and by European agencies. Many promising but unapproved agents in clinical trials are also discussed, as are key pre-clinical developments. The major challenges and intellectual issues facing investigators developing novel immunotherapeutics are discussed in detail as are conceptual developments influencing current and future treatment strategies.Each chapter begins by defining all relevant key terms and concepts and provides pertinent background information so that the text will be accessible to newcomers to the field as well as to the expert. This text book should provide an excellent reference resource for investigators in tumor immunology, life sciences students, drug developers designing novel anti-cancer immunotherapeutics, and to other individuals with some scientific training wishing to gain a better understanding of the field of tumor immunotherapy.Although the field is evolving rapidly, we have taken pains to ensure that information was as up to date as possible as the text went to press.
  • 2014 Springer
    Cedrik Michael Britten, Sebastian Kreiter, Mustafa Diken, Hans-Georg Rammensee, editors.
    This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical development of new approaches and to pinpoint the optimal treatment for each patient. The book acknowledges the continuing dynamic nature of the field as reflected in the development of next-generation immunotherapies that are already in clinical testing. Cancer Immunotherapy Meets Oncology is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients.
  • 2007 Springer
    W. Archie Bleyer, Ronald D. Barr (eds.) ; [Karen H. Albritton, Marianne Phillips, Stuart E. Siegel, co-editors].
    Introduction / W. Archie Bleyer ... [et al.] -- History of adolescent oncology / Cameron K. Tebbi -- Epidemiology and etiology of cancer in adolescents and young adults / Jillian M. Birch and W. Archie Bleyer -- Access to care before and during therapy / Karen H. Albritton and Tim Eden -- Older adolescents and young adults with cancer, and clinical trials: lack of participation and progress in North America / W. Archie Bleyer, Troy Budd, and Michael Montello -- Acute lymphoblastic leukemia / James Nachman, Giuseppe Masera, and W. Archie Bleyer -- Acute myelogenous leukemia / Ursula Creutzig and William G. Woods -- Hodgkin lymphoma / Tanya M. Trippett ... [et al.] -- Non-hodgkin lymphoma / Catherine Patte, W. Archie Bleyer, and Mitchell S. Cairo -- Central nervous system tumors in adolescents and young adults / David A. Walker ... [et al.] -- Soft-tissue sarcomas / Karen H. Albritton, Andrea Ferrari, and Michela Casanova -- Bone sarcomas / Michael S. Isakoff ... [et al.] -- Malignancies of the ovary / Jubilee Brown, Thomas Olson, and Susan Sencer -- Testicuar tumors / John W. Cullen and Robert Fallon -- Non-germ-cell genitourinary tract tumors / Michael Leahy and W. Archie Bleyer -- Thyroid cancer / Steven G. Waguespack and Samuel A. Wells -- Malignant melanoma / Cynthia E. Herzog, W. Archie Bleyer, and Alberto S. Pappo -- Breast cancer / Marianne Phillips, Banu Arun, and W. Archie Bleyer -- Liver tumors / Marcio H. Malogolowkin, Arthur Zimmermann, and Jack Plaschkes -- Colorectal cancer / Wayne L. Furman, D. Ashley Hill, and Michael LaQuaglia -- Models of care and specialized units / Ian Lewis and Sue Morgan -- Drug compliance by adolescent and young adult cancer patients: challenges for the physician / Benjamin Gesundheit ... [et al.] -- Psychological support for adolescents and young adults / Christine Eiser and Aura Kuperberg -- Psychosocial support / Brad J. Zebrack, Mark A. Chesler, and Anthony Penn -- Health-related quality of life / Ernest R. Katz ... [et al.] -- Rehabilitation and exercise / Marilyn J. Wright -- Adolescent and young adult cancer survivors: late effects of treatment / Smita Bhatia ... [et al.] -- Ethical issues for the adolescent and young adult cancer patient: assent and end-of-life care / Susan Shurin and Eric Kodish -- Access to care after therapy / Karen E. Kinahan ... [et al.] -- Future health of survivors of adolescent and young adult cancer / Melissa M. Hudson and Kevin C. Oeffinger -- Information and resources for young adults and adolescents with cancer / David R. Freyer and Leonard J. Mattano -- Making ends meet: financial issues from the perspectives of patients and their healthcare team / David R. Freyer and Ronald D. Barr -- Challenges and opportunities - the way ahead / W. Archie Bleyer ... [et al.].
  • 2007 Springer
    edited by Igor Jurisica, Dennis A. Wigle, Bill Wong.
    Also available: Print – 2007
  • 2011 Springer
    edited by Boris R. Minev.
    This book represents a comprehensive description and evaluation of the most up-to-date approaches to cancer management. Each chapter, prepared by leading basic researchers and clinicians, provides an in depth description of a specific method for cancer management. The chemotherapy section of the book is updated to include the newest drugs as well as those currently in development. Organized by drug class, this section provides the latest information on most drugs, including their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance.
  • 2006
    Donald W. Kufe, Robert C. Bast Jr., William N. Hait ... [et al.], editors.
    Status: Not Checked OutLane Catalog Record
    Cancer biology -- Cancer immunology -- Cancer etiology -- Cancer epidemiology, prevention, and screening -- Clinical trials and outcomes assessment -- Cancer pathology -- Imaging -- Surgical oncology -- Radiation oncology -- Medical oncology -- Chemotherapy -- Chemotherapeutic agents -- Biotherapeutics -- Endocrine therapy -- Gene therapy -- Bone marrow transplantation -- Psycho-oncology -- Oncology nursing -- Cancer rehabilitation medicine -- Multidisciplinary management -- Pain and palliation -- Societal oncology -- Central nervous system -- The Eye -- Endocrine glands -- Head and neck -- The Thorax -- Gastrointestinal tract -- Genitourinary tract -- Female reproductive organs -- The Breast -- The Skin -- Bone and soft tissue -- Hematopoietic system -- Neoplasms in AIDS --- Unknown primary site -- Pediatric oncology -- Complications of cancer and their treatment -- Infection in the cancer patient -- Oncologic emergencies -- Oncology and informatics.
  • 2010 STAT!Ref, Limited to 7 simultaneous users
    editors, Waun Ki Hong ... [et al.].
    Also available: Print – 2010
  • v. 1-, 2000- Springer
  • 2007 Springer
    edited by Stanley P.L. Leong.
    Also available: Print – 2007
  • 2009 Springer
    Gianfranco Baronzio, Giammaria Fiorentini, Christopher R. Cogle, editors.
  • 2013 CRCnetBASE
    edited by Sang Hyun Cho, Sunil Krishnan.
    Basic principles of radiation therapy of cancers / Laurence Court and Radhe Mohan -- Biological principles of radiosensitization / Vikas Bhardwaj ... [et al.] -- Principles and applications of hyperthermia combined with radiation / Mark Hurwitz -- Synthesis and surface modification of nanomaterials for tumor targeting / Glenn Goodrich -- Safety concerns for nanomaterials in nanomedicinal applications / Qingxin Mu ... [et al.] -- Imaging with nanoparticles / Amit Joshi -- Optical microscopy of plasmonic nanoparticles / Varun P. Pattani and James Tunnell -- X-ray fluorescence computed tomography imaging of nanoparticles / Bernard L. Jones and Sang Hyun Cho -- Gold nanoparticle-mediated radiosensitization / Devika B. Chithrani -- Quantification of gold nanoparticle-mediated radiation dose enhancement / Sang Hyun Cho and Bernard L. Jones -- Semiconductor nanomaterials for radiotherapy / Ke Sheng -- Radioactive gold nanoparticle for tumor therapy / Raghuraman Kannan, Kattesh V. Katti, and Cathy Cutler -- Nanoparticles for the selective radioprotection of normal tissues / Jacob M. Berlin and Kathy A. Mason -- Gold nanoparticle-mediated hyperthermia in cancer therapy / Dev K. Chatterjee and Sunil Krishnan -- Magnetic resonance thermometry imaging for gold nanoparticle-mediated thermal therapy / R. Jason Stafford and John D. Hazle -- Modeling of plasmonic heat generation from gold nanoparticles / Francisco Reynoso and Sang Hyun Cho -- Carbon nanotubes for thermal therapy / Ravi N. Singh ... [et al.] -- Regulatory issues for clinical translations / J. Donald Payne -- Clinical translations of nanotechnology : present and future outlook / Dev K. Chatterjee, Sang Hyun Cho, and Sunil Krishnan.
  • 2008 Springer
    edited by David Schiff, Santosh Kesari, Patrick Y. Wen.
    Overview -- Diagnostic studies -- Neurologic symptoms -- Direct complications of cancer -- Indirect complications of cancer -- Complications of cancer therapy -- Neurologic complications of specific malignancies.
  • 2016 Springer
    edited by Jesus E. Medina, Nilesh R. Vasan.
    Preface -- 1. Evidence-Based Medicine -- 2. Oral Cavity -- 3. Oropharynx -- 4. Nasopharynx -- 5. Hypopharynx -- 6. Larynx -- Index.
  • 2011 ClinicalKey
    [edited by] Darrell S. Rigel [and others].
    Cancer of the Skin, edited by Drs. Rigel, Robinson, Ross, Friedman, Cockerell, Lim, Stockfleth, and Kirkwood, is your complete, multimedia guide to early diagnosis and effective medical and surgical treatment of melanoma and other skin cancers. Thoroughly updated with 11 new chapters, this broad-based, comprehensive reference provides you with the latest information on clinical genetics and genomics of skin cancer, targeted therapy for melanoma, the Vitamin D debate concerning the risks and benefits of sun exposure, and other timely topics. A new, multi-disciplinary team of contributors and editors comprised of leading experts in this field offers truly diverse perspectives and worldwide best practices.
  • 2010 Springer
    edited by M. Pilar Laguna, Peter Albers, Carsten Bokemeyer, and Jerome P. Richie.
    The book covers the complete field of testis cancer including the germ cell tumors and the stromal tumors, from epidemiology to new chemotherapeutic agents and schedules, throughout genetic features, risk factors, risk adapted treatments, role of different types of surgery and special clinical situations. Special attention is focused on fertility issues, late effects of the primary therapy and the economical aspects of the different treatment policies. As a result of the third Consensus Conference, a consensual follow-up can be devised and a chapter dedicated to this controversial and not yet defined matter.
  • 2016 Springer
    Alwin Krämer, Harald Löffler, editors.
    This book presents an up-to-date and thorough overview of cancer of unknown primary, encompassing topics ranging from epidemiology, tumor biology, and prognostic factors through to the most recent diagnostic and therapeutic advances. All aspects of management are covered, including radiological, nuclear medicine, and pathological diagnosis, site-specific therapies, platinum-based combination chemotherapy, radiotherapy, and novel targeted treatments. Clear guidance is offered on diagnosis of the tissue of origin by means of gene expression and micro-RNA analyses and its therapeutic implications. Detailed directions are also provided on the identification of subsets of patients with a more favorable prognosis, in whom specific treatment offers the chance of long-term survival or even cure. Readers will find Cancer of Unknown Primary to be an ideal source of practically oriented information that will assist in delivery of the best possible care for patients with this challenging diagnosis. .
  • 2013 Springer
    Magdi Hanna, Ben Zylicz, editors.
    Cancer remains a major challenge for medicine and it continues to claim lives and cause great suffering. Pain is a symptom experienced by most cancer patients regardless of disease stage, and less than 50% of cancer pain patients achieve effective pain and symptom control though available therapies. If these therapies are utilized correctly, many more patients can achieve effective control. While opioids are still seen as the mainstay of cancer pain treatment, it is necessary to examine whether this treatment strategy still holds true in the 21st century. Cancer Pain provides a comprehensive, up-to-date, practical guide to the management of pain in cancer patients. The book provides a clear, concise explanation of cancer pain syndromes, a modern understanding of the pathophysiological mechanism and an overview of recent developments in creating pre-clinical cancer pain models. It offers the reader the wide and improved options for management of cancer pain in clinical practice, including the use of opioid and non-opioid drugs, and defines the role of non-pharmacological methods for pain control. Cancer Pain also provides an overview of the latest developments in the management of cancer, which have major implications for the current and future thinking in cancer pain treatment strategy. This text is an invaluable resource for doctors, trainees and clinical nurse specialists in palliative medicine and oncology, and would be of interest to anyone who wishes to gain a better understanding of the complex nature of cancer pain and the tools available to alleviate it.
  • 2007 Springer
    H.-J. Senn, U. Kapp (eds.).
    Also available: Print – 2007
  • 2006 CRCnetBASE
    edited by Anne McTiernan.
  • 2014 Springer Protocols
    edited by Ann M. Bode and Zigang Dong.
    Combining computational and experimental methods for identifying molecular targets of phytochemicals / Ann M. Bode and Zigang Dong -- Common methods used for the discovery of natural anticancer compounds / Min Tang ... [et al.] -- Nrf2-target approaches in cancer chemoprevention mediated by dietary phytochemicals / Francisco Fuentes ... [et al.] -- Methods to analyze chemopreventive effect of silibinin on prostate cancer biomarkers protein expression / Gagan Deep, Swetha Inturi, and Rajesh Agarwal -- Approach to the evaluation of berries for cancer prevention with emphasis on esophageal cancer / Gary D. Stoner ... [et al.] -- Use of mouse models for lung cancer chemoprevention studies / Yian Wang ... [et al.] -- Azoxymethane plus dextran sulfate sodium-induced mouse colon cancer model for the study of dietary chemoprevention of inflammation-associated carcinogenesis / Ha-Na Lee, Hye-Won Yum, and Young-Joon Surh -- Use of seahorse extracellular flux analyzer in mechanistic studies of naturally occurring cancer chemopreventive agents / Michelle B. Moura ... [et al.] -- Utilizing RNA-seq to define phytochemical-induced alterations in insulin and IGF-regulated transcriptomes / Heather Beckwith and Douglas Yee -- Ex vivo use of keratinocytes from adult mice to define stem cell activities in cancer research / Rebecca J. Morris ... [et al.] -- Quantitation of acetaldehyde-DNA adducts : biomarkers of alcohol consumption / Silvia Balbo and Stephen S. Hecht -- Imaging tools in discovery and development of phytochemical chemopreventive agents / Marna Ericson -- Designing the chemoprevention trials of tomorrow : applying lessons learned from past definitive trials / Karen Colbert Maresso and Ernest Hawk.
  • 2009 Springer
    volume editors, Hansjörg Senn, Ursula Kapp, Florian Otto.
    Also available: Print – 2009
  • 2015 Ovid
    editors, Vincent T. DeVita, Jr, Theodore S. Lawrence, Steven A. Rosenberg.
  • 2012 Ovid
    editor, Ramaswamy Govindan ; assistant editors, Maria Q. Baggstrom, Thomas H. Fong, Janakiraman Subramanian.
  • 2008 (8th ed.) Ovid
    editors, Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg ; associate scientific advisors, Robert A. Weinberg, Ronald A. DePinho.
    Also available: Print – v. 1-2., 2008
  • 2011 Ovid
    [edited by] Vincent T. DeVita, Jr., Theodore S. Lawrence, Steven A. Rosenberg ; associate scientific advisors, Robert A. Weinberg, Ronald A. DePinho ; with 431 contributing authors.
    The Cancer Genome -- Mechanisms of Genomic Instability -- Epigenetics of Cancer -- Telomeres, Telomerase, and Cancer -- Cell Signaling Growth Factors and Their Receptors -- Cell Cycle -- Mechanisms of Cell Death -- Cancer Metabolism -- Angiogenesis -- Invasion and Metastasis -- Cancer Stem Cells -- Biology of Personalized Cancer Medicine -- Tobacco -- Cancer Susceptibility Syndromes -- DNA Viruses -- RNA Viruses -- Inflammation -- Chemical Factors -- Physical Factors -- Dietary Factors -- Obesity and Physical Activity -- Epidemiologic Methods -- Global Cancer Incidence and Mortality -- Trends in Cancer Mortality -- Surgical Oncology: General Issues -- Surgical Oncology: Laparoscopic Surgery -- Radiation Oncology -- Medical Oncology -- Assessment of Clinical Response -- Cancer Immunotherapy -- Health Services Research and Economics of Cancer Care -- Pharmacokinetics and Pharmacodynamics -- Pharmacogenomics -- Alkylating Agents -- Platinum Analogs -- Antimetabolites -- Topoisomerase-Interacting Agents -- Antimicrotubule Agents -- Targeted Therapy with Small Molecule Kinase Inhibitors -- Histone Deacetylase Inhibitors and Demethylating Agents -- Proteasome Inhibitors -- Poly(ADP-Ribose) Polymerase Inhibitors -- Miscellaneous Chemotherapeutic Agents -- Interferons -- Interleukin Therapy -- Antisense Agents -- Antiangiogenesis Agents -- Monoclonal Antibodies -- Endocrine Manipulation -- Preventive Cancer Vaccines -- Tobacco Dependence and Its Treatment -- Role of Surgery in Cancer Prevention -- Principles of Cancer Risk Reduction Intervention -- Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention -- Drugs and Nutritional Extracts for Cancer Risk Reduction (Chemoprevention) -- Principles of Cancer Screening -- Early Detection Using Proteomics -- Screening for Gastrointestinal Cancers -- Screening for Gynecologic Cancers -- Screening for Breast Cancer -- Screening for Prostate Cancer -- Screening for Lung Cancer -- Genetic Counseling -- Vascular Access and Specialized Techniques -- Interventional Radiology -- Functional Imaging -- Molecular Imaging -- Photodynamic Therapy -- Biomarkers -- Design and Analysis of Clinical Trials -- Molecular Biology of Head and Cancers -- Treatment of Head and Neck Cancer -- Rehabilitation after Treatment of Head and Neck Cancer -- Molecular Biology of Lung Cancer -- Non-Small Cell Lung Cancer -- Small Cell and Neuroendocrine Tumors of the Lung -- Neoplasms of the Mediastinum -- Molecular Biology of the Esophagus and Stomach -- Cancer of the Esophagus -- Cancer of the Stomach -- Molecular Biology of Pancreas Cancer -- Cancer of the Pancreas -- Molecular Biology of Liver Cancer -- Cancer of the Liver -- Cancer of the Biliary Tree -- Cancer of the Small Intestine -- Gastrointestinal Stromal Tumor -- Molecular Biology of Colorectal Cancer -- Cancer of the Colon -- Cancer of the Rectum -- Cancer of the Anal Region -- Molecular Biology of Kidney Cancer -- Cancer of the Kidney -- Molecular Biology of Bladder Cancer -- Cancer of the Bladder, Ureter, and Renal Pelvis -- Molecular Biology of Prostate Cancer -- Cancer of the Prostate -- Cancer of the Urethra and Penis -- Cancer of the Testis -- Molecular Biology of Gynecologic -- Cancer of the Cervix, Vagina, and Vulva -- Cancers of the Uterine Body -- Gestational Trophoblastic Neoplasms -- Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma -- Molecular Biology of Breast Cancer -- Malignant Tumors of the Breast -- Molecular Biology of Endocrine Tumors -- Thyroid Tumors -- Parathyroid Tumors -- Adrenal Tumors -- Pancreatic Neuroendocrine Tumors -- Neuroendocrine (Carcinoid) Tumors and the Carcinoid Syndrome -- Multiple Endocrine Neoplasias -- Molecular Biology of Soft Tissue Sarcoma -- Soft Tissue Sarcoma -- Sarcomas of Bone -- Cancer of the Skin -- Molecular Biology of Cutaneous Melanoma -- Cutaneous Melanoma -- Molecular Biology of Central Nervous System Tumors -- Neoplasms of the Central Nervous System -- Molecular Biology of Childhood Cancers -- Solid Tumors of Childhood -- Leukemias and Lymphomas of Childhood -- Molecular Biology of Lymphomas -- Hodgkin Lymphoma -- Non-Hodgkin Lymphomas -- Cutaneous Lymphomas -- Primary Central Nervous System Lymphoma -- Molecular Biology of Acute Leukemias -- Management of Acute Leukemias -- Molecular Biology of Chronic Leukemias -- Chronic Myelogenous Leukemia -- Chronic Lymphocytic Leukemias -- Myelodysplastic Syndromes -- Plasma Cell Neoplasms -- Cancer of Unknown Primary Site -- Benign and Malignant Mesothelioma -- Peritoneal Surface Malignancy -- Intraocular Melanoma -- AIDS-Related Malignancies -- Transplantation-Related Malignancies -- Superior Vena Cava Syndrome -- Increased Intracranial Pressure -- Spinal Cord Compression -- Metabolic Emergencies -- Metastatic Cancer to the Brain -- Metastatic Cancer to the Lung -- Metastatic Cancer to the Liver -- Metastatic Cancer to the Bone -- Malignant Effusions of the Pleura and the Pericardium -- Malignant Ascites -- Paraneoplastic Syndromes -- Autologous Stem Cell Transplantation -- Allogeneic Stem Cell Transplantation -- Infections in the Cancer Patient -- Leukopenia and Thrombocytopenia -- Cancer-Associated Thrombosis -- Nausea and Vomiting -- Diarrhea and Constipation -- Oral Complications -- Pulmonary Toxicity -- Cardiac Toxicity -- Hair Loss -- Gonadal Dysfunction -- Fatigue -- Second Primary Cancers -- Neurocognitive Effects -- Cancer Survivorship -- Management of Cancer Pain -- Nutritional Support -- Sexual Problems -- Psychological Issues in Cancer -- Communicating News to the Cancer Patient -- Specialized Care of the Terminally Ill -- Community Resources -- Rehabilitation of the Cancer Patient -- Regulatory Issues -- Health Disparities in Cancer -- Cancer Information on the Internet -- Complementary, Alternative, and Integrative Therapies in Cancer Care.
  • 2008 Springer
    edited by Sayed S. Daoud.
    Proteomics technologies -- Cell signaling proteomics -- Tumor proteomics -- Bioinformatics and regulatory aspects of proteomics.
  • 2016 Springer
    Daniela Cristina Stefan, editor.
    1.Introduction: the need to conduct cancer research in developing countries -- 2.Steps of a research study: from research question to publication -- 3.Types of research designs -- 4.Clinical research in developing countries: An overview -- 5.The research protocol -- 6.Ethics of conducting cancer research in developing countries -- 7.Data management and statistics -- 8.Funding For Cancer Research and Clinical Studies in Low and Middle-Income Countries -- 9.International Collaboration in Cancer Research -- 10.Publication and dissemination of research findings.
  • 2014 Wiley
    editor, Vinagolu K. Rajasekhar.
    Oxytocin and vasopressin systems: oxytocin, vasopressin, and their interplay with gonadal steroids: essentials of cancer stem cells and conceptual modeling -- Theoretical and experimental foundations of the "cancer stem cell" model -- The hallmarks of prostate cancer stem cells -- Self-renewal, induced proliferation, and autonomous cell growth represent distinct modes of cell multiplication: relevance to the cancer stem cell theory -- Human embryonic stem cells and cancer: modeling disease in a dish -- Cancer stem cell as a result of a reprogramming-like mechanism: implications in tumor development and treatment -- A cancer stem cell model: an insight into the conversion of induced pluripotent stem cells to cancer stem-like cells -- Altruistic stem cells and cancer stem cells -- The emerging concept of EMT-induced cancer stem cells -- Models to study chronic myeloid leukemia cancer stem cells -- Cancer stem cells in melanoma: biomarkers and mathematical models -- Stem cells in liquid tumors -- Acute myeloid leukemia stem cells: updates and controversies -- Leukemia-initiating cells in acute lymphoblastic leukemia -- Stem cells in solid tumors -- Lung cancer stem cells and resistance to radiotherapy -- Prostate cancer cell heterogeneity and prostate cancer stem cells -- Glioblastoma stem cells drive tumor recurrence and patient relapse: what's the evidence? -- Stem cells and pancreatic cancer -- Melanoma subpopulations with cancer stem cell phenotypes -- Sarcoma stem cells -- Cancer stem cells in tumor metastasis perspective -- Cancer stem cells in metastasis and minimal residual disease -- Role of cancer stem cells in metastasis -- Cancer stem cells and the stromal microenvironment -- A perspective on breast cancer malignant progression: from cancer stem cell intra tumor heterogeneity to metastasis-initiating cells -- Novel and potential targets in cancer stem cells -- Targeting cancer stem cells: modulating embryonic stem cell signaling, epigenetics, and tumor metabolism -- Oct4, Oct1, and cancer stem cells -- The role of Cripto-1 in cancer and cancer stem cells -- Leptin signaling in the regulation of stem and cancer stem cells -- Tumor-initiating stem-like cells: carcinogenesis through toll-like receptors, environmental factors, and virus -- The role of epithelial cell polarity pathways on cancer stem cells -- Cancer-initiating cells, exosomes, and the premetastatic niche -- Microrna therapeutics to target brain tumor stem cells -- The riboproteome orchestrates self-renewal and cell fate in leukemia -- Clinical relevance of cancer stem cells in patients -- Targeting different states of breast cancer stem cells -- Difficulties in targeting the beating heart: therapeutic implications of the cancer stem cell hypothesis in melanoma -- Targeting cancer stem cells for overcoming drug resistance and cancer progression -- The role of cancer stem cells in tumor radioresistance.
  • 2011 Springer
    Alison L. Allan, editor.
    Cancer stem cells : historical perspectives and lessons from leukemia / Christopher R. Cogle -- Cancer stem cells in breast cancer / Jenny E. Chu and Alison L. Allan -- Cancer stem cells in brain cancer / Xin Wang, Chitra Venugopal, and Sheila K. Singh -- Cancer stem cells in colorectal cancer / Mauro Biffoni, Eros Fabrizi, and Lucia Ricci-Vitiani -- Cancer stem cells in pancreatic cancer / Jorge Dorado, Alicia G. Serrano, and Christopher Heeschen -- Cancer stem cells in prostate cancer / Paula Kroon ... [et al.] -- Cancer stem cells in melanoma / Ping Jin ... [et al.] -- Cancer stem cells in lung cancer / Jun Shen and Feng Jiang -- Cancer stem cells in ovarian cancer / Fang Fang ... [et al.] -- Cancer stem cells in hepatocellular cancer / Russell C. Langan and Itzhak Avital -- Cancer stem cells in head and neck cancer / Mark E.P. Prince and Samantha J. Davis -- Relationship between regulatory pathways in pluripotent stem cells and human tumors / Olga Gaidarenko and Yang Xu -- Influence of the embryonic microenvironment on tumor progression / Daniela Quail ... [et al.] -- The epithelial-to-mesenchymal transition and cancer stem cells / Jonas Fuxe -- Application of stem cell assays for the characterization of cancer stem cells / Pamela M. Willan and Gillian Farnie -- Zebrafish as a model to study stem cells in development, disease, and cancer / Viviana Anelli, Cristina Santoriello, and Marina C. Mione -- Imaging cancer stem cells / Paula Foster -- Mouse models for studying normal and cancer stem cells / David A. Hess -- Cancer stem cells and disease prognosis / Zeshaan A. Rasheed, Jeanne Kowalski, and William H. Matsui -- Mechanisms of radioresistance in cancer stem cells / Cleo Y-F Lee and Maximilian Diehn -- The role of ABC transporters in cancer stem cell drug resistance / Vera S. Donnenberg, Ludovic Zimmerlin, and Albert D. Donnenberg -- Resistance to endocrine therapy in breast cancer : are breast cancer stem cells implicated? / Ciara S. O'Brien ... [et al.] -- Future directions : cancer stem cells as therapeutic targets / Alysha K. Croker and Alison L. Allan -- Final thoughts : complexity and controversy surrounding the "cancer stem cell" paradigm / Craig Gedye, Richard P. Hill, and Laurie Ailles.
  • 2007 Springer
    O.D. Wiestler, B. Haendler, D. Mumberg, eds.
  • 2011 IARC
    edited by R. Sankaranarayanan, R. Swaminathan.
    Also available: Print – 2011
  • 2007 Springer
    Patricia A. Ganz, editor ; foreword by Sandra J. Horning.
    Cancer survivors: a physician's perspective / Patricia A. Ganz -- Cancer survivorship: a nursing perspective / Susan Leigh -- Oncology social work for survivorship / Patricia Fobair -- Survivorship research: past, present, and future / Julia H. Rowland -- Surveillance after primary therapy / Craig C. Earle -- Late effects of cancer treatments / Noreen M. Aziz -- Medical and psychosocial issues in childhood cancer survivors / Smita Bhatia ... [et al.] -- Medical and psychosocial issues in Hodgkin's disease survivors / Jon Håvard Loge and Stein Kaasa -- Medical and psychosocial issues in testicular cancer survivors / S.D. Fosså, L.B. Travis, and A.A. Dahl -- Medical and psychosocial issues in gynecologic cancer survivors / Karen Basen-Engquist and Diane C. Bodurka -- Medical, psychosocial, and health-related quality of life issues in breast cancer survivors / Julie Lemieux, Louise J. Bordeleau, and Pamela J. Goodwin -- Medical and psychosocial issues in prostate cancer survivors / Tracey L. Krupski and Mark S. Litwin -- Physical and psychosocial issues in lung cancer survivors / Linda Sarna, Frederic W. Grannis, and Anne Coscarelli -- Cancer survivorship issues in colorectal cancer / Clifford Y. Ko and Patricia A. Ganz -- Medical and psychosocial issues in transplant survivors / Karen L. Syrjala ... [et al.] -- Cancer survivorship issues in older adults / Karim S. Malek and Rebecca A. Silliman -- Second malignancies after radiation treatment and chemotherapy for primary cancers / Lydia B. Zablotska, Matthew J. Matasar, and Alfred I. Neugut -- Psychosocial rehabilitation in cancer care / Richard P. McQuellon and Suzanne C. Danhauer -- Reproductive complications and sexual dysfunction in cancer survivors / Leslie R. Schover -- The employment and insurance concerns of cancer survivors / Barbara Hoffman -- Cancer advocacy / Ellen L. Stovall -- The survivorship care plan: what, why, how, and for whom / Craig C. Earle ... [et al.]
  • 2008 Springer
    P. Rubin, L.S. Constine, L.B. Marks, P. Okunieff (eds.) ; with contributions by M.J. Adams ; foreword by L.W. Brady ... [et al.].
  • 2010 Springer Protocols
    edited by Michelle Webb.
  • 2010 CRCnetBASE
    edited by Edwin Wang.
    A roadmap of cancer systems biology / Edwin Wang -- Network biology : the framework of systems biology / Jing-Dong Han -- Reconstructing gene networks using gene expression profiles / Mario Lauria and Diego di Bernardo -- Understanding cancer progression in protein interaction networks / Jinsheng Sun, Jie Li, and Edwin Wang -- From tumor genome sequencing to cancer signaling maps / Cong Fu and Edwin Wang -- Ubiquitin-mediated regulation of human signaling networks in normal and cancer cells / Cong Fu, Jie Li, and Edwin Wang -- MicroRNA regulation of networks of normal and cancer cells / Pradeep Kumar Shreenivasaiah, Do Han Kim, and Edwin Wang -- Network model of survival signaling in T-cell large granular lymphocyte leukemia / Ranran Zhang, Thomas P. Loughran Jr., and Réka Albert -- Cancer metabolic networks : metabolic pathways modelling and metabolomics in cancer research / Miroslava Cuperlovic-Culf -- Warburg revisited : modeling energy metabolism for cancer systems biology / Mathieu Cloutier -- Cancer gene prediction using a network approach / Xuebing Wu and Shao Li -- Cancer genomics to cancer biology / Maria Luz Jaramillo and Chabane Tibiche -- Epithelial-to-mesenchymal transition (EMT) : the good, the bad, and the ugly / Anne EG Lenferink -- Tumors and their microenvironments / Nicholas R. Bertos and Morag Park -- Tumor angiogenesis : cell-microenvironment interactions / Ally Pen, Danica B. Stanimirovic, and Maria J. Moreno -- Modeling tools for cancer systems biology / Wayne Materi and David S. Wishart -- Advanced visualization, analysis, and inference of biological networks using visANT / Zhenjun Hu -- Gene set and pathway-based analysis for cancer omics / Dougu Nam and Seon-Young Kim -- SH2 domain signaling network and cancer / Shawn S.-C. Li and Thamara K.J. Dayarathna -- Data sources and computational tools for cancer systems biology / Yun Ma, Pradeep Kumar Shreenivasaiah, and Edwin Wang.
  • 2011 Springer
    Alfredo Cesario, Frederick B. Marcus, editors.
    pt. 1. Introduction and background -- pt. 2. Laboratory, clinical, data and educational resources -- pt. 3. Bioinformatics and systems biology analysis -- pt. 4. Diagnosis, clinical and treatment applications -- pt. 5. Perspectives and conclusions.
  • 2013 Springer
    You Han Bae, Randall J. Mrsny, Kinam Park, editors.
    A Time Travel Journey Through Cancer Therapies -- Nanotechnology for Cancer Treatment: Possibilities & Limitations -- Vascular Targeting Approaches to Treat Cancer -- Tumor Immunotherapy by Utilizing a Double-Edged Sword Chemokines -- Cancer Biology: Some Causes for a Variety of Different Diseases -- Cancer Stromal Targeting (CAST) Therapy and Tailored Antibody Drug Conjugate Therapy Depending on Nature of Tumor Stroma -- Cancer Cell Respiration: Hypoxia and pH in Solid Tumors -- Tumor Vasculature, EPR Effect, and Anticancer Nanomedicine: Connecting the Dots -- Pressure Gradients in Solid Tumors -- The ADAMs: New Therapeutic Targets for Cancer? -- Role of the Extracellular Matrix Enzyme Activities and Metastasis -- The Role of Non-Cancerous Cells in Cancer: Pancreatic Ductal Adenocarcinoma as Model to Understand the Impact of Tumor Microenvironment on Epithelial Carcinogenesis -- Heterogeneity of Cancers and its Implication for Targeted Drug Delivery -- A Study of Cancer Heterogeneity: From Genetic Instability to Epigenetic Diversity in Colorectal Cancer -- Nanotherapeutics in Multidrug Resistance -- Stem Cells and Cancer -- Mechanisms of Metastasis -- Cancer-Specific Ligand/Receptor Interactions -- Targeting Drugs to Cancer: A Tough Journey to the Tumor Cell -- Long Circulation and Tumor Accumulation -- Convective and Diffusive Transport in Drug Delivery -- Intravital Real-Time Confocal Laser Scanning Microscopy for the in Situ Evaluation of Nanocarriers -- The EPR effect in Cancer Therapy -- In Vitro 3-dimensional Cancer Culture Model -- Complex Transport Around Tumor: Need for Realistic In Vitro Tumor Transport Model -- The Missing Components Today and the New Treatments Tomorrow.
  • 2015 ScienceDirect
    edited by Xiaoyuan Chen, Stephen Wong.
    I: In vitro diagnostics. Cancer theranostics: an introduction -- Genomics-based cancer theranostics -- Proteomics-based theranostics -- II: Molecular imaging. Radionuclide imaging of cancer therapy -- Near-infrared fluorescence imaging probes for cancer diagnosis and treatment -- Bioluminescence imaging of cancer therapy -- Magnetic resonance imaging of cancer therapy -- Ultrasound imaging of cancer therapy -- Photoacoustic imaging for cancer diagnosis and therapy guidance -- III: Imaging-guided therapy. Multimodality image-guided lung intervention systems -- Label-free molecular vibrational imaging for cancer diagnosis -- Multimodality image-guided treatment -- Medical robotics for cellular and molecular imaging -- IV: Theranostic platforms. Porphyrins for imaging, photodynamic therapy, and photothermal therapy -- Magnetic resonance imaging and alternating magnetic fields -- Ultrasound for drug/gene delivery -- Radionuclides for imaging and therapy in oncology -- Noble metal nanoparticle platform -- Cancer theranostics with carbon-based nanoplatforms -- Silica nanoparticle platform -- Quantum dots for traceable therapeutic delivery -- Polymer- and protein-based nanotechnologies for cancer theranostics -- V: Other. Clinical translation and regulations of theranostics -- Scale-up production of theranostic nanoparticles -- Market considerations for nanomedicines and theranostic nanomedicines -- Application of theranostics to measure and treat cell heterogeneity in cancer.
  • v. 122-, 2004- Springer
    Freireich, Emil J.; McGuire, William L.; Rosen, Steven T.
  • 2015 ScienceDirect
    edited by Richard A. Anderson, Norah Spears.
    Section I. Clinical -- Section II. Laboratory models -- Section III. Strategies to protect the ovary.
  • 2014 Springer Protocols
    edited by Michael J.P. Lawman and Patricia D. Lawman.
    Single Step Antigen Loading and Maturation of Dendritic Cells Through mRNA Electroporation of a Tumor-Associated Antigen and a TriMix of Costimulatory Molecules -- Generation of Multiple Peptide Cocktail-Pulsed Dendritic Cells as a Cancer Vaccine -- Pulsing Dendritic Cells with Whole Tumor Cell Lysates -- Antigen Trapping by Dendritic Cells for Anti-Tumor Therapy -- Ex Vivo Loading of Autologous Dendritic Cells with Tumor Antigens -- Tumor Antigen/Cytokine-Pulsed Dendritic Cells in Therapy Against Lymphoma -- Dendritic Cells Primed with Protein-Protein Fusion Adjuvant -- Antigen-Specific mRNA Transfection of Autologous Dendritic Cells -- Electroporation of Dendritic Cells with Autologous Total RNA from Tumor Material -- Dendritic Cells Transfected with Adenoviral Vectors as Vaccines -- Genetic Modification of Dendritic Cells with RNAi -- Fast Monocyte-Derived Dendritic Cells-Based Immunotherapy -- Intratumoral Injection of BCG-CWS Pretreated Dendritic Cells Following Tumor Cryoablation -- Exploiting the CD1d-iNKT Cell Axis for Potentiation of DC-Based Cancer Vaccines -- Modification of T Lymphocytes to Express Tumor Antigens -- Genetic Modification of Mouse Effector and Helper T Lymphocytes Expressing a Chimeric Antigen Receptor -- Genetic Modification of Cytotoxic T Lymphocytes to Express Cytokine Receptors -- Monitoring the Frequency and Function of Regulatory T Cells and Summary of the Approaches Currently Used to Inhibit Regulatory T Cells in Cancer Patients -- Cytokine Activation of Natural Killer Cells -- Loading of Acute Myeloid Leukemia Cells with Poly(I:C) by Electroporation -- Autologous Tumor Cells Engineered to Express Bacterial Antigens -- Tumor Cell Transformation Using Antisense Oligonucleotide -- The Direct Display of Costimulatory Proteins on Tumor Cells as a Means of Vaccination for Cancer Immunotherapy -- Cloning Variable Region Genes of Clonal Lymphoma Immunoglobulin for Generating Patient-Specific Idiotype DNA Vaccine -- Heat Shock Proteins Purified from Autologous Tumors Using Antibody-Based Affinity Chromatography -- Invariant Chain-Peptide Fusion Vaccine Using HER-2/neu -- TLR-9 Agonist Immunostimulatory Sequence Adjuvants Linked to Cancer Antigens -- Production of Multiple CTL Epitopes from Multiple Tumor-Associated Antigens -- Preparation of Polypeptides Comprising Multiple TAA Peptides -- Idiotype Vaccine Production Using Hybridoma Technology -- Preparation of Cancer-Related Peptide Cocktails that Target Heterogeneously-Expressed Antigens -- Making an Avipoxvirus Encoding a Tumor-Associated Antigen and a Costimulatory Molecule -- Bacterial Vectors for the Delivery of Tumor Antigens -- Preparation of Peptide Microspheres Using Tumor Antigen-Derived Peptides -- Production of Antigen-Loaded Biodegradable Nanoparticles and Uptake by Dendritic Cells -- Development of Plasmid-Lipid Complexes for Direct Intratumoral Injection -- The Use of Dendritic Cells for Peptide-Based Vaccination in Cancer Immunotherapy -- Advances in Host and Vector Development for the Production of Plasmid DNA Vaccines -- Challenges Facing the Development of Cancer Vaccines -- Future of Cancer Vaccines.
  • 2015
    Juan Alvarado Valdivia.
    Status: Not Checked OutLane Catalog Record
    Recounts the author's experience as a cancer patient. He was diagnosed with stage 2A Hodgkin lymphoma at age 30, and was cancer free in 2010, and five years later considered in complete remission.
  • 2015 Springer
    Joachim Weis, Markus Horneber.
    Cancer-related fatigue (CrF) is increasingly recognized as a significant problem for patients with cancer at all stages, including those undergoing therapy and in remission. In fact, studies have shown that CrF causes patients more distress than pain, nausea, or vomiting and yet fatigue is still often undertreated and rarely studied. However, several new treatments such as are being investigated to determine the most effective ways to manage this debilitating symptom and improve patient quality of life. Cancer-Related Fatigue will provide a concise overview of this condition, with an evidence-based discussion of diagnosis, treatment, and long-term management.
  • 2010 IARC
    Carbon Black -- 1. Exposure data -- 2. Studies of cancer in humans -- 3. Studies of cancer in experimental animals -- 4. Mechanistic and other relevant data -- 5. Summary of data reported -- 6. Evaluation and rationale -- -- Titaniium Dioxide -- 1. Exposure data -- 2. Studies of cancer in humans -- 3. Studies of cancer in experimental animals -- 4. Mechanistic and other relevant data -- 5. Summary of data reported -- 6. Evaluation and rationale -- -- Talc Not Containing Asbestiform Fibres -- 1. Exposure data -- 2. Studies of cancer in humans -- 3. Studies of cancer in experimental animals -- 4. Mechanistic and other relevant data -- 5. Summary of data reported -- 6. Evaluation and rationale.
    Also available: Print – 2010
  • 2015 Springer
    Gonzalo Baron Esquivias, Riccardo Asteggiano, editors.
    Introduction -- Physiopathology and toxic drugs heart effects -- Radiotherapy heart effects -- Cardiac imaging technology in cardio-oncology -- Evaluation of the oncologic patient before, during and after chemotherapy -- What drug/what possible complication -- What cancer type/what possible drug -- what cancer/what possible complication -- Management (prevention/diagnosis/evaluation/therapy) of hypertension -- Management (prevention/diagnosis/evaluation/therapy) of coronary disease and thrombo-embolic complication -- Management (prevention/diagnosis/evaluation/therapy) of arrhythmic complication -- Management (prevention/diagnosis/evaluation/therapy) of systolic dysfunction.
  • 2013 Springer
    Cristina Basso, Marialuisa Valente, Gaetano Thiene, editors.
    Cardiac tumors were once a nosographic entity of scarce clinical interest because of the rarity and of the intrinsic diagnostic and therapeutic impossibilities, and were considered a fatal morbid entity. It has now become a topical subject due to advances in clinical imaging (echo, magnetic resonance, computed tomography) as well as innovation in technologies of in-vivo diagnosis. Cardiac Tumor Pathology presents a spectacular example of these advances with clinico-pathologic correlations. This timely volume covers history, epidemiology, demographics, clinical diagnosis, pathology, imaging by echo, CT and MRI of both benign and malignant cardiac tumors, either primary or secondary. Chemotherapy of malignant neoplasms is also addressed. Special emphasis is given to clinico-pathologic correlations. With all chapters written by experts in their fields, this volume will serve as a useful resource for physicians dealing with, and interested in, this special branch of cardiac oncology and will represent a useful guide for pathologists, clinicians, cardiologists, cardiac surgeons, and radiologists as well as for postgraduate students training in these areas.
  • 2012 Cambridge
    edited by Victor H. Gerbaudo.
    A Case-Based Approach to PET/CT in Oncology describes the role of PET/CT in the diagnosis, staging and monitoring of treatment response in today's practice of oncology. It provides a detailed analysis of over 100 cases occurring in daily clinical practice, emphasizing the central role that PET imaging plays in the care of cancer patients. The text is organized into two sections; Part I guides the reader through general introductory concepts, including basic science, while Part II covers in-depth oncologic applications. Each case is illustrated throughout with full color images and explains the key management issues and the advantages and limitations of the modality. Written by a team of renowned international experts, A Case-Based Approach to PET/CT in Oncology is an invaluable resource for all imaging practitioners, oncologists and nuclear medicine specialists.
  • 2007 Thieme Book
    László Tabár, Tibor Tot, Peter B. Dean ; with contributions by Tony Hsiu-Hsi Chen [and others].
    The first of several satellite volumes to Tabar's Breast Cancer: The Art and Science of Early Detection with Mammography. Each volume will cover in depth a specific class of mammographic findings. Here, casting-type calcifications, and their significance in diagnosing cancer, are explored. Thick-section pathologic specimens are provided to help the reader understand why the mammograms look the way they do. A selection of full color pathologic images is provided in 3-D, allowing one to visualize the breast substructures in their spatial context.
  • 2012 Springer
    edited by Jean-François Jasmin, Philippe G. Frank, Michael P. Lisanti.
    Lipid rafts, caveolae, and GPI linked proteins / Valerie L. Reeves, Candice M. Thomas, and Eric J. Smart -- Caveolae and the regulation of endocytosis / Anna L. Kiss -- Caveolin : role in cell signaling / Cecile Boscher and Ivan Robert Nabi -- Regulation of ENOS in caveolae / Chieko Mineo and Philip W. Shaul -- Recent developments in the interactions between caveolin and pathogens / Fabiana S. Machado ... [et al.] -- Caveolin and breast cancer : a new clinical perspective / Isabelle Mercier and Michael P. Lisanti -- Caveolin and prostate cancer progression / Michael R. Freeman, Wei Yang, and Dolores Di Vizio -- Caveolins and caveolae, roles in insulin signalling, and diabetes / Peter Strolfors -- Atherosclerosis, caveolae, and caveolin / Stephanos Pavlides ... [et al.] -- Caveolins and heart diseases / Mathivadhani Panneerselvam, Hemal H. Patel, and David M. Roth -- Caveolins and lung function / Nikolaos A. Maniatis ... [et al.].
    Also available: Print – 2012
  • 2012 Springer
    Isabelle Mercier, Jean-François Jasmin, Michael P. Lisanti, editors.
    1. Local and Distant Effects of Caveolin-1 on Prostate Cancer Progression / T.C. Thompson, S.A. Tahir, L. Li, M. Watanabe, K. Naruishi, G. Yang, Ken-ichi Tabata, S. Kurosaka, K. Edamura, R. Tanimoto, P. Corn, D. Kadmon, C.J. Logothetis, P. Troncoso, C. Ren, A. Goltsov, and S. Park -- 2. Caveolin-1 in Colon Cancer: The Flexible Connection to Wnt Signaling / Andrew F.G. Quest, Vicente A. Torres, Diego A. Rodriguez, Jorge Gutierrez-Pajares, and Julio C. Tapia -- 3. Caveolin-1 and Pancreatic Ductal Adenocarcinoma / David W. Rittenhouse, Oeendree Mukherjee, Nathan G. Richards, Charles J. Yeo, Agnieszka K. Witkiewicz, and Jonathan R. Brody -- 4. Caveolin-1 in Brain Tumors / Rebecca Senetta and Paola Cassoni -- 5. The Role of Caveolin-1 in Skin Cancer -- / Alessandra Carè, Isabella Parolini, Federica Felicetti, and Massimo Sargiacomo -- 6. Caveolins in Tumor Angiogenesis / Grzegorz Sowa -- 7. Caveolin-1 and Breast Cancer / Gloria Bonuccelli and Michael P. Lisanti -- 8. Caveolin-1 and Cancer-Associated Stromal Fibroblasts / Isabelle Mercier and Michael P. Lisanti.
  • 2006 Springer
    edited by Anne E. Cress and Raymond B. Nagle.
  • 2013 Springer
    Heide Schatten, editor.
    Histopathology and grading of breast cancer / Magda Esebua -- Multicentric/multifocal breast cancer : overview, biology, and therapy / Federico Buggi ... [et al.] -- Immune system in breast cancer initiation and progression : role of epithelial to mesenchymal transition / Keith L. Knutson and Erik C. Radisky -- Remodelling of the extracellular matrix : implication for cancer / Thomas R. Cox and Janine T. Erler -- Biology and treatment of basal-like breast cancer / Bingchen Han ... [et al.] -- Re-excision after lumpectomy for breast cancer / Suzanne B. Coopey -- Novel anti-angiogenic therapies using naturally occurring and synthetic drugs to combat progestin-dependent breast cancer / Salman M. Hyder, Benford Mafuvadze, and Cynthia Besch-Williford -- New insights on estrogen receptor actions in hormone-responsive breast cancer cells by interaction proteomics / Concetta Ambrosino ... [et al.] -- Reprogramming breast cancer cells with embryonic microenvironments : insights from nodal signaling / Gina Kirsammer and Mary J.C. Hendrix - Metastatic determinants : breast tumour cells in circulation / Nisha Kanwar and Susan J. Done -- Breast cancer epigenetics : biomarkers and therapeutic potential / Nancy H. Nabilsi ... [et al.] -- Impact of centrosome abnormalities on breast cancer development and progression with a focus on targeting centrosomes for breast cancer therapy / Heide Schatten -- New perspective on cyclin D1 : beyond cell cycle regulation / Chenguang Wang, Timothy G. Pestell, and Richard G. Pestell -- Gene signatures of inflammatory breast cancer : epithelial plasticity and a cancer stem cell phenotype / Fredika M. Robertson ... [et al.] -- Integrated human mammary epithelial cell culture system for studying carcinogenesis and aging / Martha R. Stampfer, Mark A. LaBarge, and James C. Garbe -- New breast cancer treatment considerations a brief review of the use of genetically modified (attenuated) bacteria as therapy for advanced and metastatic breast cancer / Robert A. Kazmierczak ... [et al.].
  • 2010 Springer
    Greg H. Enders, editor.
    Part I: Starting the Cell Division Cycle -- 1 Escape from Cellular Quiescence -- 2 Interplay Between Cyclin-Dependent Kinases and E2F-Dependent Transcription -- 3 Regulation of Pre-RC Assembly: A Complex Symphony Orchestrated by CDKs -- Part II: Proliferation Under Duress -- 4 Mitotic Checkpoint and Chromosome Instability in Cancer -- 5 Mitotic Catastrophe -- 6 p53, ARF, and the Control of Autophagy -- Part III: Long-Term Proliferation -- 7 Regulation of Self-Renewing Divisions in Normal and Leukaemia Stem Cells -- 8 Maintenance of Telomeres in Cancer -- 9 The Senescence Secretome and Its Impact on Tumor Suppression and Cancer -- Part IV: Applications in Preventing and Treating Cancer -- 10 Cell Cycle Deregulation in Pre-neoplasia: Case Study of Barrett8217;s Oesophagus -- 11 Targeting Cyclin-Dependent Kinases for Cancer Therapy -- Index.
  • 2010
    Stacey Ellen Wirt.
    The ability of stem/progenitor cells to exit the cell cycle is essential for proper embryonic development, but the mechanisms governing cell cycle exit are still not fully understood. Correct regulation of G1 is critical for ensuring proper organismal development, tissue homeostasis, and tumor suppression. The Retinoblastoma (Rb) gene family is composed of three genes, Rb, p107, and p130, which are collectively thought to serve as essential regulators of the G1 phase of the cell cycle in most proliferating cell types. The Rb family has also been implicated in promoting the gene expression of several differentiation programs in different cell lineages. However, due to the overlapping and compensatory functions among the Rb family members, a complete understanding of how the Rb family controls the cell cycle and differentiation programs within a cell remains unclear. Furthermore, it has not yet been tested whether the Rb family members are the only mediators of these cellular processes, or if there are alternative mechanisms for cell cycle exit and differentiation in mammalian stem and progenitor cells. Here we tested the requirement for the Rb protein and its family members p107 and p130 in G1 arrest and differentiation in mammalian cells. We employed several strategies to conditionally remove the Rb family genes in entire embryos and in specific neural lineages, as well as multiple differentiation systems in vitro. We found that Rb family triple knock-out (TKO) mouse embryos survive until days 9-11 of gestation, with similar patterning and organogenesis as seen in wild type embryos. Strikingly, a number of TKO cells, including in the neural lineage, are able to exit the cell cycle in G1 and fully differentiate in vivo and in culture. This ability of TKO cells to arrest in G1 is associated with the repression of key cell cycle target genes for E2F and Myc transcription factors. Thus, G1 arrest can be achieved independently of Rb family members, illustrating the robustness of cell cycle regulatory networks during embryogenesis, and identifying a novel program that regulates cell cycle exit in G1 in mammalian cells.
  • 2013 Springer
    Daniel E. Johnson, editor.
    Defects in cell death pathways promote tumor development and progression, with potentially devastating consequences for cancer patients. Greater understanding of the defects occurring in cancer cells, and the unique characteristics of tumors which can make them vulnerable to cell death stimuli, offers tremendous opportunities for developing novel and effective anti-cancer therapies. In Cell Death in Cancer Biology and Treatment leading experts in the field provide a wealth of up-to-date knowledge regarding the molecular mechanisms and cell biological processes that control cell death. Each chapter also highlights recent advances in the translation of basic research findings into clinical trials. Beginning and established investigators alike will benefit from the thorough presentations of the most promising avenues for future development of cell death-based, anti-cancer strategies and agents. The volume begins with a detailed description of many of the cell death defects that have been identified in human tumor specimens. The unique bioenergetics of cancer cells, and the influence of the tumor microenvironment, autophagy, and cellular microRNAs on cancer cell death are then discussed, along with current progress in targeting these distinctive features and processes. Additional chapters describe recent advances, and the therapeutic benefits of targeting DNA repair pathways, protein chaperones, sphingolipid signaling, Bcl-2 family members, IAPs, death receptor signaling, the proteasome, and survival signaling emanating from the PI3K/AKT and RAS/RAF/MEK/ERK pathways. Finally, recent discoveries are presented regarding interactions between the immune system and dying cancer cells and the potential for optimizing these interactions to maximize anti-cancer activities. In summary, Cell Death in Cancer Biology and Treatment will be a valuable resource for scientists interested in cutting-edge understanding of aberrant cell death in cancer cells, and the multitude of innovative molecular targeting approaches that are actively being pursued to achieve selective activation of cell death in human malignancies.
  • 2006 Springer
    edited by Alan Wells.
    Cancer Morbidity and mortality result from invasive and metastatic spread. Advances in the field have highlighted the central role of cell motility during the dynamic and transient process of tumor invasion and metastasis. This book presents an overview of these studies.
  • 2012 Springer
    Malay Chatterjee, Khosrow Kashfi, editors.
    1. GRB2 Signaling as a Molecular Target for Cancer / Alessio Giubellino -- 2. Human Arylamine N-acetyltransferase 1: From Drug Metabolism to Drug Target / Fernando Rodrigues-Lima, Julien Dairou, Florent Busi, and Jean-Marie Dupret -- 3. Targeting Argininosuccinate Synthetase in Cancer Therapy / Niramol Savaraj, Min You, Chunjing Wu, Macus Tien Kuo, Vy Dinh, Medhi Wangpaichitr, and Lynn Feun -- 4. Parathyroid Hormone-Related Peptide Signaling in Cancer / Franco Oreste Ranelletti and Giovanni Monego -- 5. Signalling Molecules as Selective Targets for Therapeutic Strategies in Multiple Myeloma / Francesco Piazza and Gianpietro Semenzato -- 6. Role of Bile Acids in Carcinogenesis of Gastrointestinal Tract / Hiroshi Yasuda and Fumio Itoh -- 7. AIB1: A Transcriptional Coactivator Which Integrates Signaling Cross Talk in Cancer Cells / Macarena Ferrero and Jaime Font de Mora -- 8. Rational Design of DNA Anticancer Agent That Targets Signal Transducer and Activator of Transcription 3 (Stat3) for Cancer Therapy / Naijie Jing -- 9. Estrogen Receptor Signaling in Lung Cancer / P.A. Hershberger and J.M. Siegfried -- 10. Microparticle Dissemination of Biological Activities: Implications for Cancer Biology / Pauline P. Goh -- 11. Protein Kinase D Signaling in Cancer / Peter Storz -- 12. Cell Signaling and Cancer: Integrated, Fundamental Approach Involving Electron Transfer, Reactive Oxygen Species, and Antioxidants / Peter Kovacic and Ratnasamy Somanathan -- 13. Targeting Signal Transducer and Activator of Transcription (STAT) for Anticancer Therapy / Fabio P.S. Santos, Inbal Hazan-Halevy, and Zeev Estrov.
  • 2010 Springer
    Roy Zent, Ambra Pozzi, editors.
  • 2014 Springer
    W. Glenn McCluggage, John Tidy, John H.F. Smith.
    This book provides a comprehensive account of the cellular pathology of glandular lesions and uncommon neoplasms of the cervix and places these in a contemporary clinical context. The book features comprehensive, detailed descriptions and a consistent approach to each tumor or tumor-like condition with clear color illustrations. Cytological/histological correlation is emphasised and diagnostic pitfalls are highlighted. Cellular Pathology of Glandular Lesions and Uncommon Neoplasms of the Cervix is aimed at both trainee and consultant pathologists.
  • 2009 Springer
    Shireesh P. Apte, Rangaprasad Sarangarajan, editors ; foreword by Gregg L. Semenza.
  • 2010 Springer
    Peter D. Adams, John M. Sedivy, editors.
  • 2014 Springer
    César R. Lacruz, Javier Sáenz de Santamaría, Ricardo H. Bardales.
    The Essentials in Cytopathology book series fulfills the need for an easy-to-use and authoritative synopsis of site specific topics in cytopathology. These guide books fit into the lab coat pocket and are ideal for portability and quick reference. Each volume is heavily illustrated with a full color art program, while the text follows a user-friendly outline format. Central Nervous System Intraoperative Cytopathology covers the full spectrum of benign and malignant conditions of the CNS with emphasis on common disorders. The volume is heavily illustrated and contains useful algorithms that guide the reader through the differential diagnosis of common and uncommon entities encountered in the field of intraoperative neuro-cytopathology. Central Nervous System Intraoperative Cytopathology is a valuable quick reference for pathologists, cytopathologists, and fellows and trainees dealing with this exigent field.
  • 2012 Springer
    Diane Palmieri, editor.
    Introduction to brain metastasis / Diane Palmieri -- Molecular biology of brain metastasis / Stephan Woditschka ... [et al.] -- Brain microenvironment / Mami Noda -- Vascular permeability within brain metastases / Chris E. Adkins ... [et al.] -- Imaging experimental brain metastases / Amanda M. Hamilton and Paula J. Foster -- Possibilities of targeted therapies for brain metastasis / Frank Winkler -- Surgery for brain metastasis / Douglas L. Stofko, Robert J. Weil, and Steven A. Toms -- Is there a role for systemic chemotherapy in the treatment of brain metastases / Marc C. Chamberlain -- Radiation therapy of CNS metastases / DeeDee Smart -- Leptomeningeal metastasis / Priscilla K. Brastianos, Charilaos H. Brastianos, and April F. Eichler -- Quality of life with CNS metastasis / Lauren A. Chandler and Kathleen L. Fuchs.
  • 2012
    Joanna Y. Lee.
    Chromosomal translocations fusing genes that encode centrosome proteins and tyrosine kinases are frequently observed in myeloproliferative neoplasms (MPNs). Although the function of centrosome proteins in these fusions is not well understood, roles that may contribute to proliferative signaling including kinase centrosome localization and constitutive kinase dimerization have long been postulated. To test the relative contributions of localization and dimerization on kinase signaling efficiency, we targeted inducibly dimerizable FGFR1 to several subcellular locations and generated a centrosome localization mutant of the FOP-FGFR1 MPN fusion. Expression in mammalian tissue culture cells followed by substrate phosphorylation assays reveals a statistically significant decrease in kinase signaling effectiveness upon loss of FOP-FGFR1 centrosome localization. Interestingly, wild-type FOP-FGFR1 expression also caused a centrosome localization-dependent ciliogenesis defect. Further studies revealed that the fusion partner, FOP, localizes to centriolar satellites in addition to its previously described centrosomal localization. Centriolar satellites are granules clustered around the centrosome suspected to function in microtubule anchoring, protein trafficking, and ciliogenesis, though their precise function and composition remain unknown. Satellite localization is retained in the FOP-FGFR1 fusion and an increase in phosphotyrosine activity occurs at satellites in FOP-FGFR1 expressing cells. Given the importance of centriolar satellites in ciliogenesis, and the link between ciliogenesis and proliferative signaling, it is possible that increased phosphotyrosine activity at satellites is functionally significant in the progression of MPN. Finally, we assayed for ciliary signaling proteins in chronic myelogenous leukemia (CML) cells. Although FOP-FGFR1 causes a ciliogenesis defect, MPN affects blood cells, which have not been reported to contain cilia. We show here that, although CML cells do not appear to form a primary cilium, they contain masses of stabilized tubulin that co-localize with ciliary proteins. This may be evidence for a form of ciliary signaling in unciliated mammalian cells.
  • 2015 Springer Protocols
    edited by Daniel Keppler, Athena W. Lin.
    Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer / Zigui Chen, Luciana Bueno de Freitas, and Robert D. Burk -- Real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV genotyping extra assay for the detection and typing of human papillomavirus / M. Isabel Micalessi, Gaëlle A. Boulet, and Johannes Bogers -- Replication of human papillomavirus in culture / Eric J. Ryndock, Jennifer Biryukov, and Craig Meyers -- HPV binding assay to laminin-332/integrin [alpha]6[beta]4 on human keratinocytes / Sarah A. Brendle and Neil D. Christensen -- Methods to assess the nucleocytoplasmic shuttling of the HPV E1 helicase and its effects on cellular proliferation and induction of a DNA damage response / Michaël Lehoux, Amélie Fradet-Turcotte, and Jacques Archambault -- Genetic methods for studying the role of viral oncogenes in the HPV life cycle / Jason M. Bodily -- Robust HPV-18 production in organotypic cultures of primary human keratinocytes / Hsu-Kun Wang, Thomas R. Broker, and Louise T. Chow -- High-throughput cellular assay to quantify the p53- degradation activity of E6 from different human papillomavirus types / David Gagnon and Jacques Archambault -- Retroviral expression of human cystatin genes in HeLa cells / Crystal M. Diep, Gagandeep Kaur, Daniel Keppler, and Athena W. Lin -- Molecular analysis of human papillomavirus virus-like particle activated langerhans cells in vitro / Andrew W. Woodham, Adam W. Woodham, Adam B. Raff, Diane M. Da Silva, and W. Martin Kast -- Selective silencing of gene target expression by siRNA expression plasmids in human cervical cancer cells / Oscar Peralta-Zaragoza [and eleven others] -- Silencing of E6/E7 expression in cervical cancer stem- like cells / Wenyi Gu, Nigel McMillan, and Chengzhong Yu -- Two-step procedure for evaluating experimentally induced DNA damage : texas red and comet assays / Gina J. Ferris, Lauren B. Shunkwiler, and Charles A. Kunos -- Measurement of deubiquitinating enzyme Activity via a suicidal HA-Ub-VS probe / Colleen Rivard and Martina Bazzaro -- Immunocytochemical analysis of the cervical pap smear / Terry K. Morgan and Michelle Berlin -- Diagnosis of HPV-negative, gastric-type adenocarcinoma of the endocervix / Edyta C. Pirog -- Targeting of the HPV-16 E7 protein by RNA aptamers / Julia Dolores Toscano-Garibay, María Luisa Benítez-Hess, and Luis Marat Alvarez-Salas -- Use of MYBL2 as a novel candidate biomarker of cervical cancer / Cara M. Martin [and others] -- Fixation methods for the preservation of morphology, RNAs, and proteins in paraffin-Embedded human cervical cancer cell xenografts in mice / Yoko Matsuda and Toshiyuki Ishiwata -- Assessment of the HPV DNA methylation status in cervical lesions / Mina Kalantari and Hans-Ulrich Bernard -- MeDIP-on-chip for methylation profiling / Yaw-Wen Hsu, Rui-Lan Huang, and Hung-Cheng Lai -- Use of DBD-FISH for the study of cervical cancer progression / Elva I. Cortés-Gutiérrez [and four others] -- Quantitative and high-throughput assay of human papillomavirus DNA replication / David Gagnon, Amélie Fradet-Turcotte, and Jacques Archambault -- Native human papillomavirus production, quantification, and infectivity analysis / Jennifer Biryukov, Linda Cruz, Eric J. Ryndock, and Craig Meyers -- Functional analysis of HPV-like particle-activated langerhans cells in vitro / Lisa Yan, Andrew W. Woodham, Diane M. Da Silva, and W. Martin Kast -- Assessment of the radiation sensitivity of cervical cancer cell lines / Mayil Vahanan Bose and Thangarajan Rajkumar -- Mouse model of cervicovaginal papillomavirus infection / Nicolas Çuburu, Rebecca J. Cevio, Cynthia D. Thompson, and Patricia M. Day -- Establishment of orthotopic primary cervix cancer xenografts / Naz Chaudary, Karolina Jaluba, Melania Pintilie, and Richard P. Hill -- Generation of K14-E7/[delta]N87[beta] cat double transgenic mice as a model of cervical cancer / Gülay Bulut and Aykut Üren.
  • 2013
    Michelle Kathryn Zeman.
    Accurate maintenance and transmission of DNA from one cell to another is crucial for the propagation of a species, as accumulation of random mutations can result in loss of critical cellular functions. During DNA replication, DNA lesions encountered by the replication machinery cannot be repaired, as unwinding of the parental DNA separates the damaged DNA from the undamaged template which would normally be used for repair. These replication-blocking lesions can be seriously detrimental to the cell, as stalled replication forks can collapse into double-stranded DNA breaks and lead to genomic rearrangements. To prevent the accumulation of stalled and collapsed forks, the cell uses DNA damage tolerance (DDT) pathways to bypass the DNA lesion and complete replication. There are two known DDT pathways -- translesion synthesis, which uses specialized translesion synthesis polymerases to replicate directly over a DNA lesion, and template switching, which promotes invasion into the sister chromatid and extrusion of the newly synthesized strand for use as a template. These processes rely on a series of E3 ubiquitin ligases in mammalian cells, including Rad18, SHPRH, and HLTF. As a result, we wished to examine the role of ubiquitin modification, and ubiquitin-related SUMO modification, on the control of DDT. Together, the data presented here provide important new insight into how cells control the response to DNA damage and, importantly, how this response is repressed in the absence of damage. As misregulation of Rad18 and SHPRH, as well as several other DDT components, has been implicated in cancer development and progression, knowing more about this regulation may help us understand how cells avoid the generation of mutations, and ultimately the development of disease.
  • 2010 Springer
    edited by Zahid H. Siddik.
    1. Circuitry of Checkpoint Response -- Evasion of G1 Checkpoints in Cancer -- Distinct Pathways Involved in S-Phase Checkpoint Control -- Mechanisms of G2 Phase Arrest in DNA Damage-Induced Checkpoint Response -- 2. Checkpoint Response and the Aetiology of Cancer -- Chromatin Modifications and Orchestration of Checkpoint Response in Cancer -- DNA Damage Response and the Balance Between Cell Survival and Cell Death -- Dysfunction of the RB Retinoblastoma Gene in Cancer -- G1 Phase Cyclins in Cancer Development and Progression -- The BRCA1/2 Pathway Prevents Some Leukemias and Lymphomas in Addition to Breast/Ovarian Cancers: Malignancies that Overcome Checkpoint Controls -- 3. Targeting Checkpoint Response in Cancer Therapy -- Regulation of p53 Activity and Associated Checkpoint Controls -- The Importance of p53 Signaling in the Response of Cells to Checkpoint Inhibitors -- Targeting p21-Dependent Pathways for Cell Death in Cancer Therapy -- p27Kip1 as a Biomarker and Target for Treatment of Cancer -- Targeting Cyclin-Dependent Kinases with Small Molecule Inhibitors -- Chk1 and Chk2 as Checkpoint Targets -- Targeting Cdc25 Phosphatases in Cancer Therapy.
  • 2008 Springer
    edited by Wei Dai.
  • 2011 Springer
    Trevor M. Penning, Editor.
    Historical Overview of Chemical Carcinogenesis -- Multistage Carcinogenesis -- Tobacco Smoke Carcinogens and Lung Cancer -- Mechanisms of Estrogen Carcinogenesis: Modulation by Botanical Natural Products -- Heterocyclic Aromatic Amines: Potential Human Carcinogens -- Aflatoxin and Hepatocellular Carcinoma -- Metabolic Activation of Chemical Carcinogens -- Detoxication of Chemical Carcinogens and Chemoprevention -- Covalent Polycyclic Aromatic Hydrocarbon-DNA Adducts: Carcinogenicity, Structure, and Function --Oxidation and Deamination of DNA by Endogenous Sources -- Lipid Peroxide-DNA Adducts -- Chemical Carcinogenesis and Epigenetics -- Nucleotide Excision Repair from Bacteria to Humans: Structure-Function Studies -- Base-Excision Repair: Role of DNA Polymerase ss in Late-Stage Base Excision Repair -- O⁶-Alkylguanine-DNA Alkyltransferase -- Bypass DNA Polymerases -- Mutagenesis: The Outcome of Faulty Replication of DNA -- p53 and Ras Mutations in Cancer and Experimental Carcinogenesis.
  • 2006 CRCnetBASE
    David E. Thurston.
    Introduction to cancer -- Antimetabolites -- DNA-interactive agents -- Antitubulin agents -- Cell signaling inhibitors -- Hormonal therapies -- Tumour targeting strategies -- Biologicals -- The future -- Personalized medicine (oncogenomics) -- Adjunct therapies.
  • 2010 Springer
    edited by Robert B. Raffa, Ronald J. Tallarida.
    Short introduction and history / Robert B. Raffa -- Patient's perspective / Robert B. Raffa and Kathy Martin -- Oncology nurse's perspective / Jamie S. Myers -- Oncology pharmacist's perspective / Rachel Clark-Vetri -- The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas -- Oncology pharmacist's perspective / Rachel Clark-Vetri -- The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas -- Neurocognitive effects of childhood cancer treatment / Jennifer Costa -- The economic burden / Albert I. Wertheimer -- Designing conceptual model-based research in chemotherapy-related changes in cognitive function / Lisa M. Hess -- Neuropsychologic testing for chemotherapy-related cognitive impairment / Jamie S. Myers -- Imaging as a means of studying chemotherapy-related cognitive impairment / Robert B. Raffa -- Chemotherapy associated central nervous system damage / Jørg Dietrich -- Is systemic anti-cancer therapy neurotoxic? Does chemo brain exist? And should we rename it? / Sophie Taillibert -- Evaluation of multiple neurotoxic outcomes in cancer chemotherapy / Bernard Weiss -- Chemotherapy-related visual system toxicity / Robert B. Raffa -- The possible role of cytokines in chemotherapy-induced cognitive deficits / Jamie S. Myers -- Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy / Swati Nagar -- Combination analysis / Ronald J. Tallarida -- Animal models / Ellen A. Walker -- Chemo brain (chemo fog) as a potential side effect of doxorubicin administration : role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction / Christopher D. Aluise ... [et al.] -- Effects of 5-FU / Peter M. Wigmore ... [et al.] -- Future directions / Robert B. Raffa and Ronald J. Tallarida.
    Also available: Print – 2010
  • 2009 Springer
    Amy M. Fulton, editor.
  • v. 1-2, 2005. Springer Protocols
    v. 2, 2005 Springer Protocols
    edited by Rosalyn D. Blumenthal.
    v. 1. In vitro assays -- v. 2 In vitro models, imaging, and molecular regulators.
  • 2008 Ovid
    editor, Michael C. Perry.
    Scientific basis of cancer chemotherapy -- Norton-simon hypothesis -- Drug resistance -- Principles of chemotherapy -- Clinical trials -- Hematopoietic growth factors -- Biologic response modifiers: principles of biotherapy -- Intraventricular and intrathecal therapy -- Intraperitoneal chemotherapy -- Continuous intravenous infusion chemotherapy -- Intraarterial chemotherapy -- Isolated regional therapy -- Hematopoietic stem cell transplantation -- Oral toxicity -- Dermatologic toxicity -- Extravasation -- Hypersensitivity reactions -- Ocular side effects of chemotherapy -- Cardiotoxicity of cancer therapy -- Pulmonary toxicity of antineoplastic therapy -- Gastrointestinal complications of chemotherapy -- Hepatotoxicity of chemotherapeutic agents -- Renal and electrolyte abnormalities due to chemotherapy -- Chemotherapy-induced peripheral neuropathy -- Vascular toxicity of antineoplastic agents -- Second malignancies after chemotherapy -- Chemotherapy in pregnancy -- Gonadal complications and teratogenicity of cancer therapy -- Central venous access for chemotherapy -- Systemic therapy for advanced melanoma -- General issues in brain tumor chemotherapy -- Chemotherapy of head and neck cancer -- Chemotherapy of lung cancer -- Breast cancer -- Gastrointestinal cancer -- Endocrine tumors -- Chemotherapy of genitourinary cancers -- Chemotherapy of gynecologic cancers -- Chemotherapy of carcinoma of unknown primary site -- Chemotherapy of bone and soft tissue sarcomas -- Chemotherapy for pediatric solid tumors -- Chemotherapy of hodgkin's lymphoma -- Non-hodgkin's lymphoma -- Acute myeloid leukemia, acute lymphoblastic leukemia, and chronic lymphocytic leukemia -- Chemotherapy of the myelodysplastic syndromes -- Management of myeloproliferative disorders and chronic myeloid leukemia -- Chemotherapy of multiple myeloma and other plasma cell disorders.
  • 2010 Springer
    Domenico Ribatti.
  • 2012 CRCnetBASE
    David Rasnick.
    1. Introducing Cancer -- 2. Boveri's theory of cancer was ahead of its time -- 3. Genesis of "The enemy within"? -- 4. Gene mutation theory of cancer -- 5. The chromosomal imbalance theory of cancer -- 6. Theory of chromosomal imbalance solves mysteries and paradoxes -- 7. New perspectives for cancer prevention, diagnosis and therapy.
  • 2015 Springer
    B. Michael Ghadimi, Thomas Ried, editors.
    DNA repair and chromosomal translocations -- CINcere modelling: what have mouse models for chromosome instability taught us? -- Telomere dysfunction, chromosomal instability and cancer -- Genetic instability and disease progostication -- Causes of chromosomal instability -- Patterns of chromosomal aberrations in solid tumors -- Yeast as models of mitotic fidelty -- The diverse effects of complex chromosome rearrangements and chromothripsis in cancer development -- Consequence of aneuploidy in cancer: transcriptome and beyond.
  • 2005 Springer
    F. Caligaris-Cappio and R. Dalla-Favera (eds.).
  • 2016 Springer
    Rüdiger Hehlmann, editor.
  • 2010 Springer
    edited by Richard Greil, Lisa Pleyer, Viktoria Faber, Daniel Neureiter.
    This book comprises an in-depth view on the current knowledge of chronic clonal myeloid diseases. Special emphasis is laid on chronic myeloid leukaemia and a'classic' myeloproliferative disorders (essential thrombocythemia, polycythemia vera, and chronic idiopathic myelofibrosis) as well as myelodysplastic syndromes, oligoblastic leukemias, paroxysmal nocturnal hemoglobinuria and overlap diseases. Both young physicians in hematological training as well as practicing hematologists are addressed, with the aim of imparting a clear understanding of these disorders.
  • 2016 Springer
    Richard J. Cote, Ram H. Datar, editors.
    Preface -- Foreword -- Section I. Technologies for CTC Identification -- 1. Significance of Studying Circulating Tumor Cells -- 2. Affinity-Based Enrichment of Circulating Tumor Cells -- 3. Size-Based and Non-Affinity Based Microfluidic Devices for Circulating Tumor Cell Enrichment and Characterization -- 4. Molecular Assays for the Detection and Molecular Characterization of CTCs -- 5. Cancer Stem Cells and Circulating Tumor Cells Molecular Markers, Isolation Techniques and Clinical Implications -- Section II. Fundamental Studies of CTC -- 6. Circulating Tumor Cells and Tumor Dormancy.- 7. Prevention of Conversion of Tumor Dormancy into Proliferative Metastases -- 8. Genesis of Circulating Tumor Cells through Epithelial-Mesenchymal Transition as a Mechanism for Distant Dissemination -- Section III. CTC Analysis -- 9. CTC Analysis FISH, ISH, Array-CGH and Other Molecular Assays -- 10. Genome-Wide Gene Copy Number Analysis of Circulating Tumor Cells -- 11. Perspectives on the Functional Characterization and In Vitro Maintenance of Circulating Tumor Cells -- 12. Prognostic Implications of CTC in Breast Cancer -- Section IV. Potential Clinical Applications of CTC -- 13. CTC in Advanced Breast Cancer Prognosis, Monitoring and Clinical Utility -- 14. Evolution of Metastatic Disease: The Need for Monitoring and Emerging Therapeutic Opportunities -- 15. CTC for Biomarker and Companion Diagnostic Development -- 16. Perspectives on Clinical Applications of CTCs -- Index.
  • 2012 Springer
    edited by Frederick L. Greene, Andrzej L. Komorowski.
    The management of patients with thyroid cancers is a constantly changing field due to numerous developments in diagnostics and therapy. This book provides clinicians with up-to-date information on the current management of patients through all stages of their thyroid disease: from diagnosis of thyroid nodules through staging, extent and technique of surgery to adjuvant therapies, and follow-up schemes. The book is meant for medical students, residents and consultants in various disciplines, including otolaryngology, head and neck surgery and oncology.
  • 2011 Springer
    Stephen Kee, Julie Gehl, Edward W. Lee, editors.
    Introduction to Electroporation -- Electroporation and Cellular Physiology -- The Cell in the Electric Field -- Understanding Electric Fields for Clinical Use -- Generators and Applicators: Equipment for Electroporation -- Cell Electropermeabilization and Cellular Uptake of Small Molecules: The Electrochemotherapy Concept -- Vascular-Disrupting Action of Electrochemotherapy: Mode of Action and Therapeutic Implications -- Electrochemotherapy of Small Tumors; The Experience from the ESOPE (European Standard Operating Procedures for Electrochemotherapy) Group -- Electrochemotherapy for Larger Malignant Tumors -- Cell Electroporation in Bone Tissue -- Drug and Gene Electrotransfer to the Brain -- Minimally Invasive Intraluminal Tumor Ablation -- Electrotransfer of Plasmid DNA -- Gene Electrotransfer to Tumor -- Gene Electrotransfer to Lung -- Gene Electrotransfer to Muscle Tissue: Moving into Clinical Use -- Gene Electrotransfer to Skin -- Electroporation-Mediated DNA Vaccination -- Irreversible Electroporation (IRE) on Liver Tumor Ablation: A Summary of Preclinical Translational Research -- Translational Research on Irreversible Electroporation: VX2 Rabbit Head and Neck -- Clinical Research on Irreversible Electroporation of the Liver.
  • 2014 Springer
    Can Baykal ; K. Didem Yazganoğlu.
    Skin tumors are very often encountered in clinical practice but can be difficult to diagnose since the skin's histological complexity gives rise to many types and subtypes. This superb atlas presents an unrivalled wealth of original high-quality clinical photographs of almost all benign and malignant skin tumors. The diverse subtypes and clinical forms, including different localizations, are depicted, and careful attention is paid to evolution and follow-up. While the main focus is on the clinical presentation as reflected in the photographs, diagnostic clues and management considerations are also summarized in a straightforward, readily understandable way. The atlas has been designed so that it will meet clinical needs and allow rapid identification of clues relevant to daily practice. Clinical Atlas of Skin Tumors will be valuable for all dermatologists in training, as well as for those who are already established in the profession or in allied specialties such as plastic surgery and oncology.
  • 2007 Ovid
    Gilda Cardeñosa.
    My Aunt Minnie -- Screening -- Diagnostic breast imaging -- Management.
  • 2012 Wellcome Trust
    edited by E.M. Jones and E.M. Tansey.
    Transcript / edited by E M Jones and E M Tansey -- Appendix 1. Timeline for UK Clinical Cancer Genetics Groups -- Appendix 2. Archival material from St Mark's Polyposis Registry -- Register cards / interpreted by Ms Kay Neale -- Letter from Dr C Dukes to Dr J C Burne -- Adaptation of poem, You Are Old Father William / by Dr C Dukes -- Obituary for Dr H J R Bussey / by Basil Morson -- Appendix 3. Pedigree of a Newfoundland family, 'Family C', with HNPCC -- Appendix 4. -- Cancer Genetics: a personal view / Professor David Harnden -- Glossary -- Biographical notes.
  • 2011 Springer
    Hans-Jörg Senn, Florian Otto, editors.
    The main themes in this volume are the latest advances in the prevention of breast and prostate cancer and the role of infection in the development of liver and gastric cancer. Special emphasis is given to perspectives on the chemoprevention of breast cancer.
  • 2016 Springer
    Sharad P. Paul, Robert A. Norman, editors.
    1. Skin cancer of the ear: mastoid interpolation flap reconstruction tips -- 2. One technique fits all: the versatility of the full thickness graft on the lateral wall of the nose -- 3. Islands on the cheek: island flaps on the cheek and a modified oblique-sigmoid flaps -- 4. Rotation flaps of the scalp: study of the design, planning and biomechanics of single, double and triple pedicle flaps -- 5. Double-advancement 'H' flaps for very large defects of the forehead: design, planning and the use of sub-periosteal dissection to increase mobility -- 6. The modified rhomboid flap: an improvement on the traditional technique and its use in defects of the Ala Nasi --7. The keystone design perforator island flap: an easy option for the lower limb, but how does it actually work? -- 8. Amelanotic malignant melanoma of the toe presenting as an ulcer: management and biopsy guidelines -- 9. Revisiting the halo graft: why does it heal faster when compared to conventional split-skin grafts? -- 10. Balloon cell nevi and balloon cell melanomas: what are they? -- 11. Tropical treatment of skin cancers and the risks of 'figting fire and fire' -- 12. When a lipoma wasn't a lipoma: a discussion about granular cell tumors of skin -- 13. How small is small for a melanoma? -- 14. Multiple basal cell carcinomas and superficial radiotherapy (SRT) -- 15. Adenocystic carcinoma -- 16. Sebaceous carcinoma -- 17. Metastatic cutaneous adenocarcinoma -- 18. Zosteriform cutaneous metastasis -- Index.
  • 2013 Springer
    Dan Lipsker.
    Conceived as a guide for practitioners in their work in dermatology, this book is unique in its approach. From cutaneous signs to the richness of differential diagnosis, it guides practitioners through every step, from semiological analysis to diagnosis. The aim is to provide readers with the essentials of relevant dermatological reasoning. The first part of the book focuses on physical examination and on recognizing basic lesions, the practitioners building blocks. The diseases requiring understanding are then described in the form of a richly illustrated atlas, in which each diagram has been chosen as an exemplary educational tool. In the final part, differential diagnosis is proposed in the form of various tables summarizing the different cutaneous signs, providing readers with a complete toolkit to assist with diagnosis. This book will give trainee dermatologists, general physicians and internists the knowledge they need to identify basic lesions and a complete and detailed overview of the various diseases they are likely to encounter. At the same time, experienced dermatologists will find this book a valuable reference work for differential diagnosis.
  • 2012 ScienceDirect
    2012 ClinicalKey
    [edited by] Philip J. Di Saia, William T. Creasman ; associate editors, Robert S. Mannel, D. Scott McMeekin, David G. Mutch.
    Preinvasive disease of the cervix / William T. Creasman -- Preinvasive disease of the vagina and vulva and related disorders / Joan L. Walker and Cara A. Mathews -- Invasive cervical cancer / Krishnansu S. Tewari and Bradley J. Monk -- Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer / Lisa M. Landrum, Rosemary E. Zuna, and Joan L. Walker -- Adenocarcinoma of the uterine corpus / William T. Creasman and David Scott Miller -- Sarcoma of the uterus / D. Scott McMeekin -- Gestational trophoblastic disease / Emily M. Ko and John T. Soper -- Invasive cancer of the vulva / Jeanne M. Schilder and Frederick B. Stehman -- Invasive cancer of the vagina / Brian M. Slomovitz and Robert L. Coleman -- The adnexal mass / D. Scott McMeekin, Robert Mannel, and Philip J. Disaia -- Epithelial ovarian cancer / Eric L. Eisenhauer, Ritu Salani, and Larry J. Copeland -- Germ cell, stromal, and other ovarian tumors / Michael A. Bidus, John C. Elkas, and G. Scott Rose -- Fallopian tube cancer / Michael A. Bidus, G. Larry Maxwell, and G. Scott Rose -- Breast diseases / Mary L. Gemignani -- Cancer in pregnancy / Krishnansu S. Tewari -- Complications of disease and therapy / Daniel L. Clarke-Pearson -- Basic principles of chemotherapy / Christina S. Chu and Stephen C. Rubin -- Targeted therapy and molecular genetics / Shannon N. Westin, Anil K. Sood, and Robert L. Coleman -- Genes and cancer : genetic counseling and clinical management / David G. Mutch and Philip J. DiSaia -- Palliative care and quality of life / Dana M Chase ... [et al.] -- Role of minimally invasive surgery in gynecologic malignancies / Jeffrey M. Fowler, David E. Cohn, and Robert S. Mannel -- Epidemiology of commonly used statistical terms and analysis of clinical studies / Wendy R. Brewster -- Basic principles in gynecologic radiotherapy / Catheryn M. Yashar.
  • 2013 ClinicalKey
    Stephen T. Kee, Ravi Murthy, and David C. Madoff.
    Principles of embolization -- Principles of percutaneous ablative therapies -- Principles of isolated regional perfusion of the extremity or liver -- Principles of radiotherapy -- Tumor response for image-guided interventions: ASSESSMENT AND VALIDATION -- Trends in basic science research in interventional radiology: NANOTECHNOLOGY, STEM CELL, RNAi, AND RADIOGENOMICS -- Surgical management of hepatocellular carcinoma -- Interventional management of hepatocellular carcinoma -- Systemic therapy in advanced hepatocellular carcinoma -- Cholangiocarcinoma: Diagnosis, management, and prognosis -- Percutaneous management of cholangiocarcinoma -- The multidisciplinary management of liver metastases in colorectal cancer -- Surgical management of hepatic metastases -- Interventional radiology in the management of colorectal cancer liver metastases -- Gastroenteropancreatic neuroendocrine tumors -- Interventional oncology management of noncolorectal and nonneuroendocrine hepatic metastatic disease -- Percutaneous management of renal tumors -- Interventional strategies in the treatment of gynecologic cancers -- Image-based interventional therapies for benign uterine neoplasms -- Prostate cancer intervention -- Imaging of head and neck cancer -- Transcatheter chemotherapy for malignancies in the brain, head, and neck -- Head: Intracranial - gliomas, and meningiomas and extracranial - orbits, internal auditory canals, and skull base -- Primary lung carcinoma -- Metastatic disease -- Percutaneous musculoskeletal biopsy -- Musculoskeletal interventions for benign bone lesions -- Ablation of musculoskeletal metastatic lesions including cementoplasty -- Vertebroplasty and kyphoplasty in malignant vertebral fracture -- Intraarterial procedures for the musculoskeletal system.
  • 2008 Springer
    edited by Ronald M. Bukowski, and Andrew C. Novick.
  • 2013 Future Med
    editors, Kennichi Kakudo, Zhiyan Liu.
    Clinical management of thyroid cancer / Kennichi Kakudo & Zhiyan Liu -- Diagnosis of thyroid cancer / Joseph M. Shulan & Jennifer A. Sipos -- Thyroid cancer : classification and cytological diagnosis / Zvonimir L. Milas, Jennifer Brainard & Mira Milas -- Molecular genetics of thyroid cancer / Angela Greco, Claudia Miranda, Maria Grazia Borrello & Marco A. Pierotti -- Etiopathogenic factors of thyroid cancer / Ana Lourenço Almeida, Paula Boaventura & Paula Soares -- Differentiated thyroid carcinoma: prognostic stratification and molecular classification / Michele N. Minuto, Emanuela Varaldo & Giuseppina Talamo -- Radiotherapy : radioiodine and external beam irradiation treatment of differentiated thyroid carcinomas / Miguel Melo, Gracinda Costa, Francisco Carrilho, Manuela Carvalheiro & Paula Soares -- Borderline lesions in thyroid tumor classification and well-differentiated tumor of uncertain malignant potential Zhiyan Liu, Bo Han, Yanhua Bai, Yaqiong Li, Osamu Nunobiki & Kennichi Kakudo -- Differentiated thyroid cancer in children / Andrew J. Bauer, Catherine A. Dinauer, Steven G. Waguespack & Gary L. Francis -- Index.
  • 2015 Wiley
    [edited by] Antonella Surbone, Michael Rowe.
    Introduction to oncology and medical errors / Antonella Surbone and Michael Rowe -- Recognizing and facing medical errors : the perspective of a physician who is also patient / Itzhak Brook -- Psychological and existential consequences of medical error for oncology professionals / Mary J. Chalino, Evelyn Y.T. Wong, Bradley l. Collins, and Richard T. Penson -- To sue or not to sue : restoring trust in patient-doctor-family relationships / Michael Rowe and Antonella Surbone -- Prevention of errors and patient safety : oncology nurses' perspectives / Martha Polovich -- Prevention of errors and patient safety from the oncologists perspective / Meghan E.S. Shea, Nie Bohlen, and Inga T. Lennes -- Disclosing harmful medical errors / Walter Baile and Daniel Epner -- Do cross-cultural differences influence the occurrence and disclosure of medical errors in oncology / Lidia Schapira, Joseph R. Betancourt, and Alexander R. Green -- Prevention of errors and patient safety : institutional perspectives / Eric Manheimer -- Professional and ethical responsibilities in adverse events and medical errors : discussions when things go wrong / P.M. Forde and Albert W. Wu -- Medical error and patient advocacy / Juanne N. Clarke -- Conclusion : the "given" and "therefores" of clinical oncology and medical errors / Antonella Surbone and Michael Rowe.
  • 2014 Springer
    Arun D. Singh, Bertil Damato, editors.
    1. Principles of Clinical Epidemiology / Annette C. Moll, Michiel R. de Boer, Lex M. Bouter, and Nakul Singh -- 2. Etiology of Cancer / Brian T. Hill -- 3. Cancer Pathology / Katarina Bartuma, Charlotta All-Ericsson, and Stefan Seregard -- 4. Cancer Angiogenesis / Werner Wackernagel, Bela Anand-Apte, and Arun D. Singh -- 5. Immunology of Ocular Tumors / Martine J. Jager and Inge H.G. Bronkhorst -- 6. Cancer Genetics / J.William Harbour and Daniel L. Chao -- 7. Cancer Staging / Paul T. Finger -- 8. Principles of Cryotherapy / Dan S. Gombos -- 9. Principles of Laser Therapy / Stefan Sacu and Ursula Schmidt-Erfurth -- 10. Principles of Radiation Therapy / Abigail L. Stockham, Ehsan H. Balagamwala, Roger Macklis, Allan Wilkinson, and Arun D. Singh -- 11. Ocular Complications of Radiotherapy / Mitchell Kamrava, James Lamb, and Tara A. McCannel -- 12. Principles and Complications of Chemotherapy / Michael G. Levien, Nicola G. Ghazi, and Arun D. Singh -- 13. Targeted Therapy and Their Ocular Complications / Denis Jusufbegovic, Pierre L. Triozzi, and Arun D. Singh -- 14. Counseling Patients with Cancer / Laura Hope-Stone and Bertil Damato -- 15. Cataract Associated with Intraocular Tumors / Carlos A. Medina, Mary E. Aronow, and Arun D. Singh -- 16. Tumor-Associated Glaucoma / Reena S. Vaswani, Kathryn Bollinger, Annapurna Singh, and Arun D. Singh -- 17. Graft-Versus-Host Disease / Edgar M. Espana, Sejal Shah, and Arun D. Singh -- 18. Uveal Tumors: Diagnostic Techniques: Angiography / Kaan Gunduz, Jessica A. Adefusika, Thomas P. Link, and Jose S. Pulido -- 19. Diagnostic Techniques: Optical Coherence Tomography / Rubens Belfort, Andre Romano, Eduardo Rodrigues, and Arun D. Singh -- 20. Diagnostic Techniques: Autofluorescence / Edoardo Midena, Elisabetta Pilotto, and Raffaele Parrozzani -- 21. Diagnostic Techniques: Ophthalmic Ultrasonography / Brandy Hayden Lorek, Mary E. Aronow, and Arun D. Singh.
  • 2014 Springer
    edited by Jacob Peʼer, Arun D. Singh.
    Written by internationally renowned experts, Clinical Ophthalmic Oncology provides practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. The book supplies all of the state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible. Using the information provided, readers will be able to: Provide effective patient care using the latest knowledge on all aspects of ophthalmic oncology. Verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations. Locate required information quickly owing to the clinically focused and user-friendly format. In this volume, the examination techniques, classification, and differential diagnosis of eyelid tumors and conjunctival and corneal tumors are carefully explained, and treatment options are considered in detail.
  • 2014 Springer
    Julian D. Perry, Arun D. Singh, editors.
    Written by internationally renowned experts, Clinical Ophthalmic Oncology provides practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. The book supplies all of the state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible. Using the information provided, readers will be able to: Provide effective patient care using the latest knowledge on all aspects of ophthalmic oncology. Verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations. Locate required information quickly owing to the clinically focused and user-friendly format. This volume describes the classification, differential diagnosis, and imaging of orbital tumors and discusses the most suitable treatment options for different tumor types.
  • 2014 Springer
    Arun D. Singh, Bertil Damato, editors.
    Written by internationally renowned experts, Clinical Ophthalmic Oncology provides practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. The book supplies all of the state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible. Using the information provided, readers will be able to: Provide effective patient care using the latest knowledge on all aspects of ophthalmic oncology. Verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations Locate required information quickly owing to the clinically focused and user-friendly format. In this volume guidance is provided on diagnosis and therapy for retinal tumors including vitreoretinal lymphoma and paraneoplastic disorders.
  • 2015 Springer
    Arun D. Singh, A. Linn Murphree, Bertill E. Damato, editors.
    Evaluation and Diagnosis -- Leukocoria: Differential Diagnosis -- Staging and Grouping -- Epidemiologic Aspects -- International Perspective -- Tumorigenesis -- Retinocytoma or Retinoma -- Genetic Counseling and Testing -- Treatment Options -- Focal Therapy -- Intravenous Chemotherapy -- Intra-Arterial Chemotherapy -- Intravitreal Chemotherapy -- Teletherapy -- Enucleaton -- Histopathologic Features and Risk Factors -- Orbital Retinoblastoma -- Metastatic Disease -- Non Ocular Tumors -- Trilateral Retinoblastoma -- Children's Oncology Group (COG) Trials for Retinoblastoma.
  • 2014 Springer
    Bertil Damato, Arun D. Singh, editors.
    "This volume, devoted solely to uveal tumors, explains the various diagnostic and biopsy techniques that may be used and describes the therapeutic options of potential value for different types of tumor."--Publisher's website.
  • 2014 Wiley
    edited by Sing Yu Moorcraft, Daniel L.Y. Lee, David Cunningham.
  • 2016 ClinicalKey
    senior editors, Leonard L. Gunderson, Joel E. Tepper ; associate editors, Jeffrey A. Bogart [and 7 others].
    Perfect for radiation oncology physicians and residents needing a multidisciplinary, treatment-focused resource, this updated edition continues to provide the latest knowledge in this consistently growing field. Not only will you broaden your understanding of the basic biology of disease processes, you'll also access updated treatment algorithms, information on techniques, and state-of-the-art modalities. The consistent and concise format provides just the right amount of information, making Clinical Radiation Oncology a welcome resource for use by the entire radiation oncology team. Content.
  • 2008 Springer
    Alan List.
  • 2011 Springer
    [edited by] Alexis Jacquier.
    This book, unique in focusing specifically on cardiac masses, is the result of cooperation among a number of teams of radiologists working under the aegis of the French Society of Cardiovascular Imaging (SFICV). Its goal is to 1) review the different CMR sequences and CT acquisition protocols used to explore cardiac masses, 2) to demonstrate the several CMR and MDCT features of cardiac masses. It has been designed as a teaching tool and offers a fully illustrated compendium of clinical cases, tables summarizing data, and decision-making trees essential in everyday practice. It is presented as a practical handbook and can be either read cover to cover or consulted whenever needed during a cardiac imaging assignment. The book is intended for all students and experienced practitioners, whether radiologists or not, who are interested in cardiac or thoracic pathology.
  • 2009 Springer
    Erwin G. Van Meir, editor.
    Covers three areas of research in brain tumors: a) animal models for brain tumors, including spontaneous occurrence of brain tumors in mammals, transgenic models in rodents and transplant models; b) Prognostic factors and biomarkers; c) Therapeutic targets and targeting approaches to brain tumors.
  • 2014 Springer
    Alan Lichtin, John Bartholomew, editors.
    There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrand's disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP). The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field's most recent developments. This "case-directed" book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted with a coagulation consult, students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology.
  • 2009 Springer
    edited by David Green, Hau C. Kwaan.
    Also available: Print – 2009
  • 2006 IARC
    Metallic cobalt particles (with or without tungsten carbide) -- Introduction to the monographs on gallium arsenide and indium phosphide. Studies of cancer in humans -- Gallium arsenide -- Indium phosphide -- Vanadium pentoxide.
    Also available: Print – 2006
  • 2016 Springer
    Masato Kusunoki, editor.
  • 2016 Springer
    Andreas Böhler.
    In this thesis, a tracking system was developed by modifying an add-on collimator, the Siemens Moduleaf, for realtime applications in radiotherapy. As the add-on collimator works almost completely autonomously of the linear accelerator (LinAc), no modifications to the latter were necessary. The adaptations to the Moduleaf were mainly software-based. In order to reduce the complexity of the system, outdated electronic parts were replaced with newer components where practical. Verification was performed by measuring the latency of the system as well as the impact on applied dose to a predefined target volume, moving in the leaf's travel direction. Latency measurements in software were accomplished by comparing the target and current positions of the leaves. For dose measurements, a Gafchromic EBT2 film was placed beneath the target 4D phantom, in between solid water plates, and moved alongside with it. Based on the results, a tracking-capable add-on collimator seems to be a useful tool for reducing the margins for the treatment of small, slow-moving targets. Radiotherapy is one of the most important methods used for the treatment of cancer. Irradiating a moving target is also one of the most challenging tasks to accomplish in modern radiotherapy.
  • 2015 Springer
    Omer Engin, editor.
    This book explains clearly the nature of colon polyps and their relationship with colorectal cancer, which is among the three most common cancers in both men and women. Up-to-date information is provided on anatomy, pathology, types of polyp and their treatment, and the performance of colonoscopy. Particular attention is devoted to the risk factors for development of colorectal cancer, with detailed guidance on its prevention and early diagnosis and treatment. While the book is primarily intended for medical specialists and students, a deliberate and consistent effort has been made to use plain language that will enable other interested persons, including patients, to understand all aspects of the subject.
  • 2007 Springer
    edited by H.P. Soyer ... [et al.].
  • 2009 Springer
    edited by M.A. Hayat.
  • 2010 ClinicalKey
    edited by Susan L. Gearhart, Nita Ahuja.
    Epidemiology and risk factors of colorectal cancer / Kathryn M. Chu -- Presentation and initial evaluation of colorectal cancer / Susan Tsai and Susan L. Gearhart -- Hereditary colorectal cancer and polyp syndromes / Francis M. Giardiello -- Genetic screening / Cheryl J. Pendergrass -- Behavior and dietary modification in the prevention of colon cancer / Stephanie Downing, Emmanouil P. Pappou, and Nita Ahuja -- Chemoprevention of colorectal cancer / Melissa A. Munsell and Francis M. Giardiello -- Fecal occult blood test / Michel A. Kafrouni and John H. Kwon -- Colonoscopy and flexible sigmoidoscopy in colorectal cancer screening and -- Surveillance / Michelle N. Zikusoka and John H. Kwon -- Stool and blood sampling for early detection of colorectal cancer / Jason K. Sicklick and Nita Ahuja -- Radiologic techniques : virtual colonoscopy / Karen M. Horton -- Preoperative evaluation / Jerry Stonemetz, Nicole A. Phillips, and Susan L. Gearhart -- Limited resection : indications, techniques, and outcomes of transanal excision and -- Transanal endoscopic microsurgery / Elizabeth C. Wick -- Minimally invasive techniques : indications, techniques, and outcomes / Susan L. Gearhart -- Endoscopic techniques in colorectal neoplasia / Eun i. Shin and Samuel A. Giday -- Open surgical techniques in colorectal cancer / Vanita Ahuja -- Systemic therapy for colon cancer / Khaled El-Shami, Sujatha Nallapareddy, and Wells Messersmith -- Radiation therapy for colorectal adenocarcinoma : external beam and intraoperative -- Radiation therapy / Joseph M. Herman and Timothy M. Pawlik -- Surveillance and follow-up / Matthew T. Hueman and Nita Ahuja -- Clinical trials : why participate? / Jamila Mwidau and David Chang -- Vaccines and immunotherapy / Ajay Jain and Richard Schulick -- Genetic profiling in colorectal cancer / Debashish Bose and Nita Ahuja -- Coping with colorectal cancer / Eden R. Stotsky.
  • 2007 Springer
    edited by Leonard B. Saltz.
    Molecular biology of colon cancer / William M. Grady -- Chemoprevention of colorectal cancer / Yu-Ning Wong ...[et al.] -- Colorectal cancer screening and surveillance / Arnold J. Markowitz -- Cytotoxic chemotherapy for metastatic colorectal cancer / M. Wasif Saif, Richard Kim, and Edward Chu -- Integration of antiangiogenic strategies in colorectal cancer treatment / John M. Strother and Charles D. Blanke -- The role of EGFR inhibition in colorectal cancer / Nabeel Shalan and Paulo M. Hoff -- Second-line strategies in the treatment of patients with metastatic colorectal cancer / Anthony B. El-Khoueiry and Heinz-Josef Lenz -- Adjuvant chemotherapy for colon cancer / Bert H. O'Neil ... [et al.] -- Management of locally advanced rectal cancer / Yu Jo Chua and David Cunningham -- Rationale for adjuvant and neoadjuvant chemotherapy in the resection of liver metastases / Axel Grothey and Steven A. Alberts -- Percutaneous radiofrequency ablation in the management of patients with colorectal cancer / Karen Brown -- Colorectal cancer imaging / Sean D. Curran and Laurence H. Schwartz -- Nursing issues in colorectal cancer chemotherapy / Ellen Hollywood and Deborah Semple -- Pain management in the colorectal cancer patient / Vivek Tim Malhotra -- Novel agents and new paradigms for colorectal cancer / Chris Takimoto and Russell Kruzelock.
  • 2014 Wiley
    edited by John H. Scholefield, Cathy Eng.
    Epidemiology / Mala Pande and Marsha L. Frazier -- Screening for colorectal cancer / Robert J.C. Steele and Paula MacDonald -- Management of adenomas / Sunil Dolwani, Rajvinder Singh, Noriya Uedo and Krish Ragunath -- How histopathology affects the management of the multidisciplinary team / Dipen Maru -- Radical colonic resection / Kenichi Sugihara, Yusuke Kinugasa, Shunsuke Tsukamoto -- Extralevator abdominoperineal excision (ELAPE) for advanced low rectal cancer / Brendan J. Moran and Timothy J. Moore -- Neoadjuvant therapy without surgery for early stage rectal cancer? / Thomas D. Pinkney, Simon P. Bach -- Minimally invasive surgery for rectal cancer and robotics / David Jayne & Gregory Taylor -- Surgery for anal cancer / John H. Scholefield -- Controversies in adjuvant chemotherapy / Stephen Staal, Carmen Allegra -- Long versus short course radiotherapy for rectal cancer / Manisha Palta, Christopher Willett & Brian Czito -- More treatment is not necessarily better, limited options for chemotherapeutic radiosensitization / Daedong Kim -- Controversies in advanced disease/surgical approaches for metastatic resection / Amanda B. Cooper, Thomas A. Aloia, Jean-Nicolas Vauthey, Steven A. Curley -- Controversies in chemotherapy in advanced colorectal cancer / Ludmila Katherine Martin and Tanios Bekaii-Saab -- What is the role of surveillance for colorectal cancer? / Daedong Kim -- The younger patient with colorectal cancer : genetic counseling discussion / Sarah A. Bannon, Maureen E. Mork and Miguel A. Rodriguez-Bigas -- Best practices of supportive care while receiving chemotherapy : anti-emetics, diarrhea, anorexia, dermatologic recommendations / Maura Polansky -- Palliative care vignettes / Jenny Wei and Egidio Del Fabbro.
  • 2013 Springer
    Kok-Yang Tan, editor.
    As the population ages, clinicians are facing an increasing number of elderly patients with colorectal cancer. Disease management in these patients poses a unique challenge as they have more comorbidities and lower functional reserves. In addition, the treatment goals may differ from those in younger patients. Appropriate management of elderly patients demands a greater understanding of not only the physiological changes but also issues related to the delivery of holistic care. This book discusses in depth the different aspects of management of colorectal cancer in the elderly. After the provision of pertinent background information on the normal physiology of aging, screening and diagnosis are discussed. Subsequent chapters focus on a range of issues associated with the surgical and perioperative care of these patients and with adjuvant treatment and palliative care. Each chapter provides helpful take-home messages in bullet point form, and numerous informative figures and tables are also included. The authors are surgeons, physicians, anesthetists, geriatricians, oncologists, and allied health professionals with extensive experience in the field.This book discusses in depth the different aspects of management of colorectal cancer in the elderly. After the provision of pertinent background information on the normal physiology of aging, screening and diagnosis are discussed. Subsequent chapters focus on a range of issues associated with the surgical and perioperative care of these patients and with adjuvant treatment and palliative care. Each chapter provides helpful take-home messages in bullet point form, and numerous informative figures and tables are also included. The authors are surgeons, physicians, anesthetists, geriatricians, oncologists, and allied health professionals with extensive experience in the field.
  • 2011 Springer
    Joseph C. Anderson, Charles J. Kahi, editors.
    Colorectal cancer pathways / Petr Protiva -- Risk factors and screening for colorectal cancer / Joseph C. Anderson -- Hereditary adenomatous colorectal cancer syndromes / Maqsood Khan and Carol A Burke -- Screening and surveillance guidelines / Robert J. Chehade and Douglas J. Robertson -- Barriers to colorectal cancer screening : patient, physician, and system factors / Catherine R. Messina -- Screening for colorectal cancer using colonoscopy / Douglas K. Rex -- New colonoscopic technologies for colorectal cancer screening / Douglas K. Rex -- Screening for CRC using CT colonography / Brooks D. Cash -- Noninvasive screening tests / Nabil Fayad and Thomas F. Imperiale -- Removal of difficult colon polyps / Jerome Waye -- Screening for colorectal cancer in the elderly / Charles J. Kahi -- Chemoprevention / Jeffrey Singerman and Petr Protiva.
  • 2015 Springer
    Aasma Shaukat, John I. Allen, editors.
  • 2013
    Mihalis S. Kariolis.
    Ligand-receptor interactions and the specific molecular recognition events that define them govern many important physiological processes. When these interactions become dysregulated, normal physiology quickly degenerates into disease states. Nowhere is this more evident than in metastatic cancer, where aberrant signaling drives uncontrolled cell growth and systemic dissemination of disease. In spite of much effort, the management of metastatic disease has largely remained an intractable clinical challenge as effective treatment options are limited. Protein-based biologics, which leverage the inherent affinity and specificity of protein-protein interactions, offer an effective strategy for targeting and modulating dysregulated disease pathways in order to bring them under control. In this dissertation, we use combinatorial and rational protein engineering methods to develop receptor-based therapeutics that target Axl, a receptor tyrosine kinase shown to be involved in driving metastasis and disease progression in a wide range of human cancers. Using yeast-surface display and directed evolution, Axl variants were engineered for improved binding to Gas6, Axl's activating ligand. To gain an understanding of the molecular basis of the increased binding, detailed biochemical and structural studies were performed, including solving the structure of a high affinity Axl variant in complex with Gas6. When reformatted for in vivo applications, the engineered Axl decoy receptors were found to have apparent affinities to Gas6 as low as 93 fM, which are among some of the strongest protein-protein interactions ever reported. Importantly, when tested in a panel of aggressive mouse models of metastatic disease, the engineered decoy receptors showed significant efficacy, reducing metastatic disease by up to 95%. Collectively, these results validate Axl as a therapeutic target in metastatic disease and highlight the potential clinical value of the engineered Axl decoy receptors as novel anti-metastatic therapies.
  • 2007 IARC
    Also available: Print – 2007
  • 2014 CRCnetBASE
    John F. Smyth.
    Diagnosis and staging -- Primary treatment -- Communication within the context of multidisciplinary care -- Explaining follow-up -- Progression and terminal -- Explaining research -- Complementary and alternative medicines and integrative oncology.

Access restricted to Stanford community

Shortcut to Licensed Content

Lane Gateway to Licensed Content

TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.

What is it?

Lane Gateway to Licensed Content

Bookmark on Other Websites

Bookmark on Lane

  • TO INSTALL, RIGHT CLICK this button.
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page
TO INSTALL, RIGHT CLICK this button.

What is it?

A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.

Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.

MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed Plus is a clinical information resource used by physicians to answer clinical questions quickly and easily at the point of care. Topics are updated daily as new evidence becomes available.Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialtiesProvides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.

Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.

Includes cited reference searching, citation maps, and an analyze tool.

Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.

Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.

Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.

In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.

A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.

A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.

Over 10,000 notes outline the status of specific infections within each country.

Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.

Provides online, full-text access to Springer's journal titles as well as journals from other publishers.

Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.

Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.

Stanford Medicine

Lane Medical Library

CONTACT US